Investigating Mammalian Unfolded Protein Response: The Physiology And Regulatory Mechanisms Of Ire1Alpha-Xbp1 Signaling by He, Yin
	   
INVESTIGATING MAMMALIAN UNFOLDED PROTEIN RESPONSE:  
THE PHYSIOLOGY AND REGULATORY MECHANISMS OF  
IRE1α-XBP1 SIGNALING  
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
by 
Yin He 
May 2013 
	  	  
 
 
 
 
 
 
 
 
 
 
 
© 2013 Yin He 
 
	  	  
INVESTIGATING MAMMALIAN UNFOLDED PROTEIN RESPONSE: 
THE PHYSIOLOGY AND REGULATORY MECHANISMS OF  
IRE1α-XBP1 SIGNALING  
 
Yin He, Ph.D. 
Cornell University 2013 
 
 The endoplasmic reticulum (ER) serves as the site of protein synthesis, 
folding, maturation, modification, secretion, and degradation for approximately 
one-third of the proteome. Disruptions in ER homeostasis activate an ER-to-
nucleus signaling pathway termed the unfolded protein response (UPR). The 
IRE1α-XBP1 pathway is the most conserved arm of UPR and upon activation, 
acts to restore ER homeostasis. Significantly, IRE1α-XBP1 dysfunction has been 
implicated in the development and pathogenesis of protein-misfolding diseases. 
Although the general events underlying mammalian IRE1α-XBP1 activation and 
signaling have been reported, the mechanistic details remain unclear.  
 In addition to serving as a critical arm of UPR signaling, the IRE1α-XBP1 
pathway was essential and indispensable for differentiation of pre-adipocytes 
into mature fat cells. Upon adipogenesis, C/EBPβ, a key initiator of the 
adipogenic program, was shown to bind to the proximal promoter of the Xbp1 
gene and induce its expression. XBP1, an essential UPR transcription factor, was 
required for the subsequent modulation of C/EBPα, an adipogenic protein 
critical for maintaining the differentiated state. Interestingly, adipogenic 
differentiation was associated with a low degree of physiological UPR required 
	  	  
for IRE1α activation and Xbp1 splicing. These novel findings positioned the 
IRE1α-XBP1 pathway as a critical modulator of the transcriptional cascade 
underlying adipocyte differentiation, thus supporting the notion of UPR in 
metabolic dysfunction.  
 To further understand the activation mechanism of IRE1α, a proteomics-
based mass spectrometry screen was performed to uncover novel IRE1α-
interacting factors that may play a role in regulating its activation and signaling. 
Non-muscle myosin IIB (NMIIB), a component of the cytoskeleton machinery, 
was identified and shown to interact specifically with IRE1α in an ER stress-
dependent manner. NMIIB was further characterized to be required for IRE1α 
activation and downstream signaling. Specifically, the motor activity of NMIIB 
and the actin cytoskeleton were essential in modulating IRE1α higher-order 
oligomer formation, a key activating step. Physiologically, NMIIB function was 
conserved as both mammalian cells and C. elegans lacking NMII exhibited 
hypersensitivity to ER stress. Collectively, the studies presented in this 
dissertation have contributed original and novel insight into the physiology and 
mechanisms underlying mammalian IRE1α-XBP1 activation and signaling.  
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CHAPTER 1∗ 
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 CONFORMATIONAL DISEASES AND PROTEOSTASIS  
 Conformational disorders are a set of clinically and pathologically-related 
diseases that arise from protein misfolding or proteins adopting non-native 
conformational states (Carrell and Lomas, 1997). Accumulation of misfolded or 
unfolded proteins can disrupt the cell’s normal function and physiology through 
a loss- or gain-of-function mechanism. Loss-of-function occurs when the aberrant 
conformer of a protein undergoes mislocalization, engages in abnormal 
interactions or is targeted for degradation by the ubiquitin-proteasome system. 
On the other hand, a misfolded protein acquiring a new, but toxic function such 
as forming destructive amyloid fibrils or other insoluble aggregates in the cell, 
serves as the basis for gain-of-function disorders. Currently, conformational 
diseases encompass broad pathologies including prion encephalopathies, cystic 
fibrosis, neurodegenerative disorders (Alzheimer’s, Parkinson’s, Huntington’s), 
α1-antitrypsin deficiency, type 2 diabetes, amyloidosis, specific types of cancer, 
and others.  
 Recently, a new paradigm in the field of protein folding has been 
introduced and termed proteostasis, a phrase coined from the words protein and 
homeostasis (Balch et al., 2008; Powers et al., 2009). Proteostasis represents the 
delicate balance within a cell between protein synthesis and folding with its 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
∗	  Sections	  1.6-­‐1.7	  of	  this chapter have been adapted from He, Y., Sun, S., Sha, H., Liu, Z., 
Yang, L., Xue, Z., Chen, H., and Qi, L. Gene Expression 15, 13-25 (2010) and is reprinted 
here with modifications with permission.   
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degradation. The proteostasis network is comprised of pathways that regulate all 
aspects of protein maturation from protein synthesis, folding, and modification 
to trafficking and degradation. The proteostasis network is highly flexible, 
adaptable and cell-type specific. However, there does exist an inherent maximal 
capacity that can be influenced by factors including aging, metabolic or 
environmental-induced stress and overexpression of misfolding-prone proteins. 
Hence, the overall proteostasis network determines the folding energetics of a 
protein and influences the balance between folding, unfolding, aggregation and 
degradation (Powers et al., 2009).  
 Small chemical compounds have been identified that can modulate, 
increase and shift the proteostasis network towards a more favorable energetic 
landscape for misfolding-prone proteins. These fall into two categories: 
pharmacologic chaperones and proteostasis regulators (Balch et al., 2008). 
Pharmacologic chaperones can benefit loss-of-function diseases by acting in a 
similar fashion as endogenous chaperones. They bind to and stabilize proteins 
while also concomitantly preventing degradation and aggregation (Balch et al., 
2008; Fan et al., 1999). Mutant proteins that have been shown to be stabilized by 
pharmacologic chaperones include G protein-coupled receptors, cystic fibrosis 
transmembrane conductance regulator (CFTR) and neurotransmitter receptors 
(Conn et al., 2007; Loo et al., 2008; Millar and Harkness, 2008; Yoo et al., 2008). 
On the other hand, proteostasis regulators act by enhancing the capacity of the 
proteostasis network and can benefit gain-of-function diseases (Hammarström et 
al., 2003; Powers et al., 2009). Collectively, pharmacologic chaperones and 
proteostasis regulators have been proposed as an effective therapeutic 
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intervention to shift, expand and modulate the capacity of the proteostasis 
network and stabilize misfolding-prone proteins.  
 
1.2 ENDOPLASMIC RETICULUM (ER) STRESS 
 The ER is a eukaryotic organelle comprised of a vast and complex 
network of interconnected tubules and cisternae. Structurally, the ER can be 
characterized and visualized by microscopy as smooth or rough ER. Rough ER is 
appropriately named as it contains ribosomes on the cytosolic surface, thus 
creating a “rough” appearance, and serves as the site of protein translation in the 
cell; smooth ER lacks ribosomes. In addition to protein synthesis, the ER 
functions in a number of essential physiological processes including lipid and 
carbohydrate metabolism, detoxification, and productive protein folding, 
modification, transport, and secretion for approximately one-third of the 
proteome that encodes secretory or transmembrane proteins. Hence, establishing 
and maintaining homeostasis within the dynamic ER luminal environment is 
critical for normal cellular physiology and function.  
 ER homeostasis can be viewed as a delicate balance between the folding 
capacity of the ER (i.e. chaperones and components of the degradation 
machinery) and the protein load (i.e. newly synthesized proteins that require 
folding, modification, and transport). Many physiological and pathological 
conditions such as expression of misfolded proteins, viral infections, disruptions 
in calcium homeostasis, and glucose deprivation can disrupt ER homeostasis and 
lead to the harmful accumulation of misfolded proteins and ER stress (Ron and 
Walter, 2007). As unresolved and persistent ER stress can ultimately engage 
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apoptosis pathways, responding appropriately and quickly to ER stress and 
restoring ER homeostasis are vital and essential.  
 
1.3 UNFOLDED PROTEIN RESPONSE (UPR) 
 In response to ER stress, organisms have developed an evolutionarily 
conserved ER-to-nucleus signaling pathway termed the unfolded protein 
response (UPR). Together, UPR and ER-associated degradation (ERAD) maintain 
ER homeostasis and quality control. In 1988, Kozutsumi and colleagues observed 
the induction of a group of ER chaperones, glucose-regulated proteins (GRPs), in 
response to disrupted protein folding (Kozutsumi et al., 1988). This led them to 
propose the presence of an active regulatory mechanism in the ER to maintain 
ER homeostasis (Kozutsumi et al., 1988). To date, metazoan UPR consists of three 
primary ER transmembrane proteins that serve as sensors of the internal ER 
environment and initiate signaling pathways that act in parallel to coordinate 
and alleviate ER stress: inositol-requiring enzyme 1α (IRE1α), PKR-like ER 
kinase (PERK) and activating transcription factor 6 (ATF6) (Ron and Walter, 
2007; Walter and Ron, 2011). Of the three, the IRE1α pathway is the most 
conserved and represents the only UPR branch in yeast (Ron and Hubbard, 
2008). In response to perturbations in ER homeostasis, UPR sensors become 
engaged and initiate downstream signaling cascades that act to transcriptionally 
induce chaperones and components of ER-associated degradation (ERAD), 
attenuate global protein synthesis and in the face of persistent ER stress, activate 
apoptosis (Ron and Walter, 2007; Schröder and Kaufman, 2005; Walter and Ron, 
2011). ER stress and UPR activation have been implicated in the development 
	  	   5	  
and pathogenesis of various disorders including metabolic dysfunction (type 2 
diabetes, obesity), cardiovascular complications, cancer, neurodegenerative 
diseases, and conformational disorders (Schröder and Kaufman, 2005). 
Therefore, a comprehensive and thorough mechanistic understanding of UPR 
activation, signaling and regulation is of both basic and clinical relevance, and is 
essential for the development of potential therapeutics targeting these health-
related complications.  
  
1.4 ATF6 PATHWAY  
 ATF6 activation upon ER stress is mediated by a series of unique 
proteolytic cleavages at the Golgi apparatus and differs from that of PERK and 
IRE1α activation (Fig. 1.1). Mammalian ATF6 exists in two isoforms, ATF6α (Hai 
et al., 1989; Haze et al., 1999) and ATF6β (Haze et al., 2001; Khanna and 
Campbell, 1996; Min et al., 1995), with both isoforms being reported to induce the 
expression of pro-survival genes (Haze et al., 2001; Yamamoto et al., 2007). Upon 
ER stress, ATF6, a 90 kilodalton (kDa) ER transmembrane protein with a large 
luminal domain, translocates by budding to the Golgi apparatus, where it 
undergoes regulated proteolytic cleavage by two proteases (site 1 and site 2 
proteases) that sequentially remove the luminal domain and transmembrane 
linker (Chen et al., 2002; Haze et al., 1999; Shen and Prywes, 2004; Ye et al., 2000). 
The cleavage events release the N-terminal cytosolic-exposed region of ATF6. 
The 50 kDa active ATF6(N) enters the nucleus and functions as a basic region 
leucine zipper (b-ZIP) transcription factor to induce the expression of canonical 
UPR target genes including chaperones and ERAD components containing an ER 
	  	   6	  
stress response element (ERSE) in their promoters such as BiP/GRP78, protein 
disulfide isomerase (PDI) and ER degradation-enhancing alpha-mannosidase-
like protein 1 (EDEM1) (Kokame et al., 2001; Wang et al., 2000; Yoshida et al., 
1998; 2000). Of the three UPR pathways, ATF6 activation, signaling and 
regulation is the least well understood. Particularly, how ER stress activates 
ATF6 is unknown. A study proposed that similar to IRE1α and PERK activation, 
dissociation of the ER chaperone BiP/GRP78 from ATF6 upon ER stress induced 
its activation (Shen et al., 2002). However, the underlying details are unclear.  
 ATF6 signaling is primarily believed to be pro-survival and cyto-
protective through its transcriptional regulation of chaperones and degradation 
machinery. In addition, ATF6 has been reported to induce XBP1 expression, 
suggesting cross-talk and integration among the UPR pathways (Yoshida et al., 
2001). Recently, a number of ATF6 homologs were identified and although one of 
these factors, CREBH, was regulated by ER stress, the output of CREBH 
activation was not transcriptional induction of classical UPR genes but rather, 
inflammatory mediators (Ron and Walter, 2007; Zhang et al., 2006). This raised 
the intriguing possibility of the role of ATF6 and its homologs in physiology. 
Hence, the development and optimization of reagents to study ATF6 are critical 
in the future and will greatly expand our understanding of this pathway, its 
physiology and its contribution to UPR and cell fate determination.  
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Figure 1.1.  Metazoan Unfolded Protein Response (UPR). 
ER homeostasis is sensitively monitored by three transmembrane sensors, 
inositol-requiring enzyme 1 (IRE1), PKR-like ER kinase (PERK) and activating 
transcription factor 6 (ATF6). Upon ER stress, the three sensors become activated 
either through dissociation of the ER chaperone BiP/GRP78 or direct binding of 
misfolded proteins (for IRE1 and PERK). ATF6 translocates to the Golgi where it 
undergoes two sequential proteolytic cleavages to release an N-terminal 50 kDa 
fragment that enters the nucleus and functions as a b-ZIP transcription factor. 
PERK undergoes dimerization/oligomerization, trans-autophosphorylation and 
phosphorylates Ser51 of eukaryotic initiation factor 2α (eIF2α) to attenuate global 
protein synthesis. PERK also selectively induces the expression of several 
proteins including activating transcription factor 4 (ATF4), which can activate 
CHOP, a pro-apoptosis factor. Similar to PERK, IRE1α activation occurs by 
dimerization/oligomerization and trans-autophosphorylation. Activation of the 
RNase domain of IRE1α splices the Xbp1u mRNA to generate XBP1s, a b-ZIP 
transcription factor. IRE1α RNase activity also participates in regulated IRE1-
dependent mRNA decay (RIDD). Collectively, UPR sensor activation serves to 
restore ER homeostasis and promote quality control. However, persistent and 
unresolved ER stress activates apoptosis.   
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1.5 PERK PATHWAY  
 PERK is a type 1 ER transmembrane protein containing an ER luminal 
domain that monitors ER conditions and a cytosolic kinase domain. Under basal 
conditions, PERK is bound by the ER chaperone BiP/GRP78. BiP dissociation 
upon ER stress allows for PERK activation through dimerization / 
oligomerization and trans-autophosphorylation (Kebache et al., 2004). PERK 
kinase activity also acts on the serine 51 residue of eukaryotic initiation factor 2α 
(eIF2α) to attenuate global protein synthesis and decrease the protein load 
entering the ER (Harding et al., 1999; Raven and Koromilas, 2008; Shi et al., 1998). 
Hence, eIF2α phosphorylation is commonly used as a marker for detecting ER 
stress. However, as PERK belongs to a family of eIF2α kinases that respond to 
various cellular stresses including amino acid and heme deprivation (Harding et 
al., 1999; Shi et al., 1998; 1999), interpretation of UPR activation based solely on 
eIF2α phosphorylation status requires caution.  
 Apart from a global decrease in protein synthesis, a select group of 
transcripts containing an upstream open reading frame (uORF) in their 5’ 
untranslated regions (UTR) are up-regulated by PERK activation including the 
transcription factor, activating transcription factor 4 (ATF4) (Harding et al., 2003; 
Schröder and Kaufman, 2005). ATF4 subsequently induces the expression of 
transcription factor C/EBP homologous protein (CHOP), an apoptosis factor, 
and growth arrest and DNA damage-inducible 34 (GADD34), a regulatory 
subunit of protein phosphatase 1C (PP1C) that attenuates PERK signaling by 
dephosphorylating eIF2α (McCullough et al., 2001; Novoa et al., 2001; Ron and 
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Habener, 1992). Activation of the PERK pathway has typically been associated 
with apoptosis upon persistent and unresolved ER stress. 
 
1.6 IRE1α-XBP1 PATHWAY 
 Although IRE1α-XBP1 is the most evolutionarily conserved UPR pathway, 
its physiological role and regulatory mechanisms are unclear. Metazoans have 
two isoforms of IRE1, the constitutively-expressed IRE1α and the gut-specific 
IRE1β (Kaufman et al., 2002). IRE1α protein encodes an ER luminal and a 
transmembrane domain followed by two functional cytosolic domains conferring 
kinase and RNase activity (Fig. 1.2) Current literature proposes two mechanistic 
models of IRE1α activation in response to misfolded or unfolded proteins. One 
model suggests that in an inactive state, monomeric IRE1α is constitutively 
bound to the ER chaperone, BiP/GRP78 (Bertolotti et al., 2000; Kimata et al., 
2003). Accumulation of misfolded proteins requiring chaperone activity titrates 
BiP away from IRE1α, allowing IRE1α monomers to dimerize and undergo 
activation. Alternatively, IRE1α binds misfolded proteins directly through its N-
terminal MHC-like ER luminal domain, promoting its dimerization (Credle et al., 
2005). The two models are not mutually exclusive and in fact, may work together 
sequentially through BiP dissociation first followed by misfolded protein binding 
(Kimata et al., 2007). As these models were established in yeast, they may have 
different implications for mammalian IRE1α. Indeed, even under basal non-
stress conditions, mammalian IRE1α mutants unable to bind BiP can still be 
activated, and in vitro assays did not detect a direct interaction between IRE1α 
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and unfolded proteins (Oikawa et al., 2009). Furthermore, a crystal structure of 
mammalian IRE1α luminal domain suggested that unlike yeast IRE1p, the MHC-
like groove of mammalian IRE1α may not be able to bind misfolded proteins 
directly (Zhou et al., 2006).  
 Although the precise mechanistic details underlying IRE1α activation 
remain unclear, the general consensus in the field is that upon activation, the 
luminal domains of IRE1α monomers dimerize first followed by dimerization of 
the cytosolic domains and trans-autophosphorylation of neighboring IRE1α 
monomers, which further reinforce IRE1α clustering into foci or higher-order 
oligomers (Fig. 1.4). This model is supported by the crystal structure of the 
cytosolic domain of IRE1p in yeast (Korennykh et al., 2009; Lee et al., 2008b), 
which revealed higher-order oligomer formation (Korennykh et al., 2009). 
Supporting oligomerization, foci formation of mammalian IRE1α was also 
detected and visualized (Li et al., 2010). However, whether oligomer formation is 
required for activation of the RNase domain of IRE1α is debatable as studies 
have suggested that IRE1α dimerization is sufficient for enzymatic activity 
(Bertolotti et al., 2000).   
 Collectively, IRE1α dimerization/oligomerization activates the cytosolic 
RNase domain of IRE1α to splice 26 nucleotides from the mRNA encoding X-box 
binding protein 1 (Xbp1u, unspliced), resulting in a frameshift and the generation 
of XBP1s (spliced) (Fig. 1.3, Calfon et al., 2002; Lee et al., 2002; Yoshida et al., 
2006). In contrast to XBP1u, XBP1s protein is more stable and contains a 
transactivation domain, which allows it to translocate to the nucleus and 
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function as a potent b-ZIP transcription factor (Fig. 1.1, Lee et al., 2003b). XBP1s 
induces classical UPR target genes such as chaperones, ERAD components and 
ER expansion, but also exhibits tissue-specificity as the targets of XBP1 are 
critical mediators of B cell development, myogenesis, adipogenesis and 
lipogenesis (Fig. 1.4, Acosta-Alvear et al., 2007; Lee et al., 2003a). In addition to 
splicing Xbp1 mRNA, IRE1α has been implicated to participate in regulated 
IRE1α-dependent decay (RIDD) or the rapid turnover of mRNAs encoding 
secretory and trans-membrane proteins through the action of its RNase domain 
(Han et al., 2009; Hollien and Weissman, 2006; Hollien et al., 2009; So et al., 2012). 
More recently, IRE1α RNase activity was implicated in microRNA degradation 
(Upton et al., 2012). However, the physiological implications of these events are 
currently unclear. Collectively, these two outputs of IRE1α signaling, Xbp1 
splicing and RIDD processing, function primarily to alleviate ER stress and 
restore ER homeostasis.  
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Figure 1.2.  Schematic of human IRE1α  protein.  
Human IRE1α protein is drawn to scale according to UniProt domain 
predictions. This 977-amino acid type 1 ER transmembrane protein contains a N-
terminal signal peptide (SP) to direct its localization to the ER. The MHC-like 
luminal domain senses the internal ER environment and may be involved in 
direct binding of misfolded proteins although the validity of this occurrence for 
metazoan IRE1α is unclear. Following the transmembrane (TM) region is a short 
linker domain and two functional cytosolic domains conferring kinase and 
RNase activities involved in IRE1α phosphorylation and Xbp1u/RIDD mRNA 
splicing, respectively.  
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Figure 1.3.  Mouse XBP1 protein. 
Diagram depicting both the spliced (XBP1s) and unspliced (XBP1u) forms of 
mouse XBP1 protein. The cytosolic RNase domain of activated IRE1α splices 26 
nucleotides from the mRNA of Xbp1u to generate Xbp1s. Unlike yeast Hac1 
(homolog of Xbp1) in which Hac1u is not translated, both metazoan Xbp1u and 
Xbp1s are translated. The splicing event causes a frameshift and as a result, 
XBP1s protein has a different C-terminal domain containing a transactivation 
domain that is absent from XBP1u. Both forms encode a DNA binding domain 
and a basic leucine zipper domain, thus characterizing XBP1 as a b-ZIP 
transcription factor that binds to CRE-like sequences. Although XBP1u is 
translated, it has been proposed to contain a C-terminal degradation domain, 
thus rendering it unstable and susceptible to degradation.  
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Figure 1.4.  Metazoan IRE1α-XBP1 pathway. 
BiP dissociation and/or binding of misfolded proteins activate IRE1α protein at 
the ER membrane. Following dimerization, trans-autophosphorylation and 
further clustering into oligomers, the RNase domain of IRE1α splices 26 
nucleotides from Xbp1u mRNA to generate a b-ZIP transcription factor XBP1s. In 
addition to inducing canonical UPR target genes involved in quality control and 
ER homeostasis, XBP1 also regulates genes in physiological processes including 
inflammation, hepatic lipogenesis, and B cell and myocyte differentiation. IRE1α 
also splices other ER targeted mRNAs in a process known as regulated IRE1α-
dependent decay (RIDD). The role and requirement of the IRE1α-XBP1 pathway 
in other cellular processes as well as identification of regulatory factors 
modulating this pathway are discussed in this dissertation.   
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1.6.1 Biology and function of the IRE1α-XBP1 pathway 
 The human XBP1 gene was discovered and characterized in 1990 as a b-
ZIP transcription factor present in B cells that interacted specifically with the 
conserved X2 boxes located in the promoters of MHC class II genes (Liou et al., 
1990). XBP1 formed a stable functional heterodimer with c-fos that was critical 
for the expression of XBP1 target genes (Ono et al., 1991). Further analysis of the 
XBP1 promoter revealed multiple regulatory cis elements including a motif 
identical to the X2 sites bound by XBP1 (Ponath et al., 1993; Reimold et al., 1996). 
In situ hybridization studies revealed ubiquitous expression of XBP1 in adult 
tissues as well as in fetal exocrine glands and osteoblasts (Clauss et al., 1993). 
Importantly, mice with germline XBP1 deletion died in utero from severe liver or 
heart hypoplasia, and apoptosis (Masaki et al., 1999; Reimold et al., 2000).  
 In 1993, two laboratories independently reported that communication 
between the ER and nucleus, termed UPR, was mediated by an ER 
transmembrane kinase ERN1/IRE1 (Cox et al., 1993; Mori et al., 1993). 
Subsequent work in yeast demonstrated that in addition to a kinase domain, 
IRE1 possessed RNase activity and Hac1 was the substrate (Cox and Walter, 
1996). IRE1 activation led to splicing of the mRNA of Hac1u (un-induced) to 
generate Hac1i (induced) (Sidrauski and Walter, 1997). Hac1i mRNA encoded a 
potent transcription factor responsible for the up-regulation of many genes 
involved in protein folding, degradation and trafficking (Travers et al., 2000). 
XBP1 was later identified as the mammalian homolog of HAC1 (Calfon et al., 
2002; Lee et al., 2002; Yoshida et al., 2001).  
 From an evolutionary perspective, the presence of eukaryotic genes with 
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overlapping reading frames such as Xbp1u and Xbp1s presents an intriguing but 
puzzling question. Using comparative approaches, the Xbp1u coding sequence 
(CDS) was observed to be strongly conserved and both the unspliced and spliced 
CDS had similar non-synonymous substitution rates, providing evidence for a 
functional role for XBP1u (Nekrutenko and He, 2006). In the current model, 
XBP1u negatively regulates XBP1s transcriptional activity and hence UPR 
signaling (Lee et al., 2003b; Yoshida et al., 2006). However, this model was 
challenged by the observation that overexpression of stabilized XBP1u increased 
the expression of XBP1s targets (Tirosh et al., 2006), implying a much more 
complex role of XBP1u in UPR signaling. Indeed, a recent study showed that 
XBP1u recruited its own mRNA to the ER membrane for efficient IRE1α-
mediated splicing (Yanagitani et al., 2009). Thus, although the precise role of 
XBP1u remains elusive, it does appear to serve a biphasic role in UPR initiation 
and resolution.  
 
1.6.2 Transcriptional regulation of XBP1 expression 
 In addition to the well-characterized Xbp1 mRNA splicing event by IRE1α, 
accumulating evidence suggested that transcriptional regulation of Xbp1 gene 
expression may also play an important role with profound pathological and 
therapeutic implications. Indeed, several recent studies have shown that the Xbp1 
proximal promoter serves as a target for various tissue-specific and 
developmentally regulated transcription factors, contributing to the temporal- 
and spatial-specific expression of XBP1.  
 As the role of XBP1 in plasma cell differentiation was unraveled, studies 
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demonstrated that Xbp1 mRNA was induced by interleukin (IL)-6 in human 
multiple myeloma cells (Wen et al., 1999) and IL-4 in primary B cells (Iwakoshi et 
al., 2003). B lymphocyte induced maturation protein (BLIMP1) and interferon 
regulatory factor 4 (IRF4) are two major transcription factors critical for Xbp1 
expression and plasma cell differentiation. Microarray studies placed BLIMP1 
upstream of XBP1 but as BLIMP1 was a transcriptional repressor, mechanistic 
questions arose as to how BLIMP1 could induce Xbp1 expression (Shaffer et al., 
2002; 2004). It was revealed that BLIMP1 repressed paired box gene 5/B cell 
lineage-specific activator protein (BSAP/PAX5), a known repressor of Xbp1 in B 
cells (Reimold et al., 1996; Shaffer et al., 2002). IRF4 is an interferon (IFN)-
regulatory family member that is expressed in B cells committed to the plasma 
cell lineage and required for plasmacytoid differentiation (Klein et al., 2006). 
XBP1s induction was ablated in IRF4-deficient cells, but BLIMP1 expression was 
unaffected, suggesting that IRF4 acted upstream of XBP1 in a non-redundant 
manner. Furthermore, other adaptive immune responses such as effector CD8+ T 
cell differentiation and macrophage activation up-regulated Xbp1 expression 
through IL-2 (Kamimura and Bevan, 2008) and the ligand for Toll-like receptor 4- 
(TLR4), lipopolysaccharide (LPS) (Martinon et al., 2010; Roach et al., 2007). 
 Various other factors contributing to the regulation of Xbp1 gene 
expression are emerging as well. Two myogenic transcription factors, MyoD and 
myogenin, were shown to directly regulate Xbp1 expression (Blais et al., 2005). In 
addition, Xbp1 gene expression was regulated by ATF6 as well as itself, resulting 
in a positive feedback loop during UPR activation (Yoshida et al., 2001). Indeed, 
a human polymorphism in the proximal promoter of Xbp1 (-116C-G) that 
disrupted the putative binding site for XBP1s correlated with an increased risk 
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for bipolar disorder (Kakiuchi et al., 2003). Furthermore, parathyroid hormone 
played a role in regulating Xbp1 expression during osteoblast differentiation 
(Zambelli et al., 2005). Finally, a recent study identified XBP1 as a highly-
enriched white adipose gene that was repressed by PR domain containing 16 
(PRDM16), a brown fat-specific transcriptional activator (Kajimura et al., 2008; 
Seale et al., 2008).  
 Thus, although IRE1α-mediated splicing of Xbp1 mRNA is the most well 
characterized regulatory mechanism for this transcription factor, its mRNA 
expression is also tightly controlled by various factors in a highly dynamic 
manner. As UPR may be constitutively active even under basal conditions 
(Acosta-Alvear et al., 2007; Shen et al., 2005; Yang et al., 2010), regulation through 
either induction or repression of Xbp1 expression may serve to fine-tune ER 
homeostasis. Indeed, a similar situation was identified in yeast and termed 
“super-UPR” (Leber et al., 2004). Further characterization of novel XBP1 
regulators at the transcriptional level may provide insight into the role of “super-
UPR” and as well as into the design and development of therapeutic strategies 
targeting human ER-associated disorders. 
 
1.6.3 XBP1-mediated transcriptional events 
 XBP1 was initially reported to bind to cAMP-responsive elements (CRE) 
sites in the promoters of MHC class II genes (Clauss et al., 1996). Further studies 
were performed validating that XBP1 did indeed preferentially bind to CRE-like 
elements in which the core “ACGT” was highly conserved (Clauss et al., 1996). 
To identify transcriptional networks regulated by XBP1, ChIP-on-chip arrays 
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showed that XBP1 was constitutively bound to a subset of genes involved in ER 
homeostasis including folding, trafficking and ERAD (Acosta-Alvear et al., 2007), 
confirming the presence of a low level of basal or constitutive UPR (Shen et al., 
2005). In most genes, XBP1 binding occurred within 200 bp of transcriptional 
start sites (TSS) (Acosta-Alvear et al., 2007). In support of previous reports 
(Clauss et al., 1996), high-throughput studies showed that XBP1 did indeed bind 
to the core “ACGT” element under physiological conditions, but XBP1 targets 
were also enriched in additional distinct motifs including UPR element (UPRE) 
and a CCACG box (Acosta-Alvear et al., 2007).  
 As XBP1 is involved in various facets of biology, it is not surprising that 
its targets are also extremely diverse (Acosta-Alvear et al., 2007). Canonical XBP1 
targets in UPR signaling have been shown to include ER chaperones and 
components of ERAD including EDEM1, ERDJ4 and P58IPK. Additional tissue-
specific XBP1 targets that have been identified include IL-6 in plasma cells, 
lipogenic genes in hepatocytes, pro-inflammatory cytokines in macrophages and 
MIST1 in myocytes (Fig. 1.4). XBP1 was also enriched on the promoters of genes 
involved in a number of UPR-unrelated processes including glycolysis, 
gluconeogenesis, lipid metabolism, and DNA replication and repair (Acosta-
Alvear et al., 2007). The biological relevance of these bindings requires further 
investigations. 
 
1.7 ROLE OF IRE1α-XBP1 IN PHYSIOLOGY 
 As a b-ZIP transcription factor, XBP1 can exert direct influence over the 
expression of genes critical not only for classical UPR signaling, but also for 
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many other physiological processes ranging from immunity to metabolism. This 
section highlights and addresses recent reports on the relevance and importance 
of the IRE1α-XBP1 pathway in multiple pathophysiological conditions such as 
pathogen defense and immunity, obesity and type 2 diabetes, cancer, 
neurodegeneration, and aging.   
  
1.7.1 IRE1α-XBP1 in adaptive immunity 
 XBP1 is required for plasma cell differentiation (Reimold et al., 2001), but 
does not influence the decision of B cells to commit to the memory lineage (Todd 
et al., 2008; 2009). XBP1-deficient B cells exhibited normal proliferation and 
activation, but expressed decreased levels of J chain, a component required for Ig 
assembly. Consequently, these animals were more susceptible to infections, but 
restoration of XBP1s expression rescued Ig production (Reimold et al., 2001). 
Furthermore, Xbp1 mRNA splicing was attenuated in mice lacking Ig heavy 
chains, suggesting that IRE1α activity and UPR were modulated and induced by 
Ig synthesis and production (Iwakoshi et al., 2003; Zhang et al., 2005). XBP1-
mediated ER expansion was required for adoption of a “professional secretory 
cell” phenotype characteristic of plasma cells (Shaffer et al., 2004). In addition, 
XBP1s induced IL-6 expression in splenic B cells (Iwakoshi et al., 2003). Thus, 
XBP1 in professional secretory cells may have evolved additional functions 
allowing these cells to respond to “physiological” UPR (Shaffer et al., 2004). 
 In contrast to previous reports (Gass et al., 2002; 2008; Iwakoshi et al., 
2003; Zhang et al., 2005), a more recent study reported that Xbp1 induction was 
independent of differentiation as B cells lacking IgM still maintained Xbp1 
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activation. This discovery suggested that Xbp1 activation may be required for 
normal plasma cell differentiation rather than as a consequence of massive Ig 
synthesis and secretion (Hu et al., 2009). Furthermore, a study showed that while 
XBP1 was required for IgM synthesis and secretion, glycoprotein degradation 
was unaffected by loss of XBP1 (Tirosh et al., 2005). Hence, the timing and 
mechanism of UPR and XBP1 activation during plasma cell differentiation 
remain an interesting and open question. 
 
1.7.2 IRE1α-XBP1 in innate immunity 
 The IRE1α-XBP1 signaling pathway of UPR is critical for the development 
and survival of another immune population, dendritic cells (DCs). Loss of XBP1 
in DCs reduced IFN-α production upon stimulation with CpG, an agonist of 
TLR2, and rendered cells prone to ER stress-induced or differentiation-associated 
cell death (Iwakoshi et al., 2007). Indeed, both conventional and plasmacytoid 
DCs in XBP1- deficient animals exhibited decreased survival at basal levels and 
in response to TLR signaling. Conversely, forced expression of XBP1s enhanced 
DC development (Iwakoshi et al., 2007).  
 Most recently, XBP1 was shown to have a critical role in regulating the 
expression of key pro-inflammatory cytokines in macrophages (Martinon et al., 
2010). TLR2/4 signaling specifically activated the IRE1α-XBP1 branch, which in 
turn increased the expression and secretion of IL-6, tumor necrosis factor α 
(TNFα), and interferon β (IFN-β) without inducing canonical UPR genes. Mice 
with a macrophage-specific deficiency of XBP1 exhibited increased bacterial 
	  	   22	  
burden post-infection (Martinon et al., 2010). The function of XBP1 in innate 
immunity seemed to be highly conserved as similar observations were made in 
worms; XBP1-deficient worms were hypersensitive to pathogen infection during 
development (Richardson et al., 2010). Therefore, XBP1 plays a critical and 
protective role in both innate and adaptive immunity. This is not surprising 
given that the RNase domain of both isoforms of IRE1 shares unique homology 
with RNase L (Tirasophon et al., 2000), a critical component of the antiviral 
system that cleaves single-stranded RNA (Stark et al., 1998). 
 
1.7.3 IRE1α-XBP1 in inflammatory bowel disease (IBD) 
 In line with the role of the IRE1α-XBP1 pathway in immunity, XBP1 has 
been implicated in inflammatory bowel disease (IBD), a common chronic human 
disorder. Mice with specific Xbp1 deletion in intestinal epithelial cells were more 
susceptible to developing spontaneous small intestinal enteritis (Kaser et al., 
2008). Patients with Crohn’s disease and ulcerative colitis, two forms of IBD, 
exhibited decreased XBP1s levels. In addition, several genome-wide linkage 
studies hinted at an association between IBD and a region of the genome 
physically close to the Xbp1 gene (Barmada et al., 2004; Hampe et al., 1999; 
Vermeire et al., 2004) and the IRE1β gene (Brant et al., 1998; Hugot et al., 1996). 
Moreover, deep sequencing identified novel rare single nucleotide 
polymorphisms in the Xbp1 gene that along with other environmental and 
genetic risk factors, might confer susceptibility to IBD (Kaser et al., 2008). Further 
supporting a key role of XBP1 in IBD, loss of IRE1β, the isoform expressed 
predominantly in the gastrointestinal tract, resulted in hypersensitivity to 
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dextran sodium sulfate (DSS)-induced colitis in mice (Bertolotti et al., 2001). It is 
quite interesting that IRE1α expression alone in intestinal epithelial cells failed to 
protect IRE1β-/- animals from induced colitis. Thus, these studies pointed to a 
non-redundant and unique role of the IRE1β-XBP1 pathway in the pathogenesis 
of IBD. 
 
1.7.4 IRE1α-XBP1 in metabolism  
 ER stress, particularly the IRE1α-XBP1 branch, has been implicated in 
obesity-induced insulin resistance and type 2 diabetes (Ozcan et al., 2009; 2004; 
2006; Sha et al., 2011; Zhang et al., 2008). Initial reports demonstrated a link 
between IRE1α activation and c-Jun N-terminal kinase (JNK)-dependent 
inhibitory phosphorylation of insulin receptor substrate 1 (IRS-1) at serine 307 
(Ser307) (Ozcan et al., 2004; Urano et al., 2000). In line with the role of IRE1α 
activation in attenuating insulin signaling, XBP1s overexpression in mouse 
embryonic fibroblasts (MEFs) suppressed ER-stress-induced JNK activation and 
IRS-1 phosphorylation on Ser307, whereas XBP1+/- tissues showed opposite 
effects (Ozcan et al., 2004). Furthermore, XBP1+/- mice exhibited increased ER 
stress and more severe insulin resistance upon high fat-diet (HFD)-induced 
obesity accompanied with elevated p-Ser307 on IRS1 (Ozcan et al., 2004). 
Conversely, reduction of ER stress through the administration of 
chemical/pharmacologic chaperones such as 4-phenylbutyric acid (PBA) and 
tauroursodeoxycholic acid (TUDCA) attenuated phosphorylation of IRS1 at 
Ser307 and improved the insulin sensitivity of obese animals (Ozcan et al., 2006). 
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More recently, it was shown that compromised insulin signaling during obesity 
might decrease the levels of functional nuclear XBP1s in the liver of obese mice 
(Park et al., 2010). The interaction between the heterodimer p85α and p85β, the 
regulatory subunits of phosphoinositide 3-kinase (PI3K) and XBP1 was disrupted 
in obese animals, leading to defects in the nuclear entry of XBP1s and elevated 
ER stress. Overexpression of p85α or β in the liver improved glucose tolerance in 
obese animals (Park et al., 2010). Hence, ER stress has been proposed to be a 
critical link between obesity with insulin resistance (Hotamisligil, 2010).   
 Several studies, however, have suggested that this model may not be all-
inclusive. First, liver specific XBP1-null mice failed to exhibit overt changes in ER 
ultrastructure or activation of the other two UPR braches PERK and ATF6 (Lee et 
al., 2008a). This is in line with another report showing that Xbp1 expression and 
the active form of ATF6 were reduced in the hepatocytes of obese mice, 
indicative of decreased ER stress (Wang et al., 2009b). Furthermore, ER stress 
was not detectable in white adipose tissues (WAT) upon 12 weeks HFD in XBP1-
splicing reporter mice (Yoshiuchi et al., 2008), questioning the notion that ER 
stress in adipose tissues played a causal role in obesity-associated insulin 
resistance. Moreover, a recent study demonstrated that phosphorylation of IRS1 
at Ser307 was not critical for the development of insulin resistance, but rather 
promoted insulin sensitivity in mice (Copps et al., 2010). The IRS1 Ser307Ala 
knock-in mice exhibited increased insulin resistance upon HFD-induced obesity. 
Finally, liver-specific disruption of p85α improved systemic glucose tolerance 
and insulin sensitivity in both lean and obese mice while overexpression of p85α 
in the liver had the opposite effects (Taniguchi et al., 2007; 2006). Hence, the role 
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of ER stress and the IRE1α-XBP1 pathway in obesity and diabetes warrants 
further studies.  
 XBP1 has also been implicated in hepatic lipid metabolism and adipocyte 
differentiation (Fig. 1.4). Using hepatocyte-specific conditional XBP1 knockout 
mice, it was shown that XBP1-deficient hepatocytes exhibited reduced de novo 
lipid biosynthesis (Lee et al., 2008a). XBP1 played an unexpected role in 
regulating hepatic lipogenesis by directly binding to the promoters of key 
lipogenic factors including diacylglycerol acetyltransferase 2 (DGAT2), stearoyl-
CoA reductase 1 (SCD1) and acetyl-CoA carboxylase (ACC2) (Lee et al., 2008a). 
In addition, we showed that XBP1-deficient pre-adipocytes and MEF cells 
showed dramatic defects in adipogenesis (Chapter 2, Sha et al., 2009). During this 
developmental process, a key early adipogenic factor C/EBPβ induced Xbp1 
expression; subsequently, XBP1s interacted with the promoter of Cebpα, a master 
regulator of adipogenesis, and activated its expression (Sha et al., 2009). Thus, 
XBP1 played a critical regulatory role during adipogenesis by integrating into the 
transcriptional cascade underlying adipogenic differentiation. This finding was 
consistent with reports of an absence of fat depot in XBP1-/- neonates rescued 
with hepatic XBP1s overexpression (Lee et al., 2005). 
 
1.7.5 IRE1α-XBP1 in cancer 
 Genome-wide profiling along with association studies demonstrated that 
XBP1 expression was induced in a variety of cancers including lymphoid 
malignancies such as multiple myeloma and acute myeloid leukemia (Davies et 
al., 2003; Juric et al., 2007; Leleu et al., 2009; Munshi et al., 2004) as well as breast 
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cancers (Doane et al., 2006; Gomez et al., 2007; Lacroix and Leclercq, 2004). 
Moreover, multiple myeloma cells with overexpression of superoxide dismutase 
(SOD2), an enzyme that eliminates free superoxide radicals, exhibited decreased 
proliferation correlated with decreased Xbp1 expression (Hurt et al., 2007). In 
support of a direct role for XBP1 in tumorigenesis, the loss of XBP1 was shown to 
severely inhibit tumor growth (Romero-Ramirez et al., 2004). Indeed, 
transformed cells with XBP1 deficiency were more sensitized to hypoxia and 
underwent apoptosis, implicating XBP1 as a survival factor (Romero-Ramirez et 
al., 2004). In addition, mice with ectopic expression of XBP1s in B cells exhibited 
enhanced B cell proliferative potential along with development of multiple 
myeloma that recapitulated the human disease (Carrasco et al., 2007). Finally, it 
was shown that XBP1 was activated in primary mammary tumors with its 
expression correlating with enhanced tumor growth (Spiotto et al., 2010).  
 Thus, the role of XBP1 as a survival factor deems it a very attractive 
therapeutic target. However, UPR can also initiate apoptosis in the face of 
persistent ER stress. A study demonstrated that acute myeloid leukemia patients 
with UPR activation actually merited better prognosis as indicated by lower 
relapse rates coupled with a better overall and disease-free survival (Schardt et 
al., 2009). Therefore, to fully understand the involvement of XBP1 in cancer 
development and progression, future studies that can carefully monitor UPR 
activation and delineate the respective roles of all three UPR branches are 
required. 
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1.7.6 IRE1α-XBP1 in neurodegeneration and aging 
 The role of IRE1α-XBP1 in neurodegeneration remains controversial and 
appears to be disease-specific. Toxic intracellular protein aggregates, one of the 
primary underlying causes of neurodegenerative pathologies, can induce ER 
stress and activate UPR (Lindholm et al., 2006). Indeed, cellular and animal 
models of Huntington’s (Nishitoh et al., 2008; 2002) and Parkinson’s (Holtz and 
O'Malley, 2003) diseases are reportedly associated with activation of the IRE1α-
XBP1 pathway. However, it remains unclear whether UPR activation in these 
models represents a direct cause of the diseases or a secondary effect associated 
with tissue damage. 
 XBP1 occupancy was observed on the promoters of genes linked to 
neurodegenerative pathologies including Alzheimer’s disease (Acosta-Alvear et 
al., 2007), although the relevance of these events remains speculative. Ectopic 
expression of XBP1s played a protective role in cells against chemical-induced 
cell death and significantly attenuated the degeneration of dopaminergic 
neurons in a mouse model of Parkinson’s disease (Sado et al., 2009). In contrast, 
SOD1 transgenic mice with XBP1 deficiency specifically in the nervous system 
were more resistant to the development of familial amyotrophic lateral sclerosis 
(ALS) (Hetz et al., 2009). These animals exhibited increased macroautophagy 
concomitant with reduced accumulation of mutant SOD1, supporting an 
intimate link between UPR and autophagy. In contrast, XBP1 did not appear to 
influence prion pathogenesis as loss of XBP1 had no effect on prion aggregation, 
neuronal survival or overall animal survival (Hetz et al., 2008). Consistently, 
many UPR markers were unaffected in the brains of prion-infected XBP1-
	  	   28	  
deficient mice when compared to the wild-type cohort (Hetz et al., 2008). 
 Recent studies have implicated the IRE1-XBP1 pathway in aging in worms 
(Chen et al., 2009; Henis-Korenblit et al., 2010). First, loss of hypoxia inducible 
factor 1 (HIF1) extended lifespan in part through the activation of the IRE1 
pathway. Defects in IRE1 signaling significantly reduced the lifespan of the long-
lived hif1 loss-of-function mutant (Chen et al., 2009). This effect appeared to be 
IRE1-specific as a PERK deletion mutant had no effect. A similar observation was 
recently reported in insulin/IGF-1 pathway mutant worms (Henis-Korenblit et 
al., 2010). Loss of IRE1 or XBP1 shortened the lifespan of long-lived daf-2 mutants 
to a much lesser extent than in wild-type worms, suggesting that the effect of 
XBP1 on lifespan may depend on one of these factors in the insulin/IGF-1 
pathway. Nonetheless, IRE1 activity and Xbp1s mRNA were unexpectedly very 
low in the daf-2 mutant, indicative of improved overall ER homeostasis. 
Mechanistically, it was proposed that XBP1 might regulate the expression of a 
conserved Zinc-finger protein dox-1 (downstream of XBP1) in a DAF-16/FOXO 
dependent manner. The effect of IRE1-XBP1 in the aging process of higher 
organisms merits further studies. 
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Figure 1.5.  IRE1α  interacting factors constitute the IRE1α  interactome.  
List of current factors that have been reported to interact with and regulate 
IRE1α activation and signaling. Factors highlighted in green and marked with 
“+” indicate an up-regulation/activation of IRE1α signaling whereas those 
highlighted in red and marked with “-“ indicate a down-regulation/inhibition of 
IRE1α signaling.   
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1.8 REGULATING IRE1α-XBP1 SIGNALING 
 Given the importance and clinical relevance of the IRE1α-XBP1 signaling 
pathway to human health, a comprehensive understanding of the underlying 
regulatory mechanisms is essential and will be informative for the development 
of intervention strategies. Recently, reports demonstrating the dynamic assembly 
and formation of various protein complexes containing IRE1α in a tissue- or cell-
specific manner has proposed the concept of a “UPRosome” or IRE1α 
interactome that plays a key role in regulating both the activation and kinetics of 
mammalian IRE1α activation, signaling and downstream cellular responses 
(Hetz et al., 2011; Hetz and Glimcher, 2009; Woehlbier and Hetz, 2011).  
 IRE1α signaling is highly and tightly regulated by a set of co-factors 
including both activators and inhibitors (Fig. 1.5). These include apoptosis-
related proteins such as members of the apoptosis-associated BCL-2 family that 
localize to the ER membrane. BAX and BAK are pro-apoptotic factors that 
specifically activate IRE1α signaling through an interaction between the cytosolic 
domain of IRE1α and the BH domain of BAX/BAK (Hetz et al., 2006). 
Additionally, other members of the BCL-2 family containing only a BH3 domain 
such as BIM and PUMA activated the IRE1α pathway in the presence of BAK 
(Klee et al., 2009). BAX inhibitor-1 (Bl-1) is an ER protein that interacted with 
IRE1α and a deficiency in Bl-1 enhanced IRE1α activation and signaling (Lisbona 
et al., 2009). Interestingly, Bl-1 function was highly conserved, but appeared to be 
specific to multi-cellular organisms as yeast lacking a Bl-1 homolog displayed 
normal HAC1 (XBP1 homolog) expression (Lisbona et al., 2009). Furthermore, 
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the cytosolic domain of IRE1α interacted with TNFR-associated factor 2 (TRAF2) 
to activate downstream targets apoptosis signal-regulating kinase 1 (ASK1) and 
c-Jun-N terminal kinase (JNK), ultimately leading to activation of apoptosis in 
cells unable to restore ER homeostasis (Kanda and Miura, 2004; Mauro et al., 
2006; Nishitoh et al., 2002; Urano et al., 2000). Another pro-apoptotic factor 
ASK1-interacting protein 1 (AIP1) enhanced IRE1α activation and signaling 
specifically with no effect on the PERK pathway (Luo et al., 2008). AIP1 
interacted with IRE1α in an ER stress-dependent manner and promoted IRE1α 
dimerization (Luo et al., 2008). Lastly, caspase-12 cleavage and activation was 
also reported to be correlated with the TRAF2-IRE1α pathway (Yoneda et al., 
2001). All together, these co-factors interact with IRE1α to inhibit or promote its 
activation and signaling, providing an additional layer of regulation and fine-
tuning.  
 Given the role of IRE1α and XBP1 in immunity, IRE1α signaling has also 
been reported to integrate with inflammatory pathways including that of NF-κB, 
p38 and ERK potentially through interactions with the adaptor protein Nck and 
IKK or TRAF2 (Hu et al., 2006; Nguyên et al., 2004). However, the exact 
mechanistic details and biological implications and significance remain 
unknown.  
 In response to ER stress, both the UPR and ERAD networks are activated 
and coordinately function together to restore ER homeostasis. However, 
knowledge regarding the relationship and regulation between UPR and ERAD 
by ER stress and their inter-dependency remain in its infancy. Under basal non-
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stress conditions, inactive IRE1α interacted with the ubiquitin specific protease 
14 (USP14); this interaction disappeared with ER stress and IRE1α activation, 
suggesting that USP14 was a negative modulator (Nagai et al., 2009). 
Intriguingly, the same study showed that inactive IRE1α was found to be in a 
complex containing critical ERAD regulators, Derlin-1, Derlin-3, Sel1, and Hrd1 
(Nagai et al., 2009). However, the functional consequences of these findings 
require additional studies.   
 IRE1α activation is highly correlated with its phosphorylation. Not 
surprisingly, IRE1α signaling was reported to be modulated by an ER localized 
phosphatase, protein-tyrosine phosphatase 1B (PTP-1B). This regulation was 
specific to IRE1α as PERK signaling was unaffected by a PTP-1B deficiency (Gu 
et al., 2004). The physiological relevance of PTP-1B was supported by studies of 
UPR in a diabetes mouse model. However, whether PTP-1B can interact with 
IRE1α in a temporal manner remains to be established. Speculatively, PTP-1B 
would function during the later stages of ER stress to dephosphorylate and 
inactivate IRE1α. Other studies have attempted to study the later stages of IRE1α 
signaling to determine how this protein is inactivated. In addition to PTP-1B, the 
ubiquitous cytosolic chaperone protein HSP90 may also negatively regulate 
IRE1α activation and signaling by modulating IRE1α protein stability. HSP90 
inhibition by chemical drugs disrupted the interaction with the cytosolic segment 
of IRE1α and promoted proteasome-mediated IRE1α degradation (Marcu et al., 
2002). As HSP90 has reported roles in regulating the stability of other proteins 
and protein complexes, this finding suggests that HSP90 may function to 
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stabilize the IRE1α protein and permit formation of the IRE1α interactome. 
 Emergence of the IRE1α interactome has conceptualized and 
revolutionized the way in which IRE1α activation and signaling is viewed. Prior 
to these discoveries, IRE1α activation was perceived simplistically as the 
progressive arrangement of IRE1α monomers into dimers concomitant with 
trans-autophosphorylation of adjacent IRE1α monomers. The identification of 
dynamic and tissue-specific formation of regulatory complexes demonstrated 
that IRE1α signaling occurs by precise and tightly-controlled mechanisms to 
enhance or dampen IRE1α signal propagation. However, these discoveries 
inevitably raise additional questions that warrant future studies aiming to 
comprehensively identify all components of the IRE1α interactome as well as 
delineate their functional and physiological roles in IRE1α activation and 
signaling.  
 Several yeast studies have reported novel compounds that can engage 
IRE1 activation in novel ways and shed light on IRE1 activation that may be 
relevant to mammalian IRE1α. First, the use of an ATP-competitive drug 1NM-
PP1 demonstrated that a conformational change induced by the binding of 1NM-
PP1 in the kinase active site of IRE1 was sufficient to induce downstream effector 
events (Papa et al., 2003). Impaired IRE1 kinase activity was irrelevant to 
downstream functions as long as the active site was occupied, in this case by 
1NM-PP1 (Papa et al., 2003). This finding has critical implications for 
understanding metazoan IRE1α activation and drug development as 1NM-PP1 
can dissociate IRE1 RNase and kinase activities, allowing for independent 
	  	   34	  
characterizations of both domains. More recently, a study identified a novel 
ligand binding site located at the interface of the kinase and RNase domains of 
yeast IRE1 (Wiseman et al., 2010). This site was bound by the quercetin flavonol, 
which greatly enhanced IRE1 RNase activity (Wiseman et al., 2010), thus 
resulting in the identification of another compound that can disconnect IRE1 
kinase and RNase activities to allow for precise mechanistic characterizations of 
IRE1 activation. Additionally, whether an endogenous compound exists that 
structurally resembles and behaves similarly to quercetin is an intriguing 
question. 
 
1.9 TEMPORAL REGULATION OF UPR SIGNALING 
 The dynamics and kinetics of UPR signaling greatly influence cell fate 
determination. Although UPR commences as an adaptive response to restore ER 
homeostasis, the three UPR sensors are kinetically and temporally regulated 
upon ER stress and can be characterized by four stages of response (Woehlbier 
and Hetz, 2011). During the initial or acute phase of ER stress, PERK activation 
and phosphorylation of eIF2α contribute to a global decrease in protein synthesis 
(Harding et al., 1999; Novoa et al., 2003). This is coupled with IRE1α-mediated 
mRNA decay (RIDD) to attenuate protein flux and load into the ER (Han et al., 
2009; Hollien and Weissman, 2006; Hollien et al., 2009). The second wave of 
response is transcriptional and is mediated by all three pathways to collectively 
increase ER capacity and quality control. The main contributors are the 
transcription factors XBP1, ATF4 and ATF6 that induce the expression of 
chaperones, degradation machinery, and enzymes for ER expansion and lipid 
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synthesis (Yamamoto et al., 2007). The first two phases are adaptive and attempt 
to restore ER homeostasis. However, if ER stress remains unresolved, IRE1α 
signaling becomes dampened whereas PERK activation remains sustained and is 
believed to induce apoptosis through CHOP, a downstream target of ATF4. This 
transition stage highlights a shift from adaptation and pro-survival to pro-
apoptotic (Woehlbier and Hetz, 2011). The last stage of chronic ER stress involves 
further reinforcement of apoptosis through transcriptional induction of genes 
related to the BCL2 pro-apoptosis protein family and integrating with the 
canonical mitochondria-mediated apoptotic network (Woehlbier and Hetz, 2011). 
The four stages of UPR signaling highlight and emphasize the double-edged 
sword property of UPR and should be a key consideration in drug and 
therapeutic development. Whereas acute and early activation of UPR may be 
cyto-protective, prolonged and persistent ER stress engages the pro-apoptosis 
pathways.  
 Though ER stress-modulated cell fate determination by IRE1α and PERK 
has been well-studied, knowledge of the role of ATF6 is greatly lacking. 
Speculatively, as ATF6 needs to translocate to the Golgi network and undergo 
proteolysis before becoming an active UPR transcription factor, the temporal 
dynamics of ATF6 activation will be different than that of IRE1α and PERK. Also, 
as ATF6 transcriptional targets include genes functioning in folding and ERAD, 
this pathway likely promotes pro-survival. However, how ATF6 integrates with 
the IRE1α and PERK pathways to regulate cellular survival and apoptosis is an 
intriguing question. Furthermore, a key remaining enigma in the field is how 
these ER signaling pathways are inactivated. As IRE1α and PERK both undergo 
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extensive phosphorylation correlated with their activation status, the presence 
and action of phosphatases have been proposed to down-regulate these sensors. 
Notably, although IRE1α and PERK signaling are typified in the literature as pro-
survival and pro-apoptosis respectively (Lin et al., 2009), this delineation is not 
so straightforward as IRE1α signaling has also been reported to promote 
apoptosis through an interaction with apoptosis-related factors including BAX 
and BAK as well as autophagy through JNK activation (Hetz and Glimcher, 
2009). Hence, further investigations are warranted to tease out the relationship 
and dependency of these three signaling pathways on cell fate determination as 
well as the physiological and in vivo significance of these findings.  
 
1.10 RESEARCH AIM AND DISSERTATION ORGANIZATION 
 In summary, UPR activation and signaling has been implicated in a 
variety of human diseases and a complete understanding of how these pathways 
are regulated is critical in the development of therapeutics. Of the three major 
metazoan UPR pathways, the IRE1α-XBP1 is the most evolutionarily conserved. 
However, a comprehensive and mechanistic examination of how IRE1α-XBP1 
signaling is regulated as well as its function in different tissues remains 
incomplete. Hence, the overarching aim of this dissertation is to elucidate the 
regulatory mechanisms and understand the physiological relevance of IRE1α-
XBP1 activation and signaling by utilizing complementary biochemical, cellular, 
and genomics and proteomics-based assays.  
 An introduction and relevant literature review on protein homeostasis, ER 
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stress and IRE1α activation and signaling are presented in Chapter 1. Chapter 2 
focuses on the critical and indispensable role of IRE1α-XBP1 signaling in a 
cellular differentiation process in fat cells termed adipogenesis in which XBP1 
induces the expression of a key adipogenic factor, C/EBPα. Chapter 3 reports the 
identification and characterization of a novel cytoskeleton-associated factor, 
NMIIB, that regulates a key activation step of IRE1α signaling, namely 
oligomerization and foci formation. Lastly in Chapter 4, I review the 
implications, contribution and significance of my dissertation research by 
proposing a new model for the activation of the mammalian IRE1α-XBP1 
pathway as well as discuss how these studies may advance our knowledge of 
UPR signaling and their potential to identify new targets for drug intervention in 
treating conformational diseases.   
 The appendices in this dissertation are organized by independent projects 
and provide exciting and promising new insight into IRE1α activation and its 
physiological role. However, as most of these findings are preliminary, they have 
been excluded from the main chapters. Appendix A describes a novel role of 
XBP1 in macrophages in mediating the expression of key inflammatory 
mediators in response to canonical ER stress. This modulation may occur 
through a physical interaction with ATF3, a factor known to influence and 
integrate signaling pathways associated with immunity. Appendix B identifies a 
new “SSPS” motif located on the cytosolic linker region of IRE1α that is 
extensively phosphorylated upon ER stress and may be required for IRE1α trans-
autophosphorylation. Appendix C lists additional putative IRE1α-interacting 
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factors identified through a proteomics-based tandem mass spectrometry 
collaboration and postulates how they may function to modulate IRE1α 
activation and integrate into UPR signaling.  
	  39	  
CHAPTER 2∗ 
THE IRE1α-XBP1 PATHWAY OF THE UNFOLDED PROTEIN RESPONSE IS 
REQUIRED FOR ADIPOGENESIS 
 
2.1 ABSTRACT 
Signaling cascades during adipogenesis culminate in the expression of 
two essential adipogenic factors, PPARγ and C/EBPα.  Here we demonstrate that 
the IRE1α-XBP1 pathway, the most conserved branch of the unfolded protein 
response (UPR), is indispensable for adipogenesis. Indeed, XBP1-deficient mouse 
embryonic fibroblasts and 3T3-L1 cells with XBP1 or IRE1α knockdown exhibit 
profound defects in adipogenesis. Intriguingly, C/EBPβ, a key early adipogenic 
factor, induces Xbp1 expression by directly binding to its proximal promoter 
region. Subsequently, XBP1 binds to the promoter of Cebpa and activates its gene 
expression. The posttranscriptional splicing of Xbp1 mRNA by IRE1α is required 
as only the spliced form of XBP1 (XBP1s) rescues the adipogenic defect exhibited 
by XBP1-deficient cells. Taken together, our data show that the IRE1α-XBP1 
pathway plays a key role in adipocyte differentiation by acting as a critical 
regulator of the morphological and functional transformations during 
adipogenesis. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
∗ This chapter has been published as Sha, H.Ω, He, Y. Ω, Chen, H., Wang, C., Zenno, A., 
Shi, H., Yang, X., Zhang, X., and Qi, L. Cell Metabolism 9, 556-564 (2009) and is reprinted 
here with permission. Ω Co-first authors.  
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2.2 INTRODUCTION 
Excess adipose tissue mass plays a central role in obesity-related 
complications such as cancer, cardiovascular diseases, insulin resistance and type 
2 diabetes. A comprehensive understanding of the molecular mechanisms 
underlying adipocyte formation and development is of both fundamental and 
clinical relevance. Cellular models, such as 3T3-L1 and mouse embryonic 
fibroblasts (MEFs), are invaluable in studying adipocyte differentiation or 
adipogenesis (Farmer, 2006). During adipogenesis, two transcription factors, 
CCAAT/enhancer-binding protein β (C/EBPβ) and C/EBPδ, are induced very 
early and play a crucial role in initiating the differentiation program by 
activating the expression of peroxisome proliferator-activated receptor γ (PPARγ) 
and C/EBPα, two key adipogenic transcription factors that positively regulate 
each other to promote and maintain the differentiated state (Farmer, 2006; 
Tontonoz and Spiegelman, 2008). Ectopic expression of either PPARγ or C/EBPα 
induces non-adipogenic fibroblasts to differentiate into adipocytes. Cells or 
adipose tissues with disruption in either gene exhibit severe defects in adipocyte 
differentiation or fat depot formation (Farmer, 2006; Tontonoz and Spiegelman, 
2008). 
Under the regulation of this complex transcriptional circuit, pre-
adipocytes undergo dramatic transformations that ultimately lead to terminal 
adipogenic differentiation. However, it remains unclear how cells adapt to such 
dramatic morphological changes. Given their endocrine capacity and unique 
cellular structure, it has recently been hypothesized that adipocytes may display 
elevated UPR in an attempt to alleviate stress in the endoplasmic reticulum (ER) 
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caused by increased protein and lipid biosynthesis (Gregor and Hotamisligil, 
2007).  In yeast, upon ER stress, ER-resident transmembrane protein IRE1α 
oligomerizes and undergoes trans-autophosphorylation, leading to activation of 
its cytosolic endoribonuclease domain (Cox et al., 1993; Mori et al., 1993; Ron and 
Walter, 2007). Although phosphorylation of IRE1α has been used widely as an 
activation marker in experiments using ER stress inducers such as DTT or 
thapsigargin (Tg), recent studies in yeast suggest that the kinase activity may not 
be required for the endoribonuclease activity of IRE1α (Korennykh et al., 2009; 
Papa et al., 2003). However, the mechanism by which mammalian IRE1α is 
activated under physiological stress conditions remains largely unexplored. 
Once activated, mammalian IRE1α splices 26 nucleotides from the Xbp1 
mRNA, leading to a frameshift and the generation of an active b-ZIP 
transcription factor, XBP1s, that contains a C-terminal transactivation domain 
absent from the unspliced form XBP1u. XBP1s subsequently translocates to the 
nucleus and activates the transcription of genes involved in protein folding and 
degradation to restore ER homeostasis (Ron and Walter, 2007). Studies in animal 
models have revealed that the IRE1α-XBP1 pathway is essential for the 
development and function of the liver and heart as well as professional secretory 
cells such as pancreatic exocrine and plasma cells (Lee et al., 2005; Masaki et al., 
1999; Reimold et al., 2000; 2001; Zhang et al., 2005). Recently, XBP1 has been 
shown to regulate hepatic lipogenesis via a UPR-independent manner (Lee et al., 
2008a). However, its role in other cell types remains unclear. 
Interestingly, XBP1 is highly expressed in embryonic adipose depot 
(Clauss et al., 1993) and white adipose cells (Kajimura et al., 2008). Moreover, 
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XBP1-/- neonates rescued with hepatic XBP1s overexpression have no fat depot 
(Lee et al., 2005). These findings prompted us to hypothesize that XBP1 plays a 
role in adipocyte development. Indeed, our data demonstrate that XBP1 controls 
adipogenesis in part by transactivating the expression of a key adipogenic factor 
C/EBPα. In addition, our results suggest that adipogenic differentiation is 
associated with a low degree of UPR that is responsible for IRE1α activation and 
the subsequent splicing of Xbp1 mRNA. Intriguingly, IRE1α activity peaks 
during early adipogenesis and does not involve its hyperphosphorylation. 
 
2.3 MATERIALS AND METHODS 
Cells 
3T3-L1 pre-adipocytess, XBP1-/- and wild-type control MEFs (gifts from Laurie 
Glimcher, Harvard Medical School), HEK293T and phoenix cells were 
maintained in DMEM supplemented with 10% FBS (Hyclone) and 1% 
penicillin/streptomycin (Cellgro). Tg and Tm (EMD Calbiochem) were used at a 
final concentration of 300 nM and 2.5 µg/ml, respectively dissolved in DMSO. 
 
Generation of the pSuper/U6/retro vector  
The pSuper/U6/retro vector was constructed by subcloning the 350 bp EcoRI-
BamHI fragment including the U6 promoter and multiple cloning sites from the 
pBS/U6 vector to the pSuper/retro vector (EcoRI-BglII), replacing the H1 
promoter. 
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Retroviral transduction and stable cell line generation  
Phoenix cells were transfected with the plasmids encoding the gene of interest 
in pSuper or pBabe vectors and VSVG at 2:1 ratio for 16 h and then replaced 
with fresh culture media. Following 48 h culture, media containing retroviruses 
were harvested and used to transduce target cells in the presence of 5 µg/ml 
polybrene (Sigma) for 24 h. Stable cell lines were selected in the presence of 2 
µg/ml puromycin (Sigma) or 500 µg/ml G418 (EMD Calbiochem) and then 
used for differentiation. Typically, puromycin-resistant cell lines developed in 6 
days whereas G418 resistant cell lines were generated in 12 days. In rescue 
experiments, 3T3-L1 cells transduced with two retroviruses were selected with 
both puromycin and G418. To minimize the batch-to-batch difference, we only 
compared cells made from the same batch of cells.  
 
shRNA knockdown  
Two vectors were used in this study: pSuper/retro (H1 promoter, a gift from 
Lee Kraus, Cornell University) and pSuper/U6/retro (U6 promoter, described 
in Generation of the pSuper/U6/retro vector). XBP1i and IRE1αi were driven 
by the U6 promoter while C/EBPβi was driven by the H1 promoter. Control 
RNAi were against the firefly luciferase or the GFP gene. Target sequences are 
shown in Table 2.1. 
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Table 2.1. shRNA target sequences.  
List of shRNA targeting sequences designed using Dharmacon. XBP1i#4 targets 
the 3’ UTR and thus, has no effect on exogenously-transfected XBP1 cDNAs – 
the basis of the rescue experiments. All shRNAs are mouse-specific unless 
otherwise indicated.  
 
 
  
 
 
Mice and tissues   
Wildtype and ob/ob mice on C57BL/6 background were purchased from the 
Jackson Laboratory. The epididymal WAT, BAT and liver were harvested from 
(a) wildtype mice fed with either 60% HFD (Research Diets Inc.) or 10% chow 
diet for over 13 weeks; (b) ob/ob mice at the age of 12-26 week old. Tissues were 
harvested immediately following cervical dislocation, snap-frozen in liquid 
nitrogen and stored at -800C (Qi et al., 2009). All animal procedures were 
approved by the Cornell IACUC. 
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Plasmids and viruses   
XBP1u and XBP1s cDNAs, cloned from the mouse WAT cDNA library using 
pfu polymerase (Stratagene), were subcloned into pcDNA3/Flag or 3x HA 
vectors. Retroviral encoding XBP1u and Flag-XBP1s were cloned by shuttling 
XBP1 cDNA into the pBabe-puro vector. For retroviral transduction in the 3T3-
L1 experiments, cDNAs encoding the mouse C/EBPβ and rat C/EBPα were 
cloned into the pBabe-puro vector using standard PCR reactions. Promoter 
regions of mouse Xbp1 (-689 to +37 bp), Edem (-336 to +15 bp) and Cebpa (-320 to 
+45 bp) were cloned via PCR of tail genomic DNA of C57BL/6 mice and ligated 
into the pGL3-basic luciferase reporter construct (Promega). Constructs 
generated by PCR were sequenced by the Cornell DNA sequencing facility. 
 
Adipogenesis  
(a) 3T3-L1: Two days post-confluency (d0), cells were treated for 48 h with 0.25 
mM IBMX, 1 µM DXM (EMD Calbiochem) and 1 µg/ml insulin (Sigma).  
Afterwards, cells were fed every 48 h with 1 µg/ml insulin in culture media 
until d8 post confluence. (b) MEF: Cells were differentiated as 3T3-L1 with the 
following modifications: when the cells became confluent (d0), they were 
treated with 0.25 mM IBMX, 5 µM DXM, 10 µg/ml insulin and 5 µM 
troglitazone (EMD Calbiochem) for the first 48 h. Subsequently, cells were 
maintained in 1 µg/ml insulin and 5 µM troglitazone to induce terminal 
differentiation.  
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Oil Red-O staining  
Cells were fixed with 10% formaldehyde in PBS for 15 min at room temperature 
and stained with freshly-prepared Oil Red-O working solution for 30 min 
followed by three washes with water. Plates were scanned using an Epson 
scanner. Oil Red-O working solution was prepared by mixing 6 ml of 0.5% Oil 
Red-O (Sigma) in isopropanol with 4 ml of ddH2O followed by filtration through 
a Whatman #1 filter paper (Millipore). 
 
Western blot  
Western blot was performed using 15-30 µg of total cell lysates or 10 µg of 
nuclear extracts.  Antibodies used in this study: C/EBPβ (mouse, 1:1000, 
Biolegend); GRP78 (goat, 1:1,000), C/EBPα (rabbit, 1:2,000), PPARg (mouse, 
1:400), XBP1 (rabbit, 1:1,000), and HSP90 (rabbit, 1:5,000) from Santa Cruz; 
IRE1α (rabbit, 1:1,000, Cell Signaling); GAPDH (rabbit, 1:10,000, Novus 
Biologicals). Secondary antibodies, goat anti-rabbit IgG, anti-mouse IgG 
(Biorad), and donkey anti-goat IgG HRP (Jackson ImmunoResearch), were used 
at 1:10,000. The p-Ser724 IRE1α antibody from Novus Biologicals did not work 
in our hands. 
 
Nuclear-cytosolic fractionation 
Cells in a 6-cm dish were resuspended in 200 µl ice-cold hypotonic buffer (10 mM 
HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, and 1 mM DTT) and 
allowed to swell on ice for 15 min followed by addition of 10% of NP-40 to a final 
concentration of 0.6%. Lysates were vortexed vigorously for 15 s prior to 
	  	   47	  
centrifugation at top speed for 1 min. Supernatant was transferred to a fresh tube 
as the cytosolic fraction. Pellets were resuspended in 50 µl ice-cold high-salt 
buffer (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, and 1 mM 
DTT) and vortexed vigorously for 15 sec every 5 min for a total of 20 min. 
Extracts were spun at 4°C for 5 min and the supernatant (nuclear fractions) was 
collected. 
 
Phos-tag gels 
Phos-tag gel was carried out the same way as regular Western blots, except that: 
(a) 5% SDS-PAGE containing 50 µM Phos-tag (NARD Institute) and 50 µM 
MnCl2 (Sigma) were used; (b) gels were soaked in 1 mM EDTA for 10 min prior 
to transfer onto a PVDF membrane.  
 
Calf intestine phosphatase (CIP) treatment  
50 µg whole cell lysates (normally with starting concentrations around 5 µg/µl) 
were mixed with 8 µl 10x NEB buffer 3 and 5 µl CIP (10 U/µl, NEB) in a 80 µl 
reaction (fill to the volume with PBS) at 37°C for 60 min. The reaction was 
stopped by addition of 20 µl 5x SDS sample buffer followed by boiling for 5 min. 
15 µg of lysates were loaded onto a 5% gel followed by Western blot analysis of 
IRE1α. 
 
RNA extraction and Q-PCR 
Total RNA was extracted using Trizol per supplier’s protocol (Molecular 
Research Center) and reverse transcribed using Superscript III kit (Invitrogen). 
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cDNA were analyzed using the Power SYBR Green PCR kit on the ABI PRISM 
7900HT Q-PCR machine (Applied Biosystems) or the SYBR Green PCR system 
(gifts from Jeff Pleiss, Cornell University) on the iQ5 or Cfx384 Q-PCR machine 
(Bio-Rad). All Q-PCR data were normalized to ribosomal l32 gene. 
 
RT-PCR for Xbp1 splicing  
PCR primers were designed to encompass the splicing sequences of mouse Xbp1 
(Table 2.2). PCR products, amplified with annealing temperature at 580C for 30 
cycles, were separated by electrophoresis on a 2.5% agarose gel (Invitrogen). 
Quantitation of percent of splicing, defined as the ratio of Xbp1s level to total 
Xbp1 (Xbp1u +Xbp1s) levels, was carried out using the NIH ImageJ software.  
 
Quick-change mutagenesis 
Mutagenesis was carried out by PCR amplification using pfu (Stratagene) 
followed by digestion by DpnI (NEB) to get rid of the templates. Primer 
sequences are listed in Table 2.2. Mutations at specific positions were 
subsequently sequenced and confirmed. 
 
 
Luciferase reporter assay  
After overnight transfection, cells were lysed in extraction buffer (Gly-Gly buffer, 
1% Triton X-100, and 1 mM DTT). 50 µl of lysates were transferred to a 96-well 
plate containing 50 µl of assay mix (Gly-Gly buffer, 16 mM K2HPO4, 2 mM DTT 
and 2.5 mM ATP). 100 µl of 0.4 mM luciferin mix was added to each well through 
injector and readings were collected using the Synergy 2 plate reader (Biotek). 
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Luciferase activity was normalized to activity from co-transfected Rous sarcoma 
virus-β-galactosidase expression plasmid. 
 
 
 
 
Table 2.2. Primer sequences.  
Primer position, where noted, is relative to the transcription start site (TSS).  
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Chromatin immunoprecipitation (ChIP) 
3T3-L1 cells were cross-linked by 1% formaldehyde at room temperature for 20 
min. Glycine was added for 5 min to a final concentration of 0.125 M. Cells were 
resuspended in buffer containing 25 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 
0.5% NP-40, 1 mM DTT, and protease inhibitors. Nuclei were collected by 
centrifugation and pellet was resuspended in 50 mM HEPES, 140 mM NaCl, 1 
mM EDTA, 1% Triton X-100, 0.1% DOC, 0.1% SDS, and protease inhibitors. 
Samples were sonicated on ice to an average length of 600 bp. Chromatin was 
pre-cleared with protein A agarose (Invitrogen) at 4°C for 30 min, then incubated 
with 2 µg of antibody: IgG (Santa Cruz, sc-2027), XBP1 (sc-7160x), C/EBPβ 
(Biolegend, 6062). 50 µl of a 30% salmon-sperm-DNA-saturated protein A 
agarose (Invitrogen) was added to recover immune complexes for 2 hr. 
Immunoprecipitates were washed and eluted. Cross-links were reversed and 
samples were incubated in 0.5 mM EDTA, 1 mM Tris (pH 6.5), and 10 µg/ml 
proteinase K (Invitrogen) at 45°C for 1 hr. Samples were purified using Qiagen 
PCR Purification Kit (Qiagen), and assayed by Q-PCR. Primer sequence and 
positions are in Table 2.2. Annealing temperature for the PCR (Tm) is 58°C. Each 
ChIP experiment was conducted at least twice with independent chromatin 
preparations from different samples to ensure reproducibility. 
 
Electron microscopy (TEM) 
The TEM study of the ER morphology in differentiating 3T3-L1 cells was carried 
out with the assistance of the Cornell Imaging Core Facility. 3T3-L1 adipocytes 
(d5) were fixed in 2% glutaldehyde in 0.1 M cacodylate pH 7.4, for 0.5 hr at room 
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temperature and 1 hr at 4°C. After washing in cacodylate buffer, cells were 
postfixed for 1 hr in 1% osmium tetroxide in the same buffer at room 
temperature and washed again. After dehydration in a graded series of ethanol, 
cells were embedded in Epon/Araldite epoxy resin (Electron Microscopy 
Sciences) and all samples were polymerized at 60°C for 24 hr. Ultrathin sections 
were cut on a ultramicrotome (Reichert Om U2), collected on formvar- and 
carboncoated copper 200 hex grids, stained with 2% uranyl acetate and lead 
citrate, and viewed on a transmission electron microscope (Tecnai 12BioTWIN; 
FEI Company). Pictures were taken as a blind study where the photographer was 
not involved in the project. Two repeats of the experiment were carried out and 3 
representative pictures were shown. 
 
Statistical analysis  
Results are expressed as mean ± s.e.m. Comparisons between groups were 
made by unpaired two-tailed Student’s t-test. P<0.05 was considered as 
statistically significant. All experiments were repeated at least three times and 
representative data are shown. 
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2.4 RESULTS 
2.4.1 XBP1 is indispensable for adipogenesis  
In 3T3-L1 differentiating adipocytes, Xbp1 mRNA increased significantly 
at day 2 (d2) and peaked around d4 (Fig. 2.1A). Consistently, XBP1s protein also 
peaked at d4 (Fig. 2.1B); this pattern strikingly resembles the induction of PPARγ 
and C/EBPα. To examine the role of XBP1 during adipogenesis, we transduced 
3T3-L1 cells with control retroviruses (CONi) or with retroviruses encoding short 
hairpin RNAs against XBP1 (XBP1i). Lines #4 and #5 exhibited over 80 and 60% 
knockdown efficiency, respectively, as tested by immunoblots of cells treated 
with Tg (Fig. 2.1C top) and Q-PCR analysis of differentiating XBP1i cells (Fig. 
2.1A). When these cells were cultured under adipogenic conditions, XBP1i-
expressing cells demonstrated greatly attenuated differentiation, indicating an 
impaired adipogenic program (Fig. 2.1C bottom). Similar observations were 
obtained in XBP1-/- MEFs (Fig. 2.1D). Arguing against a non-specific effect 
provoked by short interference RNAs, 3T3-L1 cells expressing XBP1i that failed 
to effectively knockdown XBP1 (#1-2) exhibited no defects in adipogenesis (Fig. 
2.2B). Taken together, XBP1 is essential for adipogenesis. 
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Figure 2.1.  XBP1 is essential for adipocyte differentiation.  
(A) Q-PCR analysis showing total Xbp1 mRNA levels in 3T3-L1 CONi and XBP1i 
#4 during differentiation. Data normalized to d0 time point of 3T3-L1 CONi cells. 
Data are means ± SEM. *p<0.05 using unpaired two-tailed Student’s t test 
comparing CONi to XBP1i at the same time point. (B) Immunoblots showing the 
levels of XBP1s and key adipogenic markers (C/EBPβ, C/EBPα and PPARγ) 
during adipogenesis. 3T3-L1 pre-adipocytes treated with 300 nM Tg for 4 hr was 
loaded as a control. XBP1u (30 kDa) protein was not detectable. HSP90 and 
CREB, loading controls. (C) Top: Immunoblots of XBP1s protein in wild-type 
MEFs stably expressing CONi, XBP1i #4, #5, or both treated with 300 nM Tg for 
4 hr. CREB, a loading control. Bottom: Macroscopic pictures of Oil Red-O 
staining of 3T3-L1 cells expressing CONi and XBP1i #4 and #5 differentiated for 
8 days (d8). (D) Left: Macroscopic pictures of Oil Red-O staining of wild-type 
(WT) and XBP1-/- MEFs differentiated for 24 days (d24). Right: Immunoblots of 
XBP1s protein in MEFs treated with 300 nM Tg for 4 hr.  
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Figure 2.2.  Two constructs that fail to deplete XBP1 have no effect on 3T3-L1 
adipogenesis.  
(A) Macroscopic pictures of Oil Red-O staining of differentiating 3T3-L1 cells. 
Two-days after confluence (d0), cells were induced to differentiate for 2 days (d2) 
followed by terminal differentiation for the next 6 days (d4, d6, d8). Cells were 
fixed and stained with Oil Red-O. (B) Top, macroscopic pictures of Oil Red-O 
staining of differentiated 3T3-L1 cells (d12) expressing CONi or XBP1i #1-2 (two 
negative controls). Bottom, immunoblot of XBP1 in cells stably expressing CONi 
or XBP1i #1-2 treated with 2.5 µg/ml TM or 300 nM Tg for 4 hr.  
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2.4.2 C/EBPβ  induces Xbp1 expression  
In light of a significant induction of Xbp1 mRNA during early 
differentiation, we next examined the mechanism underlying the transcriptional 
regulation of Xbp1. We first tested which component(s) of the adipogenic-
inducing regimen was responsible for regulating Xbp1 induction. Only 
isobutylmethylxanthine (IBMX) or all three components of the regimen (IBMX, 
dexamethasone (DXM) and insulin) increased Xbp1 gene expression (Fig. 2.3A), 
suggesting that Xbp1 transcription is responsive to changes in cellular cAMP 
levels as IBMX is a phosphodiesterase inhibitor. 
The ability of cAMP signals to activate C/EBPβ during adipogenesis (Cao 
et al., 1991; Farmer, 2006) prompted us to test whether C/EBPβ regulates Xbp1 
expression. Indeed, total Xbp1 mRNA increased nearly 10-fold with a peak at 8 
hr postinduction within the first 24 hr; this upregulation occurred subsequently 
to that of the Cebpb gene, which peaked at 2 hr postinduction (Fig. 2.3B). 
Consistently, XBP1s protein levels also peaked at 8 hr postinduction (Fig. 2.3C). 
Supporting the scenario that C/EBPβ directly regulates Xbp1 expression, 
recent genome-wide analysis identified putative C/EBP binding sites on the 
Xbp1 promoter (Lefterova et al., 2008). Indeed, sequence analysis of mammalian 
Xbp1 proximal promoter revealed the presence of a highly conserved C/EBP 
binding element (Osada et al., 1996) centered at -482 bp relative to transcription 
start site (Fig. 2.4A). Chromatin immunoprecipitation (ChIP) experiments 
showed enrichment of C/EBPβ proteins on the Xbp1 proximal promoter at 8 hr 
postinduction and on d4 (Fig. 2.3D). Further confirming the specificity of the 
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C/EBPβ antisera, no signal was detected at the 3’ UTR region of Xbp1 (not 
shown). In addition, overexpression of C/EBPβ in HEK293T cells activated a 
Xbp1 promoter (-689 to +37 bp)-luciferase reporter (Fig. 2.3E). This activation was 
significantly attenuated over 50% by deleting the putative binding element (Figs. 
2.3E and 2.4B). 
To further confirm the effect of C/EBPβ on Xbp1 induction, we generated 
3T3-L1 cells stably expressing C/EBPβ shRNA with over 80% knockdown 
efficacy (Figs. 2.3F-G). Loss of C/EBPβ significantly blocked differentiation as 
expected (Fig. 2.4C). Indeed, Xbp1 mRNA levels were reduced by nearly 60% in 
differentiating C/EBPβi 3T3-L1 cells compared to CONi cells at 8 h 
postinduction (Fig. 2.3G). Taken together, our data strongly suggest that the 
Xbp1 gene is a bona fide direct target of C/EBPβ during adipogenesis. 
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Figure 2.3.  C/EBPβ  induces Xbp1 expression.  
(A) Q-PCR analysis of Xbp1 mRNA in 3T3-L1 cells (d0) treated with various 
stimuli as indicated for 8 hr. Data normalized to the mock-treated sample (CON). 
(B) Q-PCR analysis showing the expression patterns of Xbp1 and Cebpb mRNA 
within the first 24 hr postinduction in differentiating 3T3-L1 cells. (C) 
Immunoblot showing the expression patterns of XBP1s, CHOP10 and C/EBPβ 
proteins in differentiating 3T3-L1 cells. HSP90, a loading control. (D) ChIP 
analysis showing the recovery of Xbp1 promoter from immunoprecipitates of 
C/EBPβ or control IgG prepared from differentiated 3T3-L1 cells at d0, 8 hr 
postinduction and d4. The amount of Xbp1 promoter (-580 to -425 bp) recovered 
was quantitated using Q-PCR. Data normalized to the IgG controls at each point. 
(E) Luciferase assay showing effects of C/EBPβ on wild-type (WT) or mutated 
Xbp1 reporter activity (-689 to +37 bp) in HEK293T cells transiently transfected 
with control GFP (CON) or C/EBPβ. ΔC/EBP, deletion of the C/EBP binding site 
(Fig. 2.4B). (F, G) Knockdown of C/EBPβ reduces Xbp1 level. Western blot (F) 
showing the protein level of C/EBPβ in 3T3-L1 stably expressing CONi or 
C/EBPβi. Q-PCR analysis (G) of Cebpb and Xbp1 mRNA levels at 4 hr or 8 hr 
postinduction. Data are represented as mean ± SEM. *p<0.05 using unpaired 
two-tailed Student’s t test comparing either the samples included by the brackets 
or that particular sample to the rest samples.  
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Figure 2.4.  C/EBPβ  binding site on Xbp1 promoter is required for Xbp1 
induction during adipogenesis.  
(A) Putative C/EBPβ binding elements on the XBP1 proximal promoter from 
human, mouse and rat. Consensus sites are highlighted in bold. (B) Mutagenesis 
of C/EBPβ binding element. All 10 bases of the C/EBPβ binding element were 
deleted (ΔCEBP). (C) Macroscopic image of differentiated 3T3-L1 expressing 
CONi or C/EBPβi at day 8.  
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2.4.3 Adipogenesis is associated with a low measure of UPR  
IRE1α is the predominant form of IRE1 in adipocytes (not shown) and 
throughout adipogenesis, its mRNA expression level did not vary significantly 
(Fig. 2.6A). During UPR, IRE1α splices Xbp1 mRNA to generate XBP1s, a potent 
transcription factor (Ron and Walter, 2007). Phosphorylation of IRE1α and Xbp1 
mRNA splicing are two common markers of UPR activation that can be assessed 
by the mobility shift of IRE1α protein on an SDS-PAGE gel and by the ratio of the 
spliced Xbp1s mRNA to total Xbp1 mRNA using RT-PCR analysis, respectively. 
To increase the resolution of the phosphorylated forms of a protein on a 
SDS-PAGE, we incorporated Phos-tag and Mn2+ in regular SDS-PAGE gels 
(Kinoshita et al., 2006). Dramatically, in HEK293T cells, nearly 100% of IRE1a 
proteins were hyperphosphorylated upon a 1.5 h-treatment with Tg and only 
~30% after 13 h (Fig. 2.5A). Interestingly, in all the conditions and samples tested, 
IRE1α exhibited one predominant band shift which was reversible by 
phosphatase (CIP) treatment (Fig. 2.5B), suggesting that trans-
autophosphorylation of mammalian IRE1α may not be as extensive as predicted 
for the yeast counterpart (Korennykh et al., 2009). 
Surprisingly, we failed to observe a mobility shift of IRE1α at any time-
point during differentiation (Fig. 2.5B). Arguing against the possibility that 
IRE1α in 3T3-L1 cells can not be phosphorylated, Tg treatment for as little as 20 
min induced a dramatic mobility shift of nearly 100% of IRE1α proteins (Fig. 
2.5A). Consistently, the majority of IRE1α in both white and brown adipose 
tissues (WAT and BAT) of wild-type lean animals at 23-27 weeks of age were not 
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phosphorylated (Figs. 2.5C and 2.6B). In contrast, IRE1α phosphorylation was 
readily detectable in the liver from the same set of mice (Fig. 2.6B). 
Next, we quantitated the percent of Xbp1 splicing using RT-PCR as a 
direct measure of IRE1α RNase activity. Unexpectedly, Xbp1 mRNA splicing 
peaked at d0 (mean ± SEM; 55.9 ± 4.9%) and reached nadir at d4 (15.1 ± 2.4%) 
(Figs. 2.5D and 2.6C). Supporting the physiological relevance of our cell model, 
the level of Xbp1 mRNA splicing on d8 of 3T3-L1 adipocytes was very similar to 
that of adipose tissues from wild-type lean mice (23.1 ± 4.1% vs. 18.3 ± 1.3%, Fig. 
2.5E). As a positive control, Xbp1 mRNA splicing reached approximately 50% in 
pancreas of lean wild-type animals [(Iwawaki et al., 2004) and not shown]. Given 
that d0 adipocytes and pancreas exhibit similar levels of Xbp1 mRNA splicing, 
we conclude that physiological UPR is activated during early adipogenesis. 
Obesity is postulated to cause ER stress or UPR in adipose tissues. 
However, the nature and the extent of UPR in adipose tissues of obese animals 
remain unclear. To this end, we examined IRE1α phosphorylation and Xbp1 
splicing in mice that were either genetically- or dietary- induced to become obese 
(ob/ob and HFD). Unexpectedly, ~15% of IRE1α proteins were phosphorylated in 
WAT of these animals (Fig. 2.5C and not shown). Correspondingly, the splicing 
of Xbp1 in WAT was increased from 18.3 ±1.3% in lean mice to 33.9 ± 6.8% in 
obese animals (Figs. 2.5E and 2.6D). Thus, our data supports the notion that a 
low measure of UPR is associated with obesity. 
During differentiation, XBP1s protein levels were inversely correlated 
with Xbp1s mRNA levels (Figs. 2.1B vs. 2.5D and 2.3C vs. 2.6C). We reasoned that 
XBP1 may function to maintain UPR in adipocytes at a low level via feedback 
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inhibition on UPR and IRE1α activity. To directly test this possibility, we 
measured Xbp1 mRNA splicing in XBP1-deficient cells and wild-type cells. 
Indeed, Xbp1 mRNA splicing was increased over two-fold in XBP1i vs. CONi 
adipocytes on d8 (48.6 ± 1.1% vs. 21.9 ± 3.3%, Fig. 2.5F). Similar observations 
were obtained in XBP1-/- differentiating MEF adipocytes (26.1 ± 3.9% vs. 14.6 ± 
1.8%, Fig. 2.5F). Surprisingly, the majority of IRE1α was not hyper-
phosphorylated in XBP1-deficient adipocytes (Fig. 2.6E). 
As UPR is intimately linked to ER morphology and function (Ron and 
Walter, 2007), we examined the fine structure of the ER using transmission 
electron microscopy (TEM). Unlike the packed ER cisternae characteristic of 
professional secretory cells (Harding et al., 2001; Lee et al., 2005), the ER of 
adipocytes (d5) have few loosely dispersed cisternae with discernible ribosomes 
(Fig. 2.5G) as shown previously (Novikoff et al., 1980). By contrast, most of the 
ER in the XBP1i cells were fragmented and somewhat dilated compared to those 
in control adipocytes (Figs. 2.5G and 2.6I). Thus, our data suggest that XBP1 
functions to maintain ER homeostasis in adipocytes; hence loss of XBP1 in 
adipocytes disrupts ER function and activates IRE1α. 
To determine if the IRE1α-mediated splicing event is critical for 
differentiation, we transduced 3T3-L1 XBP1i cells with retroviruses encoding the 
pBabe vector, XBP1u or XBP1s (Fig. 2.6F). Only ectopic expression of XBP1s 
almost completely rescued the differentiation defect of 3T3-L1 XBP1i cells (Fig. 
2.5H). Further supporting the role of XBP1s in adipogenesis, XBP1s protein levels 
were much higher than XBP1u in differentiated 3T3-L1 cells at d6 (Fig. 2.6G). 
Thus, Xbp1 mRNA splicing by IRE1α RNase activity is required for adipogenesis. 
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 To directly test the consequences of IRE1α deficiency in adipogenesis, we 
generated 3T3-L1 cells stably expressing IRE1α shRNA (IRE1αi). One shRNA 
(#4) reduced IRE1α protein levels to less than 10% of controls (Fig. 2.5I). 
Supporting a key role of IRE1α in mediating Xbp1 splicing, knockdown of IRE1α 
significantly reduced Xbp1 splicing (54.4 ± 2.2% CONi, 41.7 ± 6.7% XBP1i vs. 24.3 
± 3.6% IRE1αi, Fig. 2.5J) and XBP1s production in cells treated with Tg for 3 h 
(Fig. 2.5I). Cells stably expressing IRE1αi#4 failed to undergo differentiation to a 
similar degree as XBP1i or C/EBPβi cells (Fig. 2.5K); cells expressing shRNA (#2) 
with no knockdown effect exhibited normal differentiation (Fig. 2.6H). Thus, our 
data indicate that adipogenic conversion is associated with UPR and the IRE1α-
XBP1 branch is indispensable for adipogenesis. 
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Figure 2.5.  Adipogenesis is associated with a low level of physiological UPR. 
(A) Western blot showing mobility shift of IRE1α using Phos-tag or regular SDS-
PAGE gels in (left) HEK293T and (right) 3T3-L1 cells treated with 300 nM Tg for 
indicated period. “p” and “0”, hyper- and non-phosphorylated IRE1α, 
respectively. Solid and dotted lines on the left-hand side indicate Phos-tag and 
regular gels, respectively. (B) Immunoblot showing separation of p-IRE1α from 
IRE1α using regular and Phos-tag gels with or without CIP treatment (1 hr) in 
differentiating 3T3-L1 adipocytes. Two positive controls: Tg1, HEK293T cells 
treated with 300 nM Tg for 1.5 hr; Tg 2, 3T3-L1 cells treated with 300 nM Tg for 4 
hr. HSP90, a loading control. (C) Western blot showing mobility shift of IRE1α in 
white adipose tissues (WAT) collected from wild-type lean and ob/ob animals 
using Phos-tag with or without CIP treatment. The age of the mice (in weeks) 
shown. (D-F) RT-PCR analysis of Xbp1 splicing (Xbp1u and s) in (D) 
differentiating 3T3-L1 adipocytes, (E) WAT of wild-type lean (wt) and obese 
animals, and (F) differentiating 3T3-L1 and MEFs with XBP1 deficiency at d8 and 
d9, respectively. Samples treated with Tg for 2 hr or 5 hr were used as controls. 
L32, a loading control. (G) Electron microscopic images of differentiated 3T3-L1 
CONi or XBP1i adipocytes at d5. Each image taken from a different cell. Arrows, 
ER; m, mitochondrion; N, nucleus; L, lipid droplets. Scale bar shown at the right 
corner of each panel. (H) Macroscopic images of differentiation of 3T3-L1 
expressing CONi and XBP1i plus pBabe-vector, XBP1s or XBP1u. Oil Red-O 
staining was carried out on d6. (I-K) Knockdown of IRE1α reduces Xbp1 splicing 
and attenuates differentiation. Western blot analysis (I) showing the IRE1α and 
XBP1s protein levels in XBP1i and IRE1αi #4 3T3-L1 cells. Nuclear-extracts were 
used for blots showing the levels of XBP1s in cells treated with 300 nM Tg for 3 
hr. HSP90 and CREB, loading controls. (J) RT-PCR analysis of Xbp1 splicing 
(Xbp1u and s) in 3T3-L1 cells treated with Tg for 3 hr and quantitated as above. 
(K) Macroscopic images of differentiation of 3T3-L1 expressing CONi, XBP1i, 
C/EBPβi, or IRE1αi #4. Oil Red-O staining was carried out on d10. For RT-PCR 
analysis of Xbp1 splicing, quantification was done using the NIH ImageJ 
software where band densities were calculated and subtracted from the 
background. Data are represented as mean ± SEM of data from at least three 
experiments. *p < 0.05 using unpaired two-tailed Student’s t test comparing the 
samples included by the brackets. 
	  66	  
 
  
	  67	  
Figure 2.6.  Basal UPR occurs during adipocyte differentiation.   
(A) Q-PCR analysis of Ire1a mRNA during 3T3-L1 adipogenic differentiation. 
Data normalized to d0. (B) Immunoblot showing separation of p-IRE1α from 
IRE1α of samples prepared from brown adipose tissues (BAT) and liver using 
Phos-tag gels. Tissues were collected from wild-type lean male mice at age of 27 
weeks. (C) RT-PCR analysis of Xbp1 splicing in samples collected during 3T3-L1 
differentiation as indicated. Quantification of percent of splicing was done using 
NIH ImageJ software where band densities were calculated and subtracted from 
the background. Samples treated with Tg for 2 or 5 hr were used as controls. L32, 
a loading control. *p<0.05 using unpaired two-tailed Student’s t test comparing 
the sample indicated by the brackets. (D) RT-PCR analysis of Xbp1 splicing in 
WAT from wild-type lean mice (wt) and obese animals (HFD and ob/ob). The 
age of the animals and the length of HFD feeding indicated. (E) Immunoblot 
showing separation of p-IRE1α from IRE1α of 3T3-L1 XBP1i cells collected at 
different time points during differentiation using Phos-tag gels. (F) Western blot 
analysis showing the protein levels of XBP1 in the rescue experiment shown in 
Figure 2.5H. 3T3-L1 cells stably expressing CONi or XBP1i expressing pBabe 
vector (-), FKBP-XBP1u (u) or Flag-XBP1s (s) were treated with 300 nM Tg for 3 
hr prior to the nuclear extraction and Western blot analysis. The FKBP tag has no 
effect on the stability of XBP1u protein with or without the ligand Shield-1. The 
bands representing Flag-XBP1s, FKBP-XBP1u, endogenous XBP1s are indicated. 
CREB, a loading control. (G) Immunoblot showing XBP1 protein levels in 
differentiating 3T3-L1 cells (d6) with or without 10 nM proteasome inhibitor 
MG132 for 1 hr. Note that XBP1u is only visible when cells were treated with 
MG132. (H) Top, Macroscopic pictures of Oil Red-O staining of differentiated 
3T3-L1 cells (d8) expressing CONi or IRE1αi #2 (a negative control). Bottom, 
Immunoblot showing the IRE1α protein levels in lysates from 3T3-L1 CONi or 
IRE1αi #2 cells. (I) Additional electron microscopic images of the differentiated 
3T3-L1 CONi or XBP1i cells. Arrows, ER; M, mitochondrion. Scale bar at the right 
corner of each image.  
	  68	  
 
 
 
 
  
	  	   69	  
2.4.4 XBP1 directly regulates C/EBPα  expression 
We speculated that XBP1 may regulate the expression of an important 
adipogenic factor. Indeed, C/EBPα protein levels were significantly decreased in 
differentiating XBP1-/- MEFs while C/EBPβ levels remained largely unaffected 
(Fig. 2.7A). Similar observations were obtained in 3T3-L1 adipocytes (Fig. 2.8A). 
Furthermore, Cebpa mRNA levels on both d4 and d6 were significantly reduced 
by over 90% in 3T3-L1 XBP1i cells compared to CONi cells whereas both Pparg1 
and Pparg2 mRNA levels were reduced by approximately 50% only on d6 (Fig. 
2.7B).  Supporting the notion that XBP1 targets are cell-type specific (Acosta-
Alvear et al., 2007; Lee et al., 2005), expression of some known XBP1 targets Erdj4 
and p58IPK (Lee et al., 2003a) was not affected in XBP1i adipocytes (Fig. 2.7B). 
XBP1 preferentially binds to CRE-like sequences containing an ACGT core 
(Acosta-Alvear et al., 2007; Clauss et al., 1996). Considering that the Cebpa 
proximal promoter region contains a highly conserved putative XBP1 binding 
element centered at -270 bp (Fig. 2.7C), we tested the role of XBP1 in modulating 
Cebpa expression in adipocytes. Pointing to a direct regulatory role for XBP1 in 
vivo, XBP1 was enriched on the Cebpa promoter on d4 (Fig. 2.7D); this binding 
was comparable to that of C/EBPβ  on d4 and was completely abolished in 
XBP1i 3T3-L1 cells (Figs. 2.7D and 2.8B). Demonstrating the specificity of the 
antibody, the XBP1 antibody is highly specific for both XBP1s and XBP1u 
proteins in immunoprecipitation (Fig. 2.8D). 
In further support of the notion that XBP1 transactivates Cebpa expression, 
XBP1s overexpression increased Cebpa promoter activity in luciferase reporter 
assays in XBP1-/- MEFs and HEK293T cells whereas XBP1u had no effect (Fig. 
	  	   70	  
2.8E). The activity of XBP1s on the Cebpa promoter was comparable to that on the 
promoter of a known target gene Edem1 (Fig. 2.8E); this activation was largely 
abolished by either mutation or deletion of the XBP1 binding element on the 
Cebpa promoter (Figs. 2.7E and 2.8C). In a rescue experiment, C/EBPα 
overexpression readily rescued the differentiation defects observed in XBP1i cells 
(Fig. 2.8F), suggesting that adipogenic attenuation in these cells may be in part 
due to the reduction in C/EBPα levels.  Taken together, our data demonstrates 
that Cebpa is a bona fide target of XBP1s in adipocytes. 
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Figure 2.7.  XBP1 controls Cebpa expression.  
(A) Western blot analysis of C/EBPα and C/EBPβ protein levels in XBP1-/- and 
wild-type MEFs. GRP78 and GAPDH, loading controls. (B) Q-PCR analysis in 
differentiating 3T3-L1 expressing CONi and XBP1i #4. Data normalized to d0 
time point of 3T3-L1 CONi adipocytes. (C) Conservation of XBP1 binding sites 
on the Cebpa promoter. The core binding element ACGT is underlined. (D) ChIP 
analysis showing the recovery of Cebpa promoter from immunoprecipitates of 
C/EBPβ, XBP1, or control IgG prepared from 3T3-L1 cells at d0, 8 hr 
postinduction and d4 as indicated. The amount of Cebpa promoter (-335 to -82 
bp) recovered was quantitated using Q-PCR. Data normalized to the IgG controls 
at each point. (E) Luciferase assay showing effects of XBP1s on Cebpa reporter 
activity (-320 to +45 bp) in HEK293T cells transiently transfected with control 
GFP (CON) and XBP1s. The Cebpa reporter constructs with either mutation 
(XBPmt) or deletion (ΔXBP) of the XBP1 binding sites were included. Data 
represented as mean ± SEM. *p<0.05 using unpaired two-tailed Student’s t test 
comparing the samples included by the brackets. (F) Model showing the role of 
IRE1α-XBP1 in adipogenesis. The new findings described in this paper are 
highlighted in bold. See text for details.  
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Figure 2.8.  XBP1 binds to the Cebpa promoter and induces its expression.  
(A) Immunoblot assay showing the level of C/EBPα and C/EBPβ in 
differentiating 3T3-L1 adipocytes at d8 expressing CONi, XBP1i, IRE1αi, and 
C/EBPβi. (B) ChIP analysis showing the recovery of Cebpa promoter from 
immunoprecipitates of control IgG or XBP1-specific antibody prepared from 
differentiating 3T3-L1 CONi or XBP1i cells at d4. The amount of Cebpa promoter 
(-335 to -82 bp) recovered was quantitated using Q-PCR. Data was normalized to 
IgG control of each sample. (C) Mutagenesis of XBP1 binding elements. The core 
ACGT nucleotides were either deleted (ΔXBP) or mutated to AAAA (XBPmt). 
(D) Left, Immunoblot assay showing recovery of endogenous XBP1 from 
immunoprecipitates of XBP1 prepared from HEK293T cells treated with 5 µg/ml 
Tm for 6 hr. Note the lack of the 30 kDa XBP1u protein in the IP samples, 
presumably because XBP1u protein is quickly degraded. Right, Western blot 
showing XBP1s and XBP1u in pancreatic lysates from wild-type mice. The same 
antibody was used in the ChIP studies shown in Figs. 2.7D and 2.8B. (E) Reporter 
assay of XBP1-/- MEFs transfected with Cebpa reporter (-320 to +45 bp) and 
XBP1u or XBP1s. Edem reporter (-336 to +15 bp), a positive control. Data was 
normalized to control GFP-transfected samples. (F) Macroscopic images of 
differentiation of 3T3-L1 expressing CONi or XBP1i plus pBabe-vector (CON) or 
pBabe-Flag-C/EBPα. Oil Red-O staining was carried out on d8.  
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2.5 DISCUSSION 
Adipocytes are specialized cell types that integrate lipid metabolism with 
protein synthesis in a very compact cellular space. Here we show that the IRE1α-
XBP1 pathway, the most conserved branch of the UPR, is indispensable for the 
cellular transformation into adipocytes (Fig. 2.7F). Investigation of the 
underlying mechanism uncovered a number of discoveries about the function of 
the IRE1α-XBP1 branch in adipogenesis that increased our understanding of this 
pathway in adipocytes. 
First, we show that adipogenesis is associated with a low level of UPR – 
termed as “physiological” UPR. IRE1α activity peaks during early adipogenesis 
with nearly 55% of Xbp1 mRNA being spliced. Subsequently, splicing is reduced 
to 10–20% in mature adipocytes. Indeed, the splicing in fully differentiated 
adipocytes in our culture system is equivalent to that in mature adipocytes from 
wild-type lean mice. Upon induction of obesity, there is approximately a 2-fold 
increase in Xbp1 mRNA splicing with only a minor fraction of the IRE1α proteins 
being hyper-phosphorylated. In support of our observations, UPR activation was 
detected mainly in the pancreas and skeletal muscles in a UPR-reporter 
transgenic mouse model with ~50% and 26% Xbp1 mRNA splicing, respectively; 
no UPR was detected in any other organs including adipose tissues (Iwawaki et 
al., 2004). Thus, we conclude that UPR is activated at an early stage of 
adipogenesis and maintained at a relatively low physiological level in mature 
adipocytes. Moreover, obesity is associated with elevated UPR, but the level of 
UPR activation incurred in adipose tissues is not as high as anticipated. 
Second, we show that the majority of IRE1α proteins are not 
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hyperphosphorylated during adipogenesis even as Xbp1 mRNA splicing 
approaches 55% on d0 of adipocyte differentiation. We speculate that 
hyperphosphorylation may not be required for activation of IRE1α RNase 
activity under physiological UPR. Indeed, although several structural studies 
have implicated the importance of dimerization and trans-autophosphorylation 
of IRE1α in activation of its RNase activity (Lee et al., 2008a; Zhou et al., 2006), an 
earlier study showed that the kinase-defective IRE1α K599A mutant has intact 
RNase activity (Tirasophon et al., 2000). Furthermore, a recent structural study 
on the cytosolic domain of yeast IRE1α (Korennykh et al., 2009) suggests that 
trans-autophosphorylation of IRE1α is not required for its RNase activation. As 
our data show that IRE1α RNase activity is dynamically regulated during 
adipogenesis, some intriguing questions arise: Is IRE1α activated by misfolded 
proteins during adipogenesis? How is IRE1α RNase activity affected by trans-
autophosphorylation during this process? Does oligomerization of IRE1α 
proteins and formation of IRE1α foci occur under physiological UPR in mammals 
as shown in drug-treated yeast? Many detailed biochemical studies are required 
before we can fully appreciate the mechanisms of mammalian IRE1α activation 
under physiological conditions. 
Third, we show that C/EBPβ regulates Xbp1 expression, which in turn 
modulates the expression of a key adipogenic factor C/EBPα. Cells or animals 
lacking XBP1 have profound defects in adipogenesis and adipose development 
[this study and (Lee et al., 2005)], similar to the phenotypes of C/EBPα-deficient 
cells or adipose tissues (Farmer, 2006; Tontonoz and Spiegelman, 2008). As 
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PPARγ and C/EBPα are critical for the induction and maintenance of each other, 
further studies are required to determine whether regulation of Cebpa by XBP1 
and PPARγ occurs independently or in concert. Additionally, generation of 
adipose-specific IRE1α or XBP1 null animals will elucidate the role of UPR in the 
pathogenesis of obesity and insulin resistance. 
Fourth, we show that the IRE1α-XBP1 pathway of the UPR is important 
for adipogenic differentiation. In light of the observations made in this study, it is 
interesting to compare the roles of XBP1 in governing adipogenesis with that of 
myogenesis or plasma cell differentiation. In myogenic differentiation, two key 
myogenic factors, MyoD and myogenin, transactivate Xbp1 expression (Blais et 
al., 2005), which in turn transactivates Mist1, a negative regulator of MyoD, 
leading to decreased differentiation (Acosta-Alvear et al., 2007). During early B 
cell differentiation, IRF4 and Blimp-1 regulate Xbp1 expression (Klein et al., 2006; 
Shaffer et al., 2004), which in turn induces the expression of IL-6, a key growth 
factor for driving B cell differentiation (Iwakoshi et al., 2003). Thus, these results 
suggest that the IRE1α-XBP1 pathway may act as a critical regulatory component 
of diverse cellular differentiation events. Further studies of the activation of the 
different UPR components during adipocyte differentiation and their 
mechanisms of action will clarify how pre-adipocytes undergo their amazing 
transformation into adipocytes and provide insights into the nature of 
physiological UPR. 
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CHAPTER 3∗ 
NON-MUSCLE MYOSIN IIB LINKS CYTOSKELETON TO IRE1α  
SIGNALING DURING ER STRESS 
 
3.1 ABSTRACT 
 Here we identify and characterize a cytoskeletal myosin protein required 
for IRE1α oligomerization, activation, and signaling. Proteomic screening 
identified non-muscle myosin heavy chain IIB (NMHCIIB), a subunit of non-
muscle myosin IIB (NMIIB), as an ER stress-dependent interacting protein 
specific to IRE1α. Loss of NMIIB compromises XBP1s and UPR target gene 
expression with no effect on the PERK pathway. Mechanistically, NMIIB is 
required for IRE1α aggregation and foci formation under ER stress. The NMIIB-
mediated effect on IRE1α signaling is in part dependent on the phosphorylation 
of myosin regulatory light chain and the actomyosin contractility of NMIIB. 
Biologically, the function of NMIIB in ER stress response is conserved as both 
mammalian cells and C. elegans lacking NMIIB exhibit hypersensitivity to ER 
stress. Thus, optimal IRE1α activation and signaling require concerted 
coordination between the ER and cytoskeleton. 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
∗ This chapter has been published as He, Y., Beatty, A., Han, X., Ji, Y., Ma, X., Adelstein, 
R.S., Yates III, J.R., Kemphues, K., and Qi, L. Developmental Cell 23, 1141-1152 (2012) and 
is reprinted here with permission.  
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3.2 INTRODUCTION 
 Perturbations in endoplasmic reticulum (ER) homeostasis culminate in ER 
stress and activate an ER-to-nucleus signal transduction cascade termed the 
unfolded protein response (UPR) (Hetz et al., 2011; Walter and Ron, 2011). In 
mammals, the ER luminal environment is sensitively monitored by three 
transmembrane sensors: inositol-requiring enzyme 1α (IRE1α), PKR-like 
endoplasmic reticulum kinase (PERK), and activating transcription factor 6 
(ATF6), with IRE1α as the most conserved (Hetz et al., 2011; Walter and Ron, 
2011). A current model of mammalian IRE1α activation speculates that upon 
alterations in ER homeostasis, the luminal domain of IRE1α undergoes a 
conformational change and subsequent homodimerization. Juxtaposition of 
IRE1α proteins promotes trans-autophosphorylation and may facilitate higher-
order oligomerization of IRE1α dimers, followed by activation of its ribonuclease 
(RNase) domain to splice 26 nucleotides from the X-box binding protein 1 (Xbp1) 
mRNA (Walter and Ron, 2011). This processing event produces a transcription 
factor XBP1 spliced (XBP1s) required for UPR target gene induction (Acosta-
Alvear et al., 2007; He et al., 2010). Given that activation of the IRE1α-XBP1 
pathway is emerging as a central paradigm underlying human pathologies, such 
as cancer, diabetes, and conformational diseases (Hetz et al., 2011; Sha et al., 
2011), a comprehensive and mechanistic understanding of IRE1α activation is of 
critical therapeutic value. 
 One model for IRE1α activation proposes that under non-stress 
conditions, IRE1α is bound in an inactive state by the ER chaperone, glucose-
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regulated protein 78 (GRP78/BiP) (Bertolotti et al., 2000; Kimata et al., 2003). 
Accumulation of misfolded proteins promotes BiP dissociation, allowing for 
IRE1α homodimerization and activation. Alternatively, misfolded proteins may 
activate IRE1α through direct binding (Credle et al., 2005; Gardner and Walter, 
2011; Kimata et al., 2007) to promote its oligomerization and optimal activation 
(Korennykh et al., 2009; Li et al., 2010; Walter and Ron, 2011). These two models 
are not mutually exclusive and may have different implications for yeast and 
mammalian IRE1α proteins (Oikawa et al., 2009). Here we identify a cytosolic 
factor required for mammalian IRE1α aggregation and optimal activation of this 
pathway. 
 Non-muscle myosin II (NMII), a member of the myosin II motor 
superfamily (Ma and Adelstein, 2012), is a hexameric molecule composed of a 
pair of heavy chains (NMHCs), a pair of regulatory light chains (RLCs), and a 
pair of essential light chains (Vicente-Manzanares et al., 2009). In mammals, the 
identity of the heavy chain, NMHCIIA, NMHCIIB, or NMHCIIC determines the 
overall NMII isoform (Vicente-Manzanares et al., 2009). NMII activation is 
largely mediated by phosphorylation of its RLC at serine residue 19 (Ser19) 
(Adelstein and Conti, 1975) and to a lesser extent by increased transcriptional 
activity (Vicente-Manzanares et al., 2009). NMII has been widely studied in 
distinct biological processes that require remodeling of the actin cytoskeleton, 
such as cell migration, polarity determination, cell adhesion, and clustering of 
signal transduction molecules (Ma and Adelstein, 2012; Vicente-Manzanares et 
al., 2009). Consequently, NMII-dependent processes span diverse physiological 
functions, including tumor-necrosis factor signaling, T cell antigen receptor 
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clustering, and viral entry (Arii et al., 2010; Flynn and Helfman, 2010; Ilani et al., 
2009). Here, we report an indispensable role of NMIIB in IRE1α signaling of 
UPR. 
 
3.3 MATERIALS AND METHODS 
Cell lines and drug treatment  
NMHCIIB-/- MEFs were generated as previously described (Meshel et al., 2005). 
XBP1-/- and IRE1α-/- MEFs were generously provided by Drs. L. Glimcher (Weill 
Cornell) and D. Ron (University of Cambridge), respectively. Matching WT 
MEFs were used in this study. T-REx293 IRE1-3F6HGFP was previously 
described (Li et al., 2010; Xue et al., 2011) and generously provided by Dr. P. 
Walter (UCSF). MEFs, HEK-293T, Phoenix, and T-REx293 IRE1-3F6HGFP cells 
were maintained in DMEM supplemented with 10% FBS (Hyclone) and 1% 
penicillin/streptomycin (Cellgro). Tg and Tm (EMD Calbiochem), Blebbistatin 
(Cayman Chemical), and ML-7 (Sigma) were dissolved in DMSO. Cytochalasin D 
(Enzo Life Sciences) and doxycycline (EMD Millipore) were dissolved in H2O.  In 
most experiments, cells were treated with 150 - 300 nM Tg or 2.5  - 5 µg/ml Tm 
for 4 - 8 hr. A drug concentration titer was performed in one experiment to 
examine the dose-response curve.  
 
Plasmids  
pMSCV-IRE1α–HA encoding WT human IRE1α (Hetz et al., 2006) was provided 
by Dr. C. Hetz (University of Chile). IRE1α mutants D123P, K599A and P830L 
	  83	  
were previously generated and described (Xue et al., 2011). CMV-GFP-NMHCII-
B was purchased from Addgene Inc. CMV-GFP-NMHCII-B R709C was 
previously described (Kim, 2005). pcDNA3-Flag-mouse XBP1s was described 
previously (Chen and Qi, 2010). 
 
Transfection   
Transfections of HEK293T were performed as we recently described (Chen and 
Qi, 2010). Transfections of MEFs were performed using Lipofectamine 2000 
(Invitrogen) per supplier’s protocol.  Cells were snap-frozen in liquid nitrogen 
24-36 hr post-transfection followed by Western blot. 
 
IRE1α  immunopurification and mass spectrometry   
IRE1α-/- MEFs stably expressing human pMSCV-IRE1α-HA were treated with 
300 nM Tg for 2 hr. Cells were harvested in lysis buffer (150 mM NaCl, 1% Triton 
X-100, 1 mM EDTA, 50 mM Tris HCl pH 7.5) supplemented with protease 
inhibitor cocktail (Sigma) and allowed to lyse on ice for 25 min. Cells were 
sonicated 10 s once with Branson Digital 250 Cell Disruptor at 10% amplitude 
followed by centrifugation. Supernatant was harvested and loaded on a 6% 
polyacrylamide SDS-PAGE gel. Gel was incubated with Coomassie Brilliant Blue 
(0.5 g Coomassie Brilliant Blue R-250 in 450 ml methanol, 450 ml MQ water, and 
100 ml acetic acid) with gentle rocking for 30 min at room temperature followed 
by 2 washes with MQ water 5 min each. Gel was destained in destaining solution 
(45% methanol, 45% MQ water, and 10% acetic acid) that was changed every 30 
min until bands could be clearly visualized. Protein bands were excised from 
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Coomassie-stained gels and destained, and subjected to an in-gel trypsin 
digestion. Briefly, digestion was performed with 12.5 ng/µL of trypsin in 50 mM 
ammonium bicarbonate and incubated overnight at 37°C. The resultant peptides 
were extracted with 50% acetonitrile/5% formic acid and dried in a vacuum 
centrifuge. Prior to measurements, dried peptides were dissolved in 0.1% formic 
acid.  
 The peptide mixtures were analyzed by online nanoflow liquid 
chromatography tandem mass spectrometry (LC-MS/MS) on an Agilent 1200 
quaternary HPLC system (Agilent, Palo Alto, CA) connected to an LTQ-Orbitrap 
mass spectrometer (Thermo Fisher Scientific) through an in-house built 
nanoelectrospray ion source. The peptide mixtures were pressure-loaded onto a 
capillary column (75 µm i.d.) packed with 15 cm of 3 µm Aqua C18 resins 
(Phenomenex, Ventura, CA). They were separated with a 3 hr gradient from 5% 
to 60% acetonitrile in 0.1% formic acid and a flow rate of 300 nL/min (through 
split). As peptides were eluted from the analytical column, they were 
electrosprayed (distal 2.5 kV spray voltage) into the mass spectrometer. MS 
instrument method consisted of an FT full-scan MS analysis (400-1600 m/z, 60000 
resolution) followed by data-dependent MS/MS scans of the 8 most intense 
precursors at a 35% normalized collision energy with dynamic exclusion for 60 s. 
Application of mass spectrometer scan functions and HPLC solvent gradients 
was controlled by the Xcalibur data system (Thermo Fisher Scientific).  
MS/MS spectra were extracted using RawXtract (version 1.9.9) 
(McDonald et al., 2004) and searched with the ProLuCID algorithm against a 
human UniProt database concatenated to a decoy database in which the 
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sequence for each entry in the original database was reversed (Peng et al., 2003). 
ProLuCID search results were assembled and filtered using the DTASelect 
(version 2.0) algorithm (Tabb et al., 2002) with a false positive rate below one 
percent. 
 
siRNA knockdown and retroviral transduction   
Retroviral transduction and stable cell lines were carried out as described (Sha et 
al., 2009). Stable cell lines expressing siRNA were selected in hygromycin at 200 
µg/ml or puromycin at 5 µg/ml. Stable cell lines were made and tested 
independently at least twice.  
 
siRNA sequences for mouse myh-10 (in MEFs) 
 shIIB#1: 5’ GAGAAGAAACTGAAAGAAA 3’ 
 shIIB#3: 5’ GGAACAAGGCTGAGAAACA 3’ 
 
siRNA sequences for human myh-10 (in HEK293T cells) 
 shIIB#1: 5’ GAGAAGAAGCTGAAAGAAA 3’ 
 shIIB#2: 5’ CCAAAGATGATGTGGGAAA 3’ 
 
Immunoprecipitation     
Whole cell lysate was harvested in lysis buffer (150 mM NaCl, 1% Triton X-100, 1 
mM EDTA, and 50 mM Tris HCl pH 7.5) supplemented with protease inhibitor 
cocktail (Sigma) and 5 mM ATP (Sigma) and incubated on ice for 25 min. 
Samples were sonicated 10 s once with Branson Digital 250 Cell Disruptor at 
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amplitude 10%. For endogenous IP, supernatant was pre-cleared with Protein A-
agarose (Invitrogen) for 30 min and rocked with 2 µg primary antibody 
overnight at 40C. Immune complexes were recovered with Protein A-agarose for 
2 h at 40C with rocking. Beads were washed four times with wash buffer (20 mM 
Tris HCl pH 7.5, 137 mM NaCl, 20 mM EDTA, 1% Triton X-100, 10% glycerol), 
eluted in boiling 2X SDS sample buffer followed by SDS-PAGE and Western blot. 
In the case of overexpressed tagged proteins, the only difference was that cells 
were incubated overnight with HA- or Flag-agarose at 40C with rocking followed 
by washes as described above.  
 
Western blot and image quantitation     
Preparation of cell lysates and Western blot were performed as we previously 
described (Sha et al., 2009).  Primary antibodies were diluted in 5% milk/TBST or 
2% BSA/TBST and incubated with PVDF membrane overnight at 40C, while 
secondary antibodies were incubated at room temperature for 45 min. To study 
IRE1α phosphorylation, we used a Phos-tag based Western blot method 
described by our group that can sensitively monitor the phosphorylation status 
of UPR sensors (Qi et al., 2011; Sha et al., 2009; Yang et al., 2010). Membranes 
were routinely strip-reprobed for HSP90 as a positional control. In addition, a 
Phos-tag based method was also used to visualize total RLC phosphorylation as 
previously described (Aguilar et al., 2011). Of note, to ensure sufficient signal for 
cleaved caspase 3, the membrane for caspase 3 was cut around the 25 kDa line 
and then probed separately with caspase 3 antibody. Band density was 
quantitated using the Image Lab software on the ChemiDOC XRS+ system (Bio-
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Rad) and presented as mean ± SEM from several independent experiments or as 
representative data from at least two independent experiments.   
 
Antibodies for western blots and immunoprecipitations  
MYH10/NMIIB (sc-99210, 1:1000), MYH9/NMIIA (sc-98978, 1:1000), XBP1 (sc-
7160, 1:1000), HSP90 (sc-7947, 1:6000), HA-HRP (sc-7392, 1:8000) were obtained 
from Santa Cruz. eIF2α (9722, 1:1000), p-eIF2α (9721, 1:1000), Caspase 3 (H277, 
1:1000), p-Ser19 RLC/MLC (3671/3675, 1:1000), RLC/MLC (3672, 1:1000), IRE1α 
(14C10, 1:2000), PERK (3192, 1:2000) were obtained from Cell Signaling. Flag-
HRP (1:8000) was obtained from Sigma. GAPDH (NB600-502, 1:20,000) was 
obtained from Novus Biologicals. Goat-anti-rabbit/mouse IgG HRP (1:5000) 
were obtained from Biorad. Donkey anti-goat IgG HRP (1:5000) was obtained 
from Jackson ImmunoResearch.  Antibodies against GFP, CREB and PARP were 
gifts from Drs. Fenghua Hu (Cornell University), Marc Montminy (Salk Institute) 
and Lee Kraus (UT Southwestern), respectively. 
 
RNA extraction and qPCR     
These experiments were performed as previously described (Sha et al., 2009). For 
nematodes, WT (N2) or nmy-2(ne3409) worms were shifted to 250C and grown on 
6 µg/ml Tm. 72 h later, approximately 300 animals of each genotype and 
condition were washed off plates with M9 buffer, pelleted and mixed with 10X 
volume of Trizol. qPCR was performed with primers in Tables 3.1 and 3.2 for 
mouse and worm genes, respectively.  
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Immunofluorescence     
MEFs were plated and grown on collagen-coated coverslips in 6-well plates 
overnight followed by treatment with indicated concentration and time of Tg. 
After a brief wash with PBS, cells were fixed in fresh 3.7% formaldehyde in PBS 
for 10 min and washed 3 times with PBS 5 min each. Cells were lysed with 0.2% 
Triton X-100 in PBS for 5 min and washed 3 times with PBS 5 min each. Cells 
were blocked in 5% BSA in PBS for 10 min and incubated 1 hr at room 
temperature with anti-myosin IIB at 1:50 dilution (Developmental Studies 
Hybridoma Bank, CMII23) (Conrad et al., 1991). Cells were washed 3 times with 
PBS 5 min each followed by 1 hr incubation with donkey anti-mouse Cy3 
(Jackson ImmunoResearch) with or without anti-rabbit FITC (Jackson 
ImmunoResearch) at 1:200 dilution in the dark. Cells were washed and mounted 
with Prolong Gold Antifade Reagent with DAPI (Invitrogen). Fluorescent 
microscopic images were taken with a Zeiss 710 Confocal microscope using a 
63x/1.4 objective (Cornell Microscopy and Imaging Facility).  
 
Foci imaging      
T-REx293 IRE1-3F6HGFP cells were treated and processed as described (Xue et 
al., 2011). Fluorescent microscopic images were taken with a Zeiss 710 Confocal 
microscope using a 63x/1.4 objective (Cornell Microscopy and Imaging Facility). 
Foci-positive was calculated as the number of cells with one or more foci out of 
total number of cells. 
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Quantitative-PCR primers   
Table 3.1. Primers for M. musculus genes for qPCR.   
 
 
Gene 
(mouse) Forward Reverse 
xbp1s GAGTCCGCAGCAGGTG GTGTCAGAGTCCATGGGA 
erdj4 CTTAGGTGTGCCAAAGTCTGC GGCATCCGAGAGTGTTTCATA 
grp78 TGTGGTACCCACCAAGAAGTC TTCAGCTGTCACTCGGAGAAT 
myh10 GGAGCTGCTGAAGGTGAAAG CTCCAGTTCCTGCTTTTTGG 
p58ipk GTGGCATCCAGATAATTTCCAG GAGTTCCAACTTCTGTGGAAGG 
hrd1 AGCTACTTCAGTGAACCCCACT CTCCTCTACAATGCCCACTGAC 
herp AACCAGGACCCCAACAATAAC CTGGAAGAAGAGAGGCAAAGAA 
l32 GAGCAACAAGAAAACCAAGCA TGCACACAAGCCATCTACTCA 
  
 
 
Table 3.2. Primers for C. elegans genes for qPCR.   
 
 
  
Gene 
(worm) Forward Reverse 
xbp1s TGCCTTTGAATCAGCAGTGG ACCGTCTGCTCCTTCCTCAATG 
hsp-4 AGTTGAAATCATCGCCAACG GCCCAATCAGACGCTTGG 
act-1 ACGACGAGTCCGGCCCATCC GAAAGCTGGTGGTGACGATGGTT 
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Sucrose gradient sedimentation      
Confluent WT and NMHCIIB-/- MEFs in 10-cm plates non-treated or treated with 
300 nM Tg for 3 hr were harvested and lysed in 300 µl lysis buffer (see above). 
Extracts were centrifuged through 20-40% sucrose gradients prepared freshly by 
progressively layering higher to lower density sucrose fractions in 5% increments 
in polyallomar tubes of 11 x 60 mm (Beckman Coulter). Extracts were centrifuged 
at 60,000 rpm for 14.5 hr at 40C using a Beckman Coulter swinging bucket SW 60 
Ti rotor. Each 4 ml gradient was divided evenly into 16 fractions (250 µl) and 
aliquots of fractions 3-16 (labeled 1-14 in Figures 3H-I) were subjected to SDS-
PAGE analysis. IRE1α-containing complexes were detected using anti-IRE1α 
antibody. The density of IRE1α in each fraction was quantitated using the Image 
Lab software on the ChemiDOC XRS+ system (Bio-Rad) and the % of IRE1α in 
each fraction was calculated as the amount of IRE1α in a fraction relative to the 
total IRE1α levels in all 14 fractions.  
 
Cell survival assay      
WT and NMHCIIB-/- or shCON and shIIB#1 MEFs were grown in 6-well plates 
and treated with 150-300 nM Tg for the indicated time. For rescue experiments, 
NMHCIIB-/- MEFs were transfected with WT or R709C NMHCIIB plasmids 
using Lipofectamine 2000 per supplier’s protocol for 24 hr prior to Tg treatment. 
Cells were counted by hemocytometer and 1.5X105 cells were re-plated onto 10-
cm plates. 4 days later, the cells were briefly washed in PBS and fixed in 3.7% 
formaldehyde in PBS (freshly prepared) for 15 min followed by 30 min 
incubation in 0.05% crystal violet in distilled water (filtered before use) with 
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gentle rocking at room temperature. Cells were washed 3 times for 5 min each 
with ddH2O, permeabilized with methanol for 15 min and sampled aliquots were 
read at OD 540 nm with Bio-Tek Synergy 2 plate reader (Bio-Tek Inc.).  
 
Brefeldin-A BODIPY and flow cytometry      
WT and various mutant MEFs were grown in 24-well plates overnight followed 
by treatment with 150 nM Tg or 2.5 µg/ml Tm for the indicated time. For rescue 
experiments, NMHIIB-/- MEFs were transfected with WT, R709C NMHCIIB or 
XBP1s plasmids with Lipofectamine 2000 per supplier’s protocol for 24 hr 
followed by Tg treatment. Cells were incubated at 370C for 30 - 45 min with 0.4 
µg/ml Brefeldin A-BODIPY (Invitrogen) in culture media followed by 
trypsinization and flow cytometric analysis using a BD FACSCalibur flow 
cytometer. Data was analyzed using the CellQuest and FlowJo software.  
 
ER stress resistance in C. elegans       
Nematodes were cultured using standard conditions (Brenner, 1974), with N2 
(Bristol) as wild type. The mutations used in this analysis include nmy-2(ne3409) 
(Liu et al., 2010) and xbp-1(zc12) (Calfon et al., 2002). For ER stress resistance 
assays, embryos were laid onto plates containing 0 or 6 µg/mL Tm.  After 18 hr, 
the number of hatching larvae was noted and compared to the number of 
L4/adult stage worms after 72 hr. In experiments using nmy-2(ne3409), embryos 
were allowed to complete embryogenesis at the permissive temperature of 16°C 
and then shifted to the restrictive temperature of 25°C after hatching. Some 
nematode strains used in this work were provided by the Caenorhabditis 
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Genetics Center (University of Minnesota), which is funded by the NIH National 
Center for Research Resources.  
 
Statistical analysis       
Results are expressed as mean ± SEM unless indicated otherwise. Comparisons 
between groups were made by unpaired two-tailed Student’s t-test, where p < 
0.05 was considered as statistically significant. All experiments were repeated at 
least two to three times and representative data are shown. 
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3.4 RESULTS 
3.4.1 NMHCIIB physically interacts with IRE1α  upon ER stress 
 To investigate mechanisms regulating mammalian IRE1α signaling, we 
performed a proteomic screen using IRE1α-/- mouse embryonic fibroblasts 
(MEFs) stably expressing hemagglutinin (HA)-tagged IRE1α to identify potential 
IRE1α-interacting proteins. Coomassie blue staining revealed a band 
approximately 250 kDa in size that was responsive to thapsigargin (Tg)-induced 
ER stress (Fig. 3.1A). Tandem mass spectrometry (MS/MS) identified this factor 
as the heavy chain of non-muscle myosin II (NMHCII) with 35.4% identity to 
NMHCIIB, 31.6% to NMHCIIA, and 5.4% to NMHCIIC; peptide coverage 
spanned all functional domains (Fig. 3.1B). 
As endogenous NMHCIIB interacted with IRE1α much more strongly 
than NMHCIIA (Fig. 3.1C), the remainder of our study focused on NMIIB. The 
ER stress-dependent interaction between NMHCIIB and IRE1α was verified in 
HEK293T cells overexpressing IRE1α-HA and GFP-NMHCIIB, or IRE1α-HA 
alone (Figs. 3.1C-D). Treatment with another ER stress agent tunicamycin (Tm) 
also promoted the interaction (Fig. 3.1E), demonstrating that this event is ER 
stress-dependent and independent of non-specific Ca2+ effects. Lastly, 
immunoprecipitation in MEFs with anti-IRE1α antibody confirmed the ER stress-
dependent interaction between endogenous proteins (Fig. 3.1F).  
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Figure 3.1.  NMIIB is an ER stress-induced IRE1α-interacting factor.  
(A) Coomassie blue staining of immunoprecipitates (IPs) of IRE1α-/- MEFs stably 
expressing C-terminal hemagglutinin (HA)-tagged IRE1α untreated or treated 
with 300 nM Tg for 2 hr. Unknown Tg-specific band at ~250 kDa was excised and 
identified as NMHCII using tandem mass spectrometry (MS/MS) analysis. (B) 
Schematic of the functional domains of the three mammalian isoforms of 
NMHCII with respective peptide coverage recovered (indicated by lines below) 
from MS/MS. Figure is drawn to scale using sequence annotation data from 
UniProt. (C) Western blot showing recovery of endogenous NMHCIIB and 
NMHCIIA from immunoprecipitates of HA-tagged IRE1α prepared from 
transiently transfected HEK293T cells treated with 150 nM Tg for the indicated 
time. (D and E) Western blot showing recovery of GFP-tagged NMHCIIB from 
IPs of HA-tagged IRE1α prepared from transfected HEK293T cells treated with 
300 nM Tg for the indicated time (D) or 300 nM Tg or 5 µg/ml Tm for 2 hr (E). 
Arrowhead points to endogenous protein. (F) Western blot showing recovery of 
endogenous NMHCIIB from IPs of endogenous IRE1α prepared from MEFs 
treated with 150 nM Tg for the indicated time. For (C)-(F), similar results were 
observed in 2-3 independent experiments.  
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3.4.2 NMIIB is required and sufficient for optimal IRE1α  activation 
To study the functional role of NMIIB in IRE1α signaling, we used loss- 
and gain-of-function models. Induction of Xbp1s mRNA, a substrate of IRE1α, 
was blunted in NMHCIIB-/- and knock-down MEFs (Fig. 3.2A). Concomitantly, 
nuclear XBP1s protein production was defective and delayed in NMHCIIB-/- 
MEFs (Fig. 3.2B), NMHCIIB knock-down MEFs (Fig. 3.2C) and cells treated with 
the NMII-specific inhibitor blebbistatin (Straight et al., 2003) (Fig. 3.2D). A similar 
observation was made in NMHCIIB-/- MEFs treated with Tm (Fig. 3.2E). Further 
pointing to defects in the IRE1α-XBP1 pathway, the expression of a subset of 
XBP1 target genes were attenuated in NMHCIIB knock-down (Fig. 3.2F) and 
NMHCIIB-/- MEFs (Fig. 3.2G).  
Conversely, overexpression of NMHCIIB in HEK293T cells increased 
XBP1s protein (Fig. 3.2H) and overexpression in NMHCIIB-/- MEFs rescued the 
levels of XBP1s protein (Fig. 3.2I). Notably, the gain-of-function effect was 
observed only under conditions of ER stress, further supporting the notion that 
NMIIB-mediated IRE1α signaling is ER stress-dependent.  
To determine the specificity of NMIIB for IRE1α, we aimed to study its 
impact on the other two major UPR branches. Upon ER stress, PERK undergoes 
trans-autophosphorylation and subsequently phosphorylates Ser51 on 
eukaryotic initiation factor 2α (eIF2α), leading to attenuation of global protein 
synthesis. Paradoxically, this event selectively upregulates the translation of a 
subset of genes including Chop (Walter and Ron, 2011). Upon ER stress, no 
interaction occurred between PERK and NMHCIIB (Fig. 3.3A). Furthermore, 
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PERK activation and signaling was unaffected in NMHCIIB knock-down MEFs 
as phosphorylation of PERK and eIF2α, and Chop transcript levels were 
unchanged (Figures 3.3B-D). We were unable to study the relationship between 
NMIIB and ATF6 activation due to the lack of a good antibody against the 
endogenous active form of ATF6. Nonetheless, our data points to a functional 
role of NMHCIIB specifically in IRE1α signaling and dispensable for the PERK 
pathway. 
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Figure 3.2.  NMIIB is required for optimal IRE1α-XBP1 signaling.  
(A) Quantitative real-time PCR analysis of Xbp1s expression from NMHCIIB-/- or 
shIIB#1 MEFs treated with 150 nM Tg for the indicated time. (B and C) Western 
blot of nuclear (XBP1s) and cytosolic extracts (NMHCIIA/B) from (B) WT and 
NMHCIIB-/- MEFs treated with 150 nM Tg for the indicated time or (C) WT MEFs 
stably expressing shRNA against control (shCON) or murine NMHCIIB 
(shIIBi#1 and shIIBi#3) treated with 150 nM Tg for the indicated time. (D) 
Western blot of XBP1s in HEK293T cells untreated or pretreated with 50 µM 
blebbistatin followed by treatment with 150 nM Tg for 3 hr. (E) Western blot of 
XBP1s in WT and NMHCIIB-/- MEFs treated with 5 µg/ml Tm for the indicated 
time. (F and G) Quantitative real-time PCR analysis of UPR genes in (F) shCON 
and shIIBi#1 MEFs treated with 150 nM Tg for 5 hr or (G) WT and NMHCIIB-/- 
MEFs treated with 150 nM Tg for the indicated time. (H and I) Western blot of 
nuclear (XBP1s) and cytosolic extracts (NMHCIIA/B) from (H) HEK293T cells 
transiently overexpressing GFP vector or GFP-NMHCIIB treated with 150 nM Tg 
for the indicated time, or (I) WT or NMHCIIB-/- MEFs transiently overexpressing 
GFP vector or GFP-NMHCIIB treated with 150 nM Tg for the indicated time. 
Arrowhead points to endogenous protein. Quantitation of XBP1s protein levels 
shown below the gel after normalization to CREB. In western blots, CREB and 
HSP90 are loading controls. In quantitative real-time PCR analysis, data are 
shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. For all, similar results 
were observed in 2-3 independent experiments. 
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Figure 3.3.  NMIIB is dispensable for PERK pathway activation and signaling.  
(A) Co-immunoprecipitation of myc-tagged PERK and GFP-tagged NMHCIIB 
upon ER stress shows no association. (B) Western blot analysis of PERK 
phosphorylation in control (shCON) and NMHCIIB knock-down MEFs (shIIB#1 
and #3) treated with 150 nM Tg for indicated time. (C) Western blot analysis of 
p-eIF2α in shCON, shIIB#1 and #3 MEFs treated with 150 nM Tg for indicated 
time. (D) Quantitative real-time PCR analysis of PERK downstream target, Chop, 
in shCON and shIIB#1 MEFs treated with 150 nM Tg for 4 hr.  
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3.4.3 IRE1α  foci formation and oligomerization require NMIIB 
To understand mechanistically how NMIIB affects IRE1α signaling, we 
investigated two key steps in IRE1α activation, namely dimerization/trans-
autophosphorylation and oligomerization/RNase activity (Walter and Ron, 
2011). Upon ER stress, IRE1α phosphorylation (Qi et al., 2011; Yang et al., 2010) 
was not affected in NMHCIIB-/- MEFs (Fig. 3.4A), cells exposed to blebbistatin 
(Fig. 3.4B) or cells overexpressing NMHCIIB (not shown), suggesting that NMIIB 
is dispensable for IRE1α trans-autophosphorylation. As ER stress persists, 
mammalian IRE1α dimers oligomerize to form foci (Credle et al., 2005; 
Korennykh et al., 2009) that may correlate with RNAse activation and Xbp1 
splicing (Li et al., 2010); this event can be visualized using a T-REx293 cell system 
in which expression of a GFP-tagged IRE1α protein, IRE1-3F6HGFP, is driven by 
a doxycycline-inducible promoter (Li et al., 2010). In line with previous studies 
(Korennykh et al., 2009; Li et al., 2010), IRE1α distribution changed dramatically 
upon ER stress from diffuse to strong punctate foci beginning as early as 1 hr and 
peaking at 4 hr (Fig. 3.4C). Knock-down of NMHCIIB (shIIB#1) drastically 
reduced foci formation from 73.3 ± 10.6% in control cells (shCON) to 20.2 ± 7.7% 
foci-positive cells in shIIB#1; cells with a shRNA targeting sequence that failed to 
deplete NMHCIIB (shIIB#2) retained the ability to form foci with 70.0 ± 17.6% 
foci-positive cells (Figs. 3.4D-G). This effect was consistently observed at various 
stages of ER stress (Fig. 3.5). Of note, IRE1α-GFP protein levels in all cell lines 
were comparable (Fig. 3.4E), thus excluding the possibility that reduced protein 
levels accounted for diminished foci formation. 
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To confirm this observation under endogenous conditions, we examined 
oligomerization of endogenous IRE1α proteins using sucrose gradient 
fractionation. In support of a role for NMIIB in IRE1α aggregation and activation, 
loss of NMIIB reduced the formation of higher-order complexes of endogenous 
IRE1α under ER stress (Figs. 3.4H-I). Overall, these results indicate that NMIIB 
regulates IRE1α aggregation and foci formation during ER stress. 
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Figure 3.4.  NMIIB promotes IRE1α  foci formation upon ER stress.  
(A and B) Phos-tag western blot of IRE1α phosphorylation prepared from lysates 
of (A) WT or NMHCIIB-/- MEFs treated with 150 nM Tg for the indicated time, 
and (B) MEF cells pretreated with Blebbistatin prior to treatment with Tg at the 
indicated concentration for 3 hr. (C) Confocal microscopic images of IRE1α-GFP 
in T-REx293 IRE1-3F6HGFP cells untreated (CON) or treated with 300 nM Tg for 
the indicated time. (D) Western blot of NMHCIIB in T-REx293 IRE1-3F6HGFP 
cells stably expressing shRNA against control (shCON) or human NMHCIIB 
(shIIB#1 and shIIB#2). HSP90, loading control. (E) Western blot of GFP in T-
REx293 cells treated with 10 nM doxycycline for 24 hr. (F and G) Confocal 
microscopic images of IRE1α-GFP in T-REx293 IRE1-3F6HGFP cells stably 
expressing shCON, shIIB#1, or shIIB#2 cells untreated (CON) or treated with 300 
nM Tg for 4 hr. Quantitation of the number of foci-positive cells from at least 30 
fields with 500-1,000 cells per group are shown in (G). Data are shown as the 
mean ± SEM. ***p < 0.001. (H and I) Western blot showing the distribution of 
IRE1α (H) and quantitation (I) in fractions 1-14 prepared from WT and 
NMHCIIB-/- MEFs treated with 300 nM Tg for 3 hr and centrifuged using 20%-
40% sucrose gradients. For all, similar results were observed in 2-3 independent 
experiments.  
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Figure 3.5.  Knock-down of NMHCIIB disrupts IRE1α  aggregation.  
Confocal microscopic analysis of T-REx293 IRE1-3F6HGFP cells stably 
expressing shRNA against (A) control (shCON) or (B) human NMHCIIB 
(shIIB#1) treated with 300 nM Tg for 2-4 hr. Images are representative of 25 
fields. Similar results were observed in three separate experiments. Scale bar, 5 
µm. 
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Figure 3.5 (Continued) 
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3.4.4 Effect of NMIIB on IRE1α signaling requires RLC phosphorylation  
To understand the mechanistic basis of the ER stress-induced NMIIB-
IRE1α complex, we first queried whether the interaction was contingent upon 
the activation status of IRE1α. We used to our advantage two IRE1α mutants: a 
kinase-dead mutant K599A (Tirasophon et al., 1998) and a loss-of-function 
mutant P830L lacking both kinase and RNase functions (Xue et al., 2011). 
Surprisingly, both mutants interacted just as strongly with NMHCIIB as WT 
IRE1α (Fig. 3.6A), suggesting that the interaction occurs independently of the 
kinase function of IRE1α. Unexpectedly, the dimerization-defective D123P IRE1α 
mutant was able to undergo trans-autophosphorylation in HEK293T cells (Figure 
3.6A), presumably due to the presence of endogenous IRE1α (Xue et al., 2011).  
Next, we examined changes in NMIIB upon ER stress. While ER stress had 
no noticeable effects on the intracellular distribution (Fig. 3.6B) or protein levels 
(Fig. 3.6C) of NMHCIIB, it dramatically induced phosphorylation of RLC at 
Ser19 (Fig. 3.6D), a critical triggering event in NMII activation (Adelstein and 
Conti, 1975; Ma and Adelstein, 2012; Vicente-Manzanares et al., 2009). 
Additionally, an independent Phos-tag-based method examining total RLC 
phosphorylation (Figure 3.6E) demonstrated that RLC phosphorylation peaked 
within 60 min following ER stress (Figures 3.6D-E), preceding IRE1α foci 
formation ((Li et al., 2010) and Fig. 3.4C).  
Further demonstrating the importance of RLC phosphorylation, treatment 
with a myosin light chain kinase (MLCK)-specific inhibitor ML-7 (Saitoh et al., 
1987) abolished ER stress-dependent IRE1α foci formation (Fig. 3.6F), reduced 
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the interaction between NMHCIIB and IRE1α (Fig. 3.6G) and dramatically 
attenuated XBP1s protein levels by over 6-fold (Fig. 3.6H). Thus, the physical 
interaction between NMIIB and IRE1α as well as the effect of NMIIB on IRE1α 
aggregation and signaling are largely dependent on MLCK-mediated RLC 
phosphorylation. How ER stress signals emanating from the ER lumen are 
transmitted to the cytosolic MLCK requires further investigation.  
 
3.4.5 Motor activity of NMIIB is indispensable for IRE1α activation and 
signaling 
As NMIIB contains several functional domains (Vicente-Manzanares et al., 
2009), we next queried whether the motor function was required for optimal 
IRE1α signaling. Unlike wild-type NMHCIIB, a motor defective mutant R709C 
with diminished ATPase activity (Kim, 2005; Takeda et al., 2003) did not exhibit 
ER stress-dependent association with IRE1α (Fig. 3.6I) and overexpression of the 
mutant failed to enhance XBP1s protein expression upon ER stress (Fig. 3.6J).  
As myosin molecules propel along actin filaments to provide movement 
through the energy of ATP hydrolysis (Vicente-Manzanares et al., 2009), we next 
addressed the role of actin in IRE1α signaling. Consistently, cells pre-treated 
with an actin inhibitor cytochalasin D also exhibited attenuated XBP1s levels 
(Fig. 3.6K). A similar observation was obtained in cells treated with blebbistatin 
(Fig.3.2D), a highly-specific drug that inhibits the ATPase activity and in vitro 
motility of NMII proteins (Straight et al., 2003). Therefore, our data collectively 
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suggest that the actomyosin contractility of NMIIB is required for IRE1α 
signaling.  
 
3.4.6 NMIIB deficient mammalian cells are defective in ER stress response  
We studied the biological consequences of NMIIB on UPR at three levels: 
organelle, cellular and organismal. At the organelle level, in line with the role of 
IRE1α-XBP1s in ER biogenesis (Hetz et al., 2006; Sriburi et al., 2004), loss of 
NMIIB, similar to the loss of IRE1α or XBP1, led to prominent defects in ER 
expansion in response to both Tg and Tm-induced ER stress (Figs. 3.7A and 3.8). 
This defect was rescued by overexpression of WT NMIIB, but not the R709C 
NMHCIIB mutant (Figs. 3.7B-C), further supporting a functional requirement of 
the motor activity of NMIIB.  Importantly, overexpression of XBP1s in NMIIB-/- 
MEFs rescued the ER expansion defect to a level similar to WT MEFs exposed to 
Tg (Figs. 3.7B-C).  Taken together, these data demonstrate that NMIIB is a critical 
component of ER stress response via IRE1α activation and XBP1s production.  
At the cellular level, NMHCIIB-/- MEFs were unable to recover 
appropriately after an ER stress challenge (Fig. 3.7D), in line with a pro-survival 
role attributed to the IRE1α-XBP1s pathway (He et al., 2010). Consistent with the 
ER expansion phenotype, WT but not R709C NMHCIIB completely rescued cell 
survival defects (Fig. 3.7E). This was further supported by an increase of caspase-
3 cleavage, a marker for apoptosis, in NMHCIIB-deficient cells upon prolonged 
Tg treatment (Fig. 3.7F).  
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Figure 3.6.  RLC phosphorylation and the actomyosin contractility of NMIIB 
are required for optimal IRE1α  signaling.  
(A) Western blot showing recovery of GFP-tagged NMHCIIB from 
immunoprecipitates of HA-tagged WT and mutant IRE1α (D123P, K599A, 
P830L) prepared from transfected HEK293T cells treated with 300 nM Tg for 2 hr. 
Bottom panel shows Phos-tag western blot analysis of IRE1α phosphorylation in 
HEK293T cells overexpressing WT or mutant IRE1α. ACC (acetyl-CoA 
carboxylase), loading control. (B) Confocal microscopic analysis of endogenous 
NMHCIIB in MEF cells treated with 300 nM Tg for the indicated time. Images are 
representative of 25 fields. Scale bar, 5 µm. (C) Western blot of NMHCIIB from 
HEK293T cells treated with 150 nM Tg for the indicated time. (D) Western blot of 
p-Ser19 and total RLC in whole-cell lysates prepared from MEFs treated with 300 
nM Tg for the indicated time. (E) Phos-tag western blot analysis of total RLC 
phosphorylation in MEFs treated with 150 nM Tg for the indicated time. 
Quantitation of p-RLC shown belown. (F) Confocal microscopic images of 
IRE1α-GFP in T-REx293 IRE1-3F6HGFP cells pretreated with 25 µM ML-7 for 30 
min prior to treatment with 300 nM Tg for 4 hr. Data is representative of at least 
30 fields with 500-1,000 cells per group. Scale bar, 5 µm. (G) Western blot 
showing recovery of endogenous NMIIB from immunoprecipitates of HA-tagged 
IRE1α prepared from transiently transfected HEK293T cells untreated or 
pretreated with 25 µM ML-7 for 30 min prior to treatment with 300 nM Tg for 2 
hr. Note that ML-7 pretreatment abolishes the interaction between IRE1α and 
NMIIB. (H) Western blot analysis of nuclear XBP1s in HEK293T cells treated as 
in (F). (I) Western blot showing recovery of GFP-tagged WT or the motor-
defective R709C NMHCIIB mutant from immunoprecipitates of HA-tagged 
IRE1α prepared from transfected HEK293T cells treated with 150 nM Tg for the 
indicated time. (J and K) Western blot of XBP1s in (J) MEFs transfected with 
GFP-tagged WT or R709C NMHCIIB treated with 150 nM Tg for 4 hr or (K) 
MEFs pretreated with an actin inhibitor, cytochalasin D, for 30 min prior to 
treatment with 150 nM Tg for 5 hr. For all, similar results were observed in 2-3 
independent experiments. CREB/GAPDH/HSP90, loading controls.  
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3.4.7 NMIIB deficient worms are hypersensitive to ER stress  
 Lastly, we explored the physiological implications of NMIIB in ER stress 
response at the organismal level. As NMHCIIB-/- mouse embryos die before birth 
(Takeda et al., 2003), we turned to the nematode C. elegans, in which NMY-2, a 
protein required for polarity establishment during worm embryogenesis, is a 
homolog of NMHCIIB (Guo and Kemphues, 1996). We examined the ability of 
temperature-sensitive NMII mutant worms nmy-2(ne3409) (Liu et al., 2010) to 
reach L4 and adulthood in response to ER stress after shifting to the restrictive 
temperature following embryogenesis. In the absence of Tm, 99% ± 1% WT and 
95% ± 3% nmy-2(ne3409) reached L4 or adulthood. However, in the presence of 
ER stress, a dramatic difference was consistently observed after 72 hr between 
the percent of WT (85% ± 4%) and nmy-2(ne3409) (23% ± 13%) animals that 
developed to L4 (Fig. 3.7G), suggesting that nmy-2(ne3409) worms were 
hypersensitive to ER stress. This effect was similar to that of a Xbp1 deficiency as 
previously reported (Henis-Korenblit et al., 2010), though less severe (Fig. 
3.7G). At the molecular level, ER stress-dependent induction of Xbp1s and its 
target hsp-4, the worm homolog of the ER chaperone GRP78/BiP, was 
completely abrogated in nmy-2(ne3409) (Fig. 3.7H). Together, these in vivo 
studies reveal a functional and conserved role for NMII specifically in IRE1α 
signaling. 
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Figure 3.7.  NMIIB deficiency renders cells and worms hypersensitive to ER 
stress.  
(A-C) Flow cytometric analysis of ER/Golgi mass of (A) WT and various mutant 
MEFs or (C) NMHCIIB-/- MEFs transfected with WT, R709C NMHCIIB, or 
XBP1s, followed by treatment with 300 nM Tg for 8 hr and stained with Brefeldin 
A-BODIPY. Numbers indicate mean channel fluorescence. Western blot analysis 
of protein levels in transfected cells shown in (B) with WT MEFs treated with 150 
nM Tg for 3 hr in the far right lane. HSP90 and CREB, loading controls whole-cell 
extract and nuclear extract, respectively. (D and E) Cell survival assays: 
Quantitative reading of crystal violet staining of WT and NMHCIIB-/- MEFs 
treated with 150 nM Tg for the indicated time, followed by recovery for 4-5 days. 
y axis indicates cell or colony numbers. In (E), MEFs expressing shCON or 
shIIB#1, or WT, NMHCIIB-/-, and NMHCIIB-/- MEFs rescued with WT or R709C 
NMHCIIB were used. Data are shown as mean ± SEM. **p<0.01, ***p<0.001. (F) 
Western blot of active and procaspase 3 from WT and NMHCIIB-/- MEFs treated 
with 150 nM Tg for the indicated time. Quantitation of cleaved caspase 3 levels 
shown below the gel after normalization to procaspase 3. (G and H) WT (N2) or 
nmy-2(ne3409) worms were shifted to 25°C after embryogenesis and grown on 6 
µg/ml Tm to assay development at 72 hr. xbp-1(zc12) worms were included as 
controls. Data are shown as mean ± SD (p = 0.004 for nmy-2(ne3409) versus WT 
and p < 0.001 for xbp-1(zc12) versus WT). (H) Quantitative real-time PCR analysis 
of UPR genes in WT (N2) or nmy-2(ne3409) worms grown on 6 µg/ml Tm for 72 
hr at 25°C. Data are shown as mean ± SEM. (I) Model for the role of NMIIB in 
IRE1α aggregation and signaling. Our data suggest that optimal IRE1α activation 
and signaling require concerted coordination between the ER and cytoskeleton in 
the cytosol. Findings from this study are highlighted in red, whereas known 
activating signals from the ER are in blue. For all, similar results were observed 
in 2-3 independent experiments 
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Figure 3.8.  NMHCIIB is required for ER stress-induced ER expansion.  
Flow cytometric analysis of ER/Golgi mass of WT, NMHCIIB-/- and IRE1α-/- 
MEFs treated with 5 µg/ml Tm for 2 hr and stained with Brefeldin A-BODIPY. 
Numbers indicate mean channel fluorescence. Similar results were observed in 
three independent experiments.  
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3.5 DISCUSSION 
Our study has identified and characterized NMIIB as a specific and 
essential component of the IRE1α-XBP1 signaling axis of UPR. We propose a 
model in which ER stress promotes an IRE1α-NMIIB interaction and 
subsequently, NMIIB facilitates the oligomerization, activation, and signaling of 
IRE1α (Fig. 3.7I). This model is supported by our findings that NMIIB is required 
for IRE1α aggregation and foci formation, induction of XBP1s protein and 
downstream UPR targets, and cellular and organismal responses to ER stress in 
vivo. The actomyosin contractility of NMIIB is required as both the motor 
domain and involvement of the actin filament are indispensable. 
Our data point to a concerted coordination between the ER and 
cytoskeleton that is essential for optimal IRE1α activation and cell fate 
determination in response to ER stress (Fig. 3.7I). Upon ER stress, RLC 
phosphorylation is required for NMIIB activation and its regulation of IRE1α; 
these events are at least in part dependent on MLCK. How MLCK or other RLC 
kinases respond to ER stress remains unclear. An intriguing possibility is that 
IRE1α itself may serve as a kinase for MLCK directly or indirectly, and thus form 
a feedback regulatory loop. Although other scenarios, such as NMIIB-mediated 
Xbp1 mRNA trafficking or ER membrane reorganization, are exciting 
possibilities that remain to be explored, our data demonstrate that NMIIB 
directly impacts IRE1α activation and signaling by interacting with IRE1α and 
regulating its oligomerization and activation. 
A number of studies have identified a repertoire of IRE1α regulatory 
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cofactors that modulate its activity, including BAX/BAK, Bax inhibitor-1, 
RACK1, HSP90, and others (Hetz et al., 2011; 2006; Lisbona et al., 2009; Qiu et al., 
2010). Collectively, these interacting proteins comprise the ‘‘UPRosome,’’ a 
scaffolding complex believed to dynamically regulate IRE1α in a cell or tissue-
specific manner (Hetz et al., 2011; Hetz and Glimcher, 2009). Identification of 
these regulatory cofactors of IRE1α signaling has greatly advanced our 
understanding of how IRE1α activity and output can be regulated 
mechanistically. Unlike other IRE1α-interacting proteins that have been 
identified, NMIIB is unique in that it is an essential component involved in the 
oligomerization step of IRE1α activation. Speculatively, NMIIB may not only 
promote IRE1α aggregation but also recruit other regulatory components to the 
foci. The interplay between NMIIB and the ‘‘UPRosome’’ is an open but exciting 
question. 
Findings from this study and others showed that IRE1α foci can be 
visualized as early as 1 hr, peaked around 4 hr and are resolved by 8 hr of ER 
stress (Fig. 3.4C and (Li et al., 2010)). However, questions such as how foci 
dispersion and deoligomerization are regulated and whether NMIIB or other 
cytoskeletal proteins are involved in this process remain unaddressed. 
Interestingly, our data convey that NMIIB activation as indicated by RLC 
phosphorylation is extremely dynamic and transient, peaking within the first 
hour and resolved after prolonged ER stress (Figs. 3.6D-E), suggesting an 
intimate relationship between NMIIB activation and the kinetics of IRE1α foci 
formation and dispersion. A recent study in yeast reported that the kinase 
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activity of IRE1α is important for its deactivation and foci dispersion (Rubio et 
al., 2011). Whether and how NMIIB are linked to the activation and inactivation 
of IRE1α during ER stress remains to be elucidated, and future studies are 
warranted to tease out the mechanistic details and dynamics of IRE1α foci 
formation and dispersion. 
 IRE1α has been reported to cleave other nonspecific mRNAs upon ER 
stress in a process termed regulated IRE1-dependent decay (RIDD), presumably 
to decrease ER load (Han et al., 2009; Hollien and Weissman, 2006; Hollien et al., 
2009; So et al., 2012). However, the molecular mechanism and signals by which 
IRE1α regulates RIDD remain largely unknown. For example, does IRE1α RNase 
activation depend on the substrate (i.e., Xbp1 versus RIDD targets) and is IRE1α 
aggregation a prerequisite for RIDD? As NMIIB regulates IRE1α oligomerization, 
it will be of great interest to determine whether and how NMIIB regulates IRE1α 
RIDD activity. 
 Although IRE1α dimers may possess RNase activity to splice Xbp1 
mRNA, IRE1α oligomers are believed to have maximal splicing efficiency as the 
arrangement of dimers into oligomers brings multiple Xbp1 mRNA binding 
pockets into close proximity (Korennykh et al., 2009; Li et al., 2010; Walter and 
Ron, 2011). This is supported by our observation that a NMIIB deficiency does 
not completely abolish XBP1s production. Nonetheless, NMIIB-mediated IRE1α 
oligomerization is significant as shown by our in vivo data on the cellular and 
organismal response to ER stress in which NMIIB is essential for initiating and 
engaging an optimal IRE1α signaling and UPR. 
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 One outstanding question is whether the involvement of NMIIB in IRE1α 
activation and signaling is relevant in vivo under physiological conditions, 
where ER stress can be much milder relative to the pharmacological insults used 
in cell culture to disrupt ER homeostasis (Pfaffenbach et al., 2010; Sha et al., 2011; 
Yang et al., 2010). Because of the lack of a good antibody for immunostaining, the 
question of whether endogenous IRE1α forms foci in vivo under physiological 
UPR remains unanswered. This is important as it will shed light on the activating 
mechanism of IRE1α under physiological and pathophysiological settings. 
Overall, our finding linking the IRE1α branch of the UPR and the cytoskeletal 
machinery of the cell enhances our comprehension of the cellular and molecular 
basis of mammalian ER stress response and may shed light on therapeutic targets 
for UPR-associated diseases. 
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CHAPTER 4  
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
4.1 DISCUSSION AND WORKING MODEL 
 The overarching aim of this dissertation is to conduct a thorough 
investigation of the underlying mechanisms regulating mammalian IRE1α 
activation and signaling as well as to characterize the physiological implications 
and significance of this pathway. Although the general outcomes of IRE1α 
activation and signaling and their corresponding sequence of events have been 
reported and reviewed, a comprehensive understanding of the underlying 
regulatory mechanisms was incomplete. Each chapter and appendix of this 
dissertation provides new insight and understanding into the activation, 
signaling, regulation and physiological function of the IRE1α-XBP1 pathway. In 
Chapter 2 and Appendix A, we uncover novel functions of IRE1α-XBP1 signaling 
in regulating two fundamental biological processes: differentiation of pre-
adipocytes into mature fat cells (Chapter 2) and ER stress-induced inflammation 
in macrophages (Appendix A). Both adipogenesis and inflammation activate the 
IRE1α-XBP1 pathway but in distinct manners. During adipogenesis, IRE1α is 
phosphorylated and activated at a low basal level as opposed to an overt 
activation typically observed with ER stress (Chapter 2). This basal level of IRE1α 
activation is sufficient to efficiently splice Xbp1u mRNA and generate XBP1s 
protein. On the contrary, ER stress-associated inflammation clearly promotes 
IRE1α phosphorylation and activation (Appendix A). These findings contribute 
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to and expand the current knowledge of cellular signaling pathways that 
integrate with UPR and specifically IRE1α. However, the source and type of 
signals that activate IRE1α during adipogenesis are not clear and it is uncertain 
whether canonical ER stress signals such as accumulation of misfolded proteins 
play a role in this process.  
 In addition to contributing to our basic understanding of the physiological 
importance of IRE1α-XBP1 signaling, our proteomics-based screen coupled with 
molecular and functional characterizations greatly enhanced our mechanistic 
understanding of how IRE1α is regulated. In Chapter 3 and Appendix C, we 
used tandem mass spectrometry as a screening tool to identify novel IRE1α-
interacting proteins. From the screen, NMIIB, a cytoskeleton-associated factor, 
was identified and shown to exert a conserved functional role essential for IRE1α 
oligomerization and foci formation (Chapter 3). NMIIB selectively interacts with 
IRE1α upon ER stress and its motor domain, along with the actin cytoskeleton, 
coordinately pull IRE1α proteins into higher-order oligomers that efficiently 
splice Xbp1 mRNA. Although several IRE1α-interacting factors have been 
reported thus far and are proposed to comprise the IRE1α interactome (see 
Chapter 1 and Fig. 1.4), NMIIB is the first interactor identified to regulate IRE1α 
activation at the step of aggregation and foci formation. In addition to NMIIB, 
several other factors were also identified from the screen with putative biological 
roles in mRNA splicing and processing, nucleosome remodeling and nonsense-
mediated decay (Appendix C). Interestingly, most of these factors and their 
interactions with IRE1α were selectively enriched for either control non-stress 
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conditions or ER stress conditions, suggesting that both positive and negative 
regulators of IRE1α signaling were identified. Although purely speculative at 
this point, it is very exciting to note the role of so many of these factors in mRNA 
processing and maturation given the role of IRE1α RNase activity in splicing 
Xbp1u and RIDD mRNAs, and potentially even microRNAs. All together, these 
findings expand our current knowledge of the repertoire of the IRE1α 
interactome and may identify potential factors as drug targets for therapeutic 
intervention in conformational diseases. 
 Lastly, in addition to uncovering novel regulatory factors of IRE1α 
signaling, our mass spectrometry analysis also identified a novel motif on IRE1α 
protein that may be required to direct its trans-autophosphorylation. Currently, 
despite efforts to identify targets of IRE1α kinase activity under ER stress, the 
only known target is itself. Yet descriptions of the exact phosphorylation 
residues and their importance and contribution to overall mammalian IRE1α 
activation remain incomplete. Our Phos-tag based Western blots typically reveal 
one fast-migrating band denoted as the phosphorylated form of IRE1α, 
suggesting that phosphorylation may not be very extensive [Chapter 3 and (Sha 
et al., 2009; Yang et al., 2010)]. This is in stark contrast with PERK 
phosphorylation, which is visualized as a smear on the gel (Qi et al., 2011; Yang 
et al., 2010). Excitingly, mass spectrometry identified a unique motif on IRE1α 
protein located on the cytosolic linker region following the transmembrane 
domain that undergoes extensive phosphorylation upon ER stress. Peptides 
containing mono-, di- and even tri-phosphorylation were detected on an “SSPS” 
	  125	  	  
motif at amino acid positions 548-551 of human IRE1α protein (977 total amino 
acids) (Appendix B). To our knowledge, this is the first report of a motif on 
IRE1α that may be critical in directing its trans-autophosphorylation. However, 
future studies, in particular mutagenesis assays in which serine residues are 
mutated to loss-of-function alanine or gain-of-function/phospho-mimetic 
aspartic acid, are required to understand whether this motif plays a functional 
role in IRE1α signaling. Also, we are interested in determining the contribution 
of each serine residue to overall IRE1α phosphorylation and whether 
phosphorylation at SSPS represents an initiating event that can trigger a rapid 
cascade of downstream trans-autophosphorylation events. An in vivo knock-in 
mouse model will be essential in deciphering the physiological significance of 
this motif.  
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Figure 4.1.  Contributions of this dissertation to the field of ER stress.  
Under conditions of ER stress, metazoan IRE1α protein undergoes activation at 
the ER membrane through BiP dissociation and/or direct binding of misfolded 
proteins. This promotes IRE1α dimerization and trans-autophosphorylation via 
its cytosolic kinase domain. Further stacking of IRE1α dimers into efficient 
higher-order oligomers in a process termed foci formation requires a 
cytoskeleton protein NMIIB (Chapter 3). IRE1α processes and splices Xbp1 
mRNA to produce a critical UPR transcription factor XBP1s. In addition to 
regulating genes associated with ER homeostasis, XBP1s is also intimately linked 
to various cellular and physiologically-relevant processes including a key 
differentiation and developmental event that occurs in fat cells called 
adipogenesis as described in this dissertation (Chapter 2). Novel contributions 
from this dissertation are highlighted in red boxes.  
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4.2 FUTURE DIRECTIONS 
 Despite the advances and contributions made from this dissertation and 
the work of others to the field of ER stress and understanding IRE1α activation, 
many more questions remain in our efforts to characterize mammalian IRE1α 
signaling and the pathophysiological consequences that arise from its 
dysfunction. Cell culture models are essential for basic science as they provide 
researchers a tool to simplify and study complex underlying molecular and 
physiological networks of an organism at the cellular level. However, the use of 
animal models is essential to bridge the gap between basic science and 
translational and clinical research. Thus, the use of in vivo models based on the 
findings from this dissertation can greatly enhance our understanding of the 
pathophysiological role of the IRE1α-XBP1 pathway. For example, as IRE1α and 
UPR have been implicated in metabolic dysfunction, a tissue-specific NMIIB 
knock-out mouse model administered a high-fat diet (HFD) to induce obesity 
would provide substantial information on the impact of NMIIB in vivo. 
Similarly, an adipose-tissue specific knock-out mouse model of IRE1α or XBP1 
will offer invaluable insight into the in vivo requirement of either of these UPR 
components in adipogenesis and the overall contribution of adipose tissue to the 
general metabolic status and parameters of the animal. Additionally, a knock-in 
mouse model containing the loss-of-function “AAPA” motif of IRE1α would 
address whether this motif functions as an in vivo cis regulator of IRE1α 
phosphorylation and activation.  
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 Studies in the field of ER stress and UPR typically turn to the use of 
pharmacological agents such as Tg and Tm to induce ER stress. However, even 
low doses of these chemical agents can cause overt UPR activation concomitant 
with initiation of apoptosis. Indeed, studies from our lab using Phos-tag gels 
have shown that MEF cells incubated with 75 nM Tg for only 30 min was 
sufficient to induce IRE1α phosphorylation (Yang et al., 2010). Alarmingly, 
reports in the literature typically use a concentration and incubation period of 2 
to 6-fold more than our report. Therefore, the question arises as to the relevance 
of these chemical agents in addressing and understanding UPR associated with 
pathophysiological conditions such as obesity. As expected, studies have 
demonstrated that physiological UPR is at times very minor and almost 
undetectable relative to chemical-induced UPR (Sha et al., 2009). Furthermore, 
physiological UPR may be reversible and sustainable in the cell for indefinite 
periods of time without inducing apoptosis, and may even lead to adaptations or 
a resetting of ER capacity and homeostasis. Therefore, observations arising from 
the use of pharmacological agents to induce ER stress should be cautiously 
interpreted. Future studies investigating the role of physiological UPR in various 
tissues will be essential for gaining a full understanding of the role of UPR in 
conformational diseases.  
 Although IRE1α-XBP1 signaling is essential for mounting a proper UPR 
upon misfolded protein accumulation, this pathway has recently emerged to 
engage in additional cellular processes including differentiation, metabolism and 
immunity. Thus, rather than simply acting as an adaptation mechanism against 
protein folding stress, UPR signaling may serve as a central hub that integrates 
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various cellular stress and metabolic inputs to determine cell fate. Likewise, 
others have proposed that UPR resembles a cellular rheostat that acts to fine-
tune, integrate, and couple different signals with an appropriate output (Hetz, 
2012). As the signals activating IRE1α-XBP1 in metabolism, cellular 
differentiation and immunity may not be directly associated with the canonical 
UPR inducing signals (defective protein folding or degradation, accumulation of 
misfolded proteins, etc.), the future of studying ER stress and UPR activation 
under pathophysiological conditions lies in identifying the initiating signals and 
understanding the mechanism by which they act to engage the IRE1α-XBP1 
pathway. 
 Canonical UPR signaling acts on the premise that all three major 
pathways are activated, albeit to differing degrees corresponding to varying 
levels of ER stress. However, the studies presented in this dissertation and the 
work of others have suggested selective activation of UPR branches. First, the 
three major ER transmembrane sensors may exhibit different sensitivities to 
various types of ER stress. Changes in ER luminal Ca2+ concentrations have been 
suggested to selectively activate IRE1α and PERK branches more rapidly than 
ATF6 (DuRose et al., 2006). On the other hand, ATF6 appears to be preferentially 
activated first in response to alterations in glycosylation and the redox 
environment (Yoshida et al., 2003). Furthermore, many of the adaptor proteins 
comprising the IRE1α interactome have been reported to selectively form a 
complex with IRE1α and not PERK or ATF6 (Hetz, 2012). Indeed, our studies 
showed a selective interaction and regulation of IRE1α signaling by NMIIB 
(Chapter 3). Thus, the localization and tissue- or cell type-specific regulated 
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expression of these interacting factors may inherently act as specific modulators 
of IRE1α activation and signaling.  
 In conclusion, studies of IRE1α-XBP1 and UPR regulation are highly 
relevant to human health and conformational disorders. This dissertation 
characterized the novel physiological role of IRE1α-XBP1 signaling in fat cell 
differentiation and identified NMIIB as an essential modulator of IRE1α 
activation and ER stress response. Future work on understanding the 
pathophysiological role and contribution of UPR activation and ER stress to 
conformational diseases will be crucial in therapeutic development. Perhaps 
targeting NMIIB or using pharmacologic chaperones such as 4-PBA or TUDCA 
that ameliorate ER stress may prove to be effective treatments for conformational 
diseases.  
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APPENDIX A 
MACROPHAGE XBP1 MODULATES ER STRESS-DEPENDENT  
INFLAMMATION THROUGH ATF3 
 
A.1 ABSTRACT 
 Innate immunity is required for host defense, but dysregulation and 
prolonged activation can trigger chronic inflammatory diseases including obesity 
and atherosclerosis. Thus, a comprehensive understanding of the mechanisms 
underlying the regulation of innate immunity and inflammation is of 
fundamental and clinical relevance. Our microarray study showed that both 
lipopolysaccharide (LPS)- and thapsigargin (Tg)-induced activation of the IRE1α-
XBP1 pathway in macrophages induced the expression of key pro-inflammatory 
mediators. However, the transcriptome induced in response to LPS or Tg 
showed vast differences in their dependency on XBP1 as well as their Gene 
Ontology-annotated biological functions. Surprisingly, of the genes induced 
under either condition, both treatments displayed similar percentages of target 
genes containing predicted XBP1 binding motifs in their proximal promoter 
regions. Mechanistically, XBP1 may modulate inflammatory gene expression 
through ATF3, a key regulator of inflammation. Loss of XBP1 in macrophages 
drastically attenuated Atf3 expression and XBP1s overexpression transactivated 
an ATF3 promoter-construct. In conclusion, XBP1-mediated regulation of crucial 
inflammatory mediators upon ER stress may occur through modulation of ATF3.  
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A.2 INTRODUCTION 
 The innate immune system, of which inflammation comprises one of the 
earliest defenses, is a non-specific response that provides immediate protection 
against infection. This surveillance system recognizes conserved microbial 
structural motifs called pathogen-associated molecular patterns (PAMPs) 
through pattern recognition receptors, such as Toll-like receptors (TLRs) 
expressed on the surfaces of cells that respond immediately to infection 
including neutrophils, macrophages and dendritic cells (Gordon, 2002). A classic 
example of a PAMP is lipopolysaccharide (LPS) derived from the outer 
membrane of Gram-negative bacteria. Upon activation by PAMPs, TLR-
mediated signaling primarily promotes the nuclear translocation of nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB) and downstream 
activation and secretion of pro-inflammatory cytokines including interleukin-1 
(IL-1), IL-6, IL-12, and tumor necrosis factor-α (TNF-α) (Armant and Fenton, 
2002; Hu et al., 2008; Medzhitov and Horng, 2009; Moynagh, 2005). Despite the 
vital role of the innate immune system as a sentinel in protecting the cell, a 
comprehensive understanding of the regulatory mechanisms governing 
inflammation as well as the interplay with other stress signaling pathways such 
as UPR remain largely uncharacterized. 
 Unfolded protein response (UPR) is an evolutionarily conserved quality-
control mechanism activated by the accumulation of misfolded proteins in the 
endoplasmic reticulum (ER). Of the three primary ER-to-nucleus signaling 
pathways, the IRE1α-XBP1 branch is the most conserved (Calfon et al., 2002). 
Upon ER stress, ER-resident transmembrane protein inositol-requiring enzyme 
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1α (IRE1α) undergoes trans-autophosphorylation, leading to activation of its 
cytosolic RNAse domain. In turn, the RNAse domain splices 26 nucleotides from 
the mRNA of X-box binding protein 1 (Xbp1) to generate XBP1 spliced (XBP1s) 
(Lee et al., 2002; Yoshida et al., 2001). In contrast to XBP1u (unspliced), the XBP1s 
protein product is stable and contains a transactivation domain, allowing it to 
function as a potent basic leucine zipper (b-ZIP) transcription factor (Tirosh et al., 
2006). XBP1s translocates to the nucleus and induces the expression of target 
genes not only involved in restoring ER homeostasis, but in many fundamental 
cellular processes as well including adipogenesis, myocyte differentiation and B 
cell maturation (Acosta-Alvear et al., 2007; Hetz et al., 2011; Iwakoshi et al., 2003; 
Lee et al., 2003a; Reimold et al., 2001; Sha et al., 2009).  
 The link between UPR and immunity has only been recently explored. In 
animal studies, XBP1 has been demonstrated to be essential for both the 
development of B-lymphocytes into plasma cells and the survival and function of 
dendritic cells (Iwakoshi et al., 2007; Reimold et al., 2001). Additionally, XBP1 
was initially identified and named for its role in binding to the X-box motif 
found in the promoters of many human MHC class II genes (Liou et al., 1990). 
More recently, a link between UPR and immunity was established when the 
regulation of a gene involved in innate immunity and inflammation, hepcidin, 
was shown to be UPR-dependent (Vecchi et al., 2009). Finally, several recent 
reports have also alluded to a potential link between UPR and inflammation. 
First, the IRE1α pathway is correlated with phosphorylation of c-Jun N-terminal 
kinases (JNK) under inflammatory physiological conditions such as obesity 
(Ozcan et al., 2004). Moreover, another UPR signaling pathway mediated by 
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pancreatic ER kinase (PERK) was implicated in extracellular signal-regulated 
kinase-1/2 (ERK1/2) activation and pro-inflammatory IL-6 induction (Urano et 
al., 2000).  
 Most relevant to this study are two recent publications examining the 
interplay between IRE1α-XBP1 signaling and inflammatory responses. During C. 
elegans development, XBP1 was induced by innate immunity pathways and 
required for protection against microbes (Richardson et al., 2010). Additionally, 
lipopolysaccharide (LPS)-induced inflammation was shown to activate IRE1α-
XBP1 signaling in macrophages and was essential for pro-inflammatory cytokine 
secretion (Martinon et al., 2010). Despite these advances in the field, precise 
characterization of the relationship between UPR activation and inflammatory 
gene expression as well as the role of canonical ER stress-induced activation of 
IRE1α-XBP1 in immune cells remain unknown.  
 Activating transcription factor 3 (ATF3) is a b-ZIP transcription factor that 
binds to CRE-like consensus sequences and can homo- or hetero-dimerize with 
other transcription factors to allow for specificity in modulating gene expression 
(Hai and Hartman, 2001; Hai et al., 1989). Whether ATF3 acts as a positive or 
negative transcriptional regulator may be dependent on its co-factor interactions 
(Hai et al., 1999). However, in immune cells, the dominant role of ATF3 has been 
as a repressor of gene expression. Indeed, ATF3 has been shown to regulate the 
expression of many LPS-responsive inflammatory genes including IL1β, IL-6, IL-
12, TNFα, and CCL4 (MIP1β) (Gilchrist et al., 2006; Hai et al., 2010; Suganami et 
al., 2009; Whitmore et al., 2007; Zmuda et al., 2010). Due to its role in integrating 
various stress inputs with downstream responses, ATF3 has often been dubbed 
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as a hub in governing immune responses including inflammation. Indeed, ATF3 
expression is highly stress-inducible and has been shown to be up-regulated in 
response to ER stress in various cell types and may serve broad functions 
associated with apoptosis and PERK downstream signaling (Jiang et al., 2004; 
Wang et al., 2009a; Zhang et al., 2001). However, the relationship between IRE1α 
signaling and ATF3 expression is not known. A thorough examination of the 
contribution of canonical ER stress and IRE1α-XBP1 activation to inflammation is 
critical for a comprehensive understanding of immune regulation and will 
permit for the manipulation of this pathway in inflammatory disease-associated 
drug interventions.    
 
A.3 MATERIALS AND METHODS 
Cell lines and drug treatment 
HEK293T cells and RAW264.7 macrophages were maintained in DMEM 
supplemented with 10% FBS (Hyclone) and 1% penicillin/streptomycin 
(Cellgro). For passaging, RAW264.7 macrophages were washed once with PBS, 
trypsinized and gently scraped with a cell scraper (Corning Costar). Tg was 
purchased from EMD Calbiochem and LPS from Sigma.  
 
Retroviral transduction and stable cell line generation 
Phoenix cells were transfected with the plasmids encoding the gene of interest in 
pSuper or pBabe vectors and VSVG at 2:1 ratio for 16 hr, and then replaced with 
fresh culture media. Following 48 hr culture, media containing retroviruses were 
harvested and used to transduce RAW264.7 macrophages in the presence of 5 
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µg/ml polybrene (Sigma) for 24 hr. Stable cell lines were selected in the presence 
of 2 µg/ml puromycin (Sigma). Typically, puromycin-resistant cell lines 
developed in 6 days.  
 
shRNA knockdown 
pSuper/U6/retro (gift from Lee Kraus, UTSW) was used. Control RNAi was 
against the firefly luciferase gene. shRNA targeting sequences were designed 
using Dharmacon and specific for mouse XBP1 (GGATTCATGAATGGCCCTTA) 
at position nucleotide 1558-1577 at 3’ UTR.  
 
Nuclear-cytosolic fractionation  
Cells in a 6 cm dish were resuspended in 200 µl ice-cold hypotonic buffer (10 mM 
HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, and 1 mM DT) and 
allowed to swell on ice for 15 min followed by addition of 10% NP-40 to a final 
concentration of 0.6%. Lysates were vortexed vigorously for 15 s prior to 
centrifugation. Supernatant was transferred to a fresh tube as the cytosolic 
fraction. Pellets were resuspended in 30-50 µl ice-cold high-salt buffer (20 mM 
HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, and 1 mM DTT) and 
vortexed vigorously for 15 s every 5 min for a total of 25 min. Extracts were 
centrifuged at 4°C for 5 min and supernatant was collected as the nuclear 
fraction.  
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Western blot 
Western blot was performed using 20-30-µg of total cell lysate or 10-15 µg 
nuclear extracts. Antibodies used in this study: XBP1 (rabbit, 1:1000, Santa Cruz), 
CREB (rabbit, 1:5000), ATF3 (rabbit, 1:500, Santa Cruz), and goat anti-rabbit IgG 
(1:5000, Jackson ImmunoResearch).  
 
Phos-tag gels 
Phos-tag gel was carried out in the same manner as regular Western blots except 
that 50 µM Phos-tag (NARD Institute) and 50 µM MnCl2 (Sigma) were 
incorporated into 5% SDS-PAGE gels. Also, gels were soaked in 1 mM EDTA for 
10 min prior to transfer onto a PVDF membrane. 
 
Immunoprecipitation 
Whole cell lysate was harvested in lysis buffer (150 mM NaCl, 1% Triton X-100, 1 
mM EDTA, and 50 mM Tris HCl pH 7.5) supplemented with protease inhibitor 
cocktail (Sigma) and incubated on ice for 25 min. Samples were sonicated 10 s 
with Branson Digital 250 Cell Disruptor at amplitude 10%. Immune complexes 
were recovered with HA-agarose beads overnight at 4°C with rocking. Beads 
were washed three times with wash buffer (20 mM Tris HCl pH 7.5, 137 mM 
NaCl, 20 mM EDTA, 1% Triton X-100, and 10% glycerol), eluted in boiling 2X 
SDS sample buffer followed by SDS-PAGE and Western blot.  
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RNA extraction and qPCR 
Total RNA was extracted using Trizol per supplier’s protocol (Molecular 
Research Center) and reverse transcribed using Superscript III kit (Invitrogen). 
cDNA were analyzed using the Power SYBR Green PCR kit on the ABI PRISM 
7900HT-QPCR machine (Applied Biosystems) or the SYBR Green PCR system on 
the iQ5 or Cfx384 Q-PCR machine (Bio-Rad). All data were normalized to the l32 
ribosomal gene. qPCR primers are listed below. 
 
Atf3   Forward: 5’ GAGGATTTTGCTAACCTGACACC 3’ 
  Reverse: 5’ TTGACGGTAACTGACTCCAGC 3’ 
 
Xbp1 total Forward: 5’ ACATCTTCCCATGGACTCTG 3’ 
  Reverse: 5’ TAGGTCCTTCTGGGTAGACC 3’ 
 
Xbp1s  Forward: 5’ GAGTCCGCAGCAGGTG 3’ 
  Reverse: GTGTCAGAGTCCATGGGA 3’ 
 
 
Microarry analysis 
RNA was extracted as described above and RNA quality was verified on an 
Agilent 2100 Bioanalyzer (Agilent Technologies, Amsterdam, The Netherlands) 
using 6000 Nano Chips according to supplier’s protocol. 100 ng of RNA was 
used for Whole Transcript cDNA synthesis (Affymetrix, Santa Clara, CA). 
Hybridization, washing, and scanning of Affymetrix GeneChip Mouse Gene 1.0 
ST Arrays were carried out according to standard Affymetrix protocols. Scans of 
the Affymetrix arrays were processed using packages from the Bioconductor 
project. Arrays were normalized using the Robust Multi-array Average method 
(Bolstad et al., 2003; Irizarry et al., 2003). Changes in gene expression were 
calculated as signal log ratios between treatment and control. These ratios were 
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used to create heatmaps within Excel. Affymetrix GeneChip analysis was carried 
out on WT and XBP1-knockdown RAW264.7 macrophages incubated with 
thapsigargin (Tg, 300 nM) for 2 hr or lipopolysaccharide (LPS, 10 ng/mL) for 2 
hr.  
 
Gene ontology (GO analysis) 
The complete list of genes induced/up-regulated in response to Tg or LPS 
incubation in RAW264.7 macrophages was analyzed against a background of all 
Mus musculus genes using the Gene Ontology AmiGO tool 
(http://amigo.geneontology.org/).  
 
Luciferase reporter assay 
Following overnight transfection, cells were lysed in extraction buffer (Gly-Gly 
buffer, 1% Triton X-100, and 1 mM DTT) and 50 µl lysates were transferred to a 
96-well plate containing equal volume of assay mix (Gly-Gly buffer, 16 mM 
K2HPO4, 2 mM DTT, and 2.5 mM ATP). 100 µl of 0.4 mM luciferin mix was added 
to each well through an injector and readings were collected using the Synergy 2 
plate reader (Biotek). Luciferase activity was normalized to activity from co-
transfected Rous sarcoma virus-β-galactosidase expression plasmid. 
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A.4 RESULTS AND DISCUSSION 
Lipopolysaccharide (LPS)-induced inflammation activates UPR 
 A recent study by Martinon and colleagues showed that LPS-induced 
TLR2/4 signaling in macrophages specifically activated the IRE1α-XBP1 
signaling pathway, which in turn was required for mounting an appropriate 
response to inflammation by regulating the production and secretion of a subset 
of pro-inflammatory cytokines (Martinon et al., 2010).  Interestingly, LPS-
induced activation of IRE1α-XBP1 in macrophages did not affect the expression 
of canonical UPR target genes. Rather, the production and secretion of select pro-
inflammatory cytokines including IL-6, TNF and IFN-β required XBP1. 
Biologically, an XBP1 deficiency rendered macrophages more susceptible to 
bacterial infections by F. tularensis (Martinon et al., 2010).  However, the role of 
canonical ER stress and IRE1α-XBP1 signaling in macrophages was not 
addressed. Hence, our study aimed to understand the relationship between 
classical activation of IRE1α-XBP1 signaling and inflammation in macrophages. 
 First, to compare the activation status of the IRE1α-XBP1 pathway by 
classical ER stress and LPS, we treated RAW264.7, a well-established 
macrophage cell line, with 10 ng/ml LPS to induce TLR2/4-associated 
inflammation and 300 nM thapsigargin (Tg) to induce canonical ER stress. As 
expected and consistent with Martinon et al.’s study, RAW264.7 macrophages 
incubated with both LPS and Tg displayed an increase in IRE1α phosphorylation 
as visualized by the Phos-tag Western blot system (Fig. A.1A). Notably, LPS-
induced phosphorylation of IRE1α was not as extensive as canonical ER stress. 
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Consistently, both Tg and LPS incubation induced Xbp1s mRNA (Fig. A.1B) and 
protein levels (Fig. A.1C). Similar to IRE1α phosphorylation, XBP1s protein 
induction by LPS was not as pronounced as that in response to ER stress (Fig. 
A.1C). Thereby, IRE1α-XBP1 signaling in macrophages is responsive to and 
activated by both inflammation and canonical ER stress.  
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Figure A.1.  LPS-associated inflammation activates the IRE1α-XBP1 pathway.  
(A) Phos-tag Western blot of RAW264.7 macrophages treated with 10 ng/ml LPS 
for indicated time or 300 nM Tg for 2 hr. *, phosphorylated IRE1α. HSP90, 
loading and positional control. (B) qPCR analysis of Xbp1 total and Xbp1s mRNA 
expression in RAW264.7 macrophages treated with 300 nM Tg for 2 hr or 10 
ng/ml LPS for the indicated time. All expression was normalized to the 
ribosomal l32 gene. (C) Immunoblot of XBP1s protein from nuclear extracts 
harvested from RAW264.7 macrophages incubated with 300 nM Tg for 2 hr or 10 
ng/ml LPS for the indicated time.  
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Canonical ER stress promotes inflammatory gene induction in macrophages 
 As both canonical ER stress and LPS can activate IRE1α-XBP1 signaling, 
we sought to examine the downstream effects by analyzing changes in the 
macrophage transcriptome. Microarray analysis was performed in collaboration 
with Dr. Sander Kersten’s lab at Wageningen University on RAW264.7 cells 
treated with 300 nM Tg or 10 ng/ml LPS for 2 hr. LPS incubation induced the 
expression of over 300 genes and Tg treatment induced the expression of 210 
genes (Fig. A.2A). Of the genes induced in response to either treatment, Tg and 
LPS shared 155 transcripts, indicative of a correlation between ER stress and 
inflammation (Fig. A.2A). Interestingly, when the dataset was sorted by the top 
10 genes with the greatest induction, both ER stress and LPS treatment promoted 
the expression of key inflammatory mediators including Il23a, Il1b and Il1a (Fig. 
A.2B), which were validated by qPCR analysis (Fig. A.2C). We had previously 
anticipated that canonical ER stress would have the greatest impact on classical 
UPR target genes such as chaperones and degradation components. However, 
this data suggested a macrophage cell-type specificity in that canonical ER stress 
regulated the expression of pro-inflammatory cytokines. Thus, our 
transcriptomics data in macrophages showed that in response to both ER stress 
and LPS, a subset of inflammatory genes were highly induced, suggesting cross-
talk between canonical ER stress activation and inflammation.  
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Figure A.2.  Microarray of RAW264.7 macrophages in response to ER stress.  
RAW264.7 cells treated with ER stress (Tg) or LPS, a known potent inducer of 
TLR2/4-associated inflammation, were subjected to microarray analysis. (A) Tg 
induced the expression of 210 genes and LPS induced 317 genes. However, there 
were 155 genes shared between the two treatments, suggesting a link between 
ER stress and inflammation. (B) Venn diagram depicting the top 10 genes 
induced upon Tg or LPS treatment and the transcripts shared between the two 
treatments. Interestingly, Tg and LPS treatment have 5 of the 10 genes in 
common and Tg up-regulates key inflammatory mediators, further reinforcing 
the model that ER stress promotes inflammation in macrophages. (C) qPCR 
analysis of RAW264.7 macrophages treated with 300 nM Tg for 2 hr. Tg strongly 
and expectedly induced the expression of Xbp1s and Erdj4, a canonical UPR 
target gene. In validation of the microarray, both Il23a and Il1b mRNA levels 
were induced by ER stress.  
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ER stress-associated inflammation in macrophages is dependent on XBP1 
 To determine the molecular mechanism underlying these transcriptional 
changes, we generated RAW264.7 cells stably expressing an shRNA targeting the 
3’ UTR of Xbp1, which resulted in a successful and potent knock-down of both 
Xbp1 total and Xbp1s mRNA levels (Fig. A.3A) as well as XBP1s protein levels 
(Fig. A.3B). Microarray analysis in collaboration with the Kersten Lab 
(Wageningen University) was performed on both wild-type (CONi) and 
macrophages deficient for XBP1 (XBP1i). Surprisingly, of the 210 genes induced 
by ER stress (Fig. A.2A), approximately 90% of the induction was dependent on 
XBP1 (Fig. A.4). However, for LPS treatment, only 20% of the up-regulated genes 
showed XBP1 dependency (Fig. A.4), suggesting that although both conditions 
activated IRE1α-XBP1 signaling, modulation of inflammatory genes by LPS 
primarily occurred through mechanisms independent of XBP1. Indeed, a closer 
examination of the top 10 genes induced in response to canonical ER stress 
clearly illustrated a high XBP1 dependency that was almost completely absent 
with LPS treatment (Fig. A.5A). Furthermore, a comparison of the changes in 
expression of the top 10 genes in control (CONi) and XBP1-deficient 
macrophages (XBP1i) supported a role for XBP1 as a transcriptional activator 
(Fig. A.5A) consistent with its function in regulating canonical UPR genes. 
However, microarray analysis of a different cell type, 3T3-L1 pre-adipocytes, by 
Haibo Sha in collaboration with the Kersten Lab also showed strong XBP1 
dependency, but in this case, XBP1 deficiency resulted in an up-regulation of 
inflammatory genes, suggesting a role for XBP1 as a repressor (Fig. A.5B).  
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Figure A.3.  Efficient knock-down of XBP1 in RAW264.7 macrophages.  
(A) qPCR analysis of the transcript levels of Xbp1 total and the active spliced 
form Xbp1s in response to Tg in control macrophages (CONi) and RAW264.7 
macrophages expressing an shRNA against Xbp1 to mediate knockdown (XBP1i). 
Xbp1 mRNA levels are dramatically attenuated in response to ER stress. * p < 
0.05. (B) Western blot analysis of XBP1s protein levels in CONi and XBP1i 
macrophages in response to Tg and the proteasome inhibitor MG132 (M). 
Consistent with the mRNA levels, XBP1s protein is greatly reduced in response 
to Tg in XBP1i cells. * denotes non-specific band. 
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Figure A.4.  XBP1 dependency profile of genes induced in response to Tg or 
LPS.  
(A) Genes induced in response to Tg or LPS in macrophages were examined for 
their dependency on XBP1 by comparing the gene induction profiles of WT 
(CONi) and XBP1-depleted (XBP1i) RAW264.7 cells. Although Tg and LPS 
shared many up-regulated genes, their XBP1 dependency profiles were very 
different as the vast majority of Tg-induced genes were dependent on XBP1 
(89%) whereas the majority of LPS-induced genes were XBP1 independent (80%). 
(B) Bar graph representation of data in (A) showing XBP1-dependency.  
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Figure A.5.  Canonical ER stress-induced inflammatory mediators are XBP1-
dependent.  
(A) Our microarray data showed that the top 10 genes induced in response to 
classical ER stress (Tg) in RAW264.7 macrophages were highly dependent on 
XBP1. In contrast, although these genes were also up-regulated by LPS to 
varying degrees, XBP1-deficient macrophages (XBP1i) retained the ability to 
induce the majority of them, suggesting XBP1-independent transcriptional 
regulation in response to LPS. Data was normalized to the non-treated 
conditions. (B) Heat map representation of a microarray performed in our lab on 
3T3-L1 pre-adipocytes by Haibo Sha demonstrated XBP1 to be a negative 
regulator of inflammatory genes, supporting the notion of cell-specificity 
transcriptional regulation. 
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 Next, to gain a deeper and more global view of the role of macrophage 
XBP1 in modulating gene expression, we queried whether specific functional 
categories of induced genes were enriched in either dataset. For Gene Ontology 
(GO) analysis, we turned to the AmiGO tool (Carbon et al., 2009) in collaboration 
with Dr. Huifeng Jiang in the Gu lab. GO analysis illustrated that XBP1-
dependent gene induction in response to Tg was significantly enriched in genes 
related to inflammatory response, apoptosis and regulation of cell proliferation 
(Fig. A.6A). However, when the dataset was filtered for XBP1-dependent gene 
induction in response to LPS, the only two statistically significant GO categories 
that were enriched were T cell activation and immune system process (Fig. A.6B). 
This observation further reinforced the notion that inflammation in response to 
canonical ER stress may be mechanistically distinct from that of LPS –TLR 2/4-
mediated inflammation.  
 As a transcription factor, XBP1 binds to the promoters of target genes 
containing a CRE site with an “ACGT” core consensus motif (Acosta-Alvear et 
al., 2007; Clauss et al., 1996). Because our data showed a huge discrepancy in the 
XBP1 dependency of Tg and LPS-regulated genes, we speculated that this may 
be due to the presence and/or distribution of XBP1 binding motifs in the 
promoter regions of target genes. In conjunction with Dr. Huifeng Jiang in the 
Gu Lab, we performed an analysis examining XBP1 binding site occupancy in the 
proximal promoter regions (-2000 to +200 bp relative to the transcription start 
site, TSS) of all genes induced in response to Tg or LPS treatment. As our search 
term, we used the XBP1 binding motif [T/C][G/C]ACGTG[G/T] containing the 
core ACGT element (underlined). The background frequency of encountering an 
XBP1 motif in the genome is approximately 11%. Interestingly, both Tg and LPS
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dependent genes had a significant increase in the frequency of XBP1 motif in 
their promoters, 15% and 14%, respectively (p-values for both = 0.02) (Fig. A.7). 
To gain additional insight into the position of the binding motif, we mapped it to 
the promoters of target genes (Fig. A.8). As expected for transcription factor 
binding, both Tg and LPS treatments showed a peak of motif enrichment around 
the TSS. However, the motif enrichment pattern for Tg and LPS were clearly 
different. Genes up-regulated in response to Tg showed a much broader peak 
around the TSS from +200 to -500 bp, but with no XBP1 binding motif at the TSS 
whereas LPS treatment displayed a much sharper peak centered at -100 bp (Fig. 
A.8). Furthermore, XBP1 binding motifs in Tg-induced genes revealed a more 
punctuated pattern containing peaks and valleys and in which the peaks were 
separated by regions of zero binding motif. This is in contrast with LPS-
dependent genes that showed a more regular and steady motif enrichment 
throughout the entire proximal promoter region (Fig. A.8). From these promoter 
studies examining XBP1 binding site enrichment, we learned that despite large 
differences in the number of XBP1-dependent genes induced upon Tg or LPS, 
this discrepancy was unlikely to be attributed to a lack of XBP1 binding motifs in 
LPS-regulated genes. Hence, our data suggested that perhaps not all XBP1 
binding motifs were occupied by XBP1. Rather, XBP1 recruitment to its binding 
site was being mediated through various interactions with different co-factors 
whose expression and regulation themselves may depend on diverse signals (i.e. 
Tg vs. LPS). Furthermore, the XBP1 binding motif used in our analysis was 
relatively short. As reported, XBP1 recognized and was bound to other motifs 
including the UPR element (UPRE) and a CCACG box, which may serve as 
additional cis regulators of XBP1 recruitment (Acosta-Alvear et al., 2007).  
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Figure A.6.  GO enrichment of XBP1-dependent genes up-regulated in 
response to Tg or LPS in RAW264.7 cells.  
Each of the categories listed were significantly enriched with a p-value listed 
next to the bars. The length of the bars determine the % cluster frequency. The 
most highly enriched biological processes that are XBP1-dependent upon Tg (A) 
are inflammatory response, apoptosis and regulation of multicellular organismal 
process. In contrast to XBP1-dependent gene induction in response to ER stress, 
LPS treatment (B) was only enriched for 2 biological processes: T cell activation 
and immune system process.   
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Figure A.7.  XBP1 binding motif is enriched in Tg and LPS-induced genes. 
Genes transcriptionally induced in response to Tg or LPS treatments were 
examined for the presence of an XBP1 binding motif in their proximal promoters 
(-2000 bp to +200 bp relative to the transcription start site). Although LPS-
induced genes displayed significantly less dependency on XBP1 (Fig. A.4 and 
A.5) than Tg-dependent genes, both treatments displayed a similar percentage of 
up-regulated genes containing a putative XBP1 binding motif. The background 
frequency of containing an XBP1 binding motif is 11%. p-values = 0.02 for both 
treatments compared to the background frequency.  
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Figure A.8.  Position of XBP1 motif in the promoters of induced genes. 
Graphical representation displaying the position and frequency of an XBP1 
binding motif in the proximal promoters (-2000 to +200 bp relative to the 
transcription start site, TSS) of up-regulated genes in response to Tg (top) and 
LPS (bottom). Notably, Tg treatment resulted in a much broader peak between 
the TSS and -500 bp whereas LPS treatment only showed a strong peak around    
-100 bp.   
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XBP1 regulates Atf3 expression 
 To understand mechanistically how IRE1α-XBP1 activation and signaling 
may modulate inflammatory mediators, we turned to the literature. Recent 
studies have proposed that activating transcription factor 3 (ATF3), a stress-
inducible transcription factor, may serve as an integration hub to modulate 
inflammatory signaling. First, to determine whether Atf3 expression was 
responsive to ER stress (Jiang et al., 2004) and whether it was dependent on 
XBP1, we used wild-type (CONi) and RAW264.7 macrophages deficient for XBP1 
(XBP1i) (Fig. A.3). Consistent with previous reports, Atf3 expression was highly 
induced upon Tg treatment (Fig. A.9A). Although we failed to observe any 
differences in basal Atf3 mRNA levels, ER stress-induced expression of Atf3 was 
severely blunted in XBP1i macrophages, demonstrating that induction of Atf3 
gene expression under canonical ER stress was dependent on XBP1 (Fig. A.9A). 
In further support of a role for XBP1s in Atf3 expression, XBP1s overexpression 
in HEK293T cells induced an Atf3 proximal 300 bp promoter activity in a 
luciferase reporter assay whereas XBP1u had no effect; ATF3 overexpression 
repressed its own promoter activity as previously reported (Fig. A.9B) (Wolfgang 
et al., 2000). Taken together, our data demonstrated that ATF3 may be a 
transcriptional target gene of XBP1s in macrophages upon ER stress.  
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Figure A.9.  XBP1 regulates Atf3 gene expression. 
(A) qPCR analysis of Atf3 gene expression in RAW264.7 macrophages stably 
expressing shRNA against control luciferase (CONi) or XBP1 (XBP1i) un-treated 
(CON) or treated with 300 nM Tg for 2 hr. Atf3 expression is drastically 
attenuated in XBP1i cells. * p < 0.05. (B) Luciferase activity of HEK293T cells 
transiently transfected with Atf3 promoter-luciferase construct (-295 to +46 bp 
relative to TSS) and XBP1u, XBP1s, or ATF3.  
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XBP1 and ATF3 form a complex 
 In a similar fashion as XBP1, ATF3 is a b-ZIP transcription factor that can 
homo- or hetero-dimerize with other transcription factors to allow for specificity 
in modulating gene expression (Hai and Hartman, 2001; Hai et al., 1989). 
Whether ATF3 acts as a positive or negative regulator of transcription may 
depend on its interactions with co-factors (Hai et al., 1999). However, in the 
context of regulating inflammation, ATF3 primarily serves as a repressor 
(Gilchrist et al., 2006; Hai et al., 2010; Suganami et al., 2009). Hence, we proposed 
that in response to canonical ER stress, ATF3 and XBP1 interact to coordinately 
activate inflammatory mediators by direct binding to their promoters. To this 
end, we first aimed to study the relationship between ATF3 and XBP1 proteins to 
delineate whether they can complex to jointly regulate inflammatory genes in 
macrophages.  
 To explore a potential interaction between XBP1 and ATF3, we 
overexpressed HA-tagged ATF3 and Flag-tagged XBP1 in HEK293T cells, 
immunoprecipitated with HA-agarose beads and probed for XBP1. Indeed, an 
interaction between ATF3 and XBP1 was detected only when both proteins were 
overexpressed (Fig. A.10A). Interestingly, ATF3 interacted with both XBP1u and 
XBP1s proteins (Fig. A.10A). Although this observation may not be 
physiologically relevant as XBP1u is highly unstable and rapidly degraded, this 
may provide insight into the interacting domains of ATF3 and XBP1 as the only 
shared overlapping regions between XBP1u and XBP1s are N-terminal of the 
splice site and inclusive of the DNA binding domain (Fig. A.10B).  
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Figure A.10.  ATF3 and XBP1 can form a complex.  
(A) HEK293T cells transiently transfected with Flag-tagged XBP1u or XBP1s and 
HA-tagged ATF3 were immunoprecipitated with HA-agarose and 
immunoblotted for XBP1. Both XBP1u and XBP1s can interact with ATF3. (B) 
Schematic of mouse XBP1s and XBP1u proteins depicting the various domains 
and IRE1α splice site. Upon ER stress-induced splicing of 26 nucleotides from the 
Xbp1u mRNA, Xbp1s mRNA encodes a C-terminal transactivation domain absent 
from XBP1u. As XBP1s and XBP1s both appear to be able to interact with ATF3, 
the interacting domain of XBP1 is likely to be N-terminal to the splice site such as 
the conserved leucine zipper domain.  
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Figure A.11.  Working model of XBP1 in ER stress and inflammation.  
A previous report by Martinon and colleagues showed that LPS-TLR2/4 
signaling activated the IRE1α-XBP1 pathway to govern the expression and 
secretion of key pro-inflammatory mediators. In this study, we examined the role 
of canonical ER stress in macrophages. From our data, we propose a model in 
which canonical ER stress activates IRE1α-XBP1s signaling in macrophages. 
XBP1s protein transcriptionally activates ATF3, a stress-inducible protein and 
important modulator of immune responses in many immune cell types including 
macrophages. XBP1s and ATF3, both b-ZIP transcription factors, act in 
conjunction to regulate a subset of critical inflammatory genes in response to 
canonical ER stress.  
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A.5 FUTURE DIRECTIONS 
 Here, we show that in murine macrophages, there exists a complex 
regulatory network underlying activation of the IRE1α-XBP1 pathway and 
inflammation. A previous study reported selective activation of the IRE1α-XBP1 
pathway in response to LPS and TLR2/4 signaling (Martinon et al., 2010). 
However, the impact and consequence of canonical activation of IRE1α-XBP1 by 
ER stress were not addressed. In this study, we showed that both ER stress and 
LPS induced the expression of key inflammatory mediators in macrophages with 
striking overlap and similarity in target gene identity (Fig. A.11). Our gene 
expression profiling demonstrated that the presence of XBP1 is required to 
mediate the expression of critical inflammatory mediators in macrophages. 
Strikingly, ER stress-induced genes in macrophages were 89% dependent on 
XBP1 whereas LPS only exhibited 20% dependency. This distinction in XBP1 
dependency suggests different underlying mechanisms regulating LPS and Tg-
induced inflammation. However, both treatments contained a similar percentage 
of induced genes containing an XBP1 binding motif in their proximal promoters; 
this enrichment reached statistical significance relative to a background level of 
XBP1 binding motifs observed in the genome. Mechanistically, XBP1 was 
required for ER stress-dependent induction of ATF3, a critical mediator of 
inflammation in many immune cell types. We showed that Atf3 expression was 
attenuated in the absence of XBP1 and XBP1s trans-activated an Atf3 promoter-
construct. Furthermore, ATF3 and XBP1, both b-ZIP transcription factors, 
interacted in an overexpression immunoprecipitation assay. We propose a 
working model in which IRE1α-XBP1 activation by canonical ER stress 
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modulates key inflammatory factors through regulation and interaction with 
ATF3 (Fig. A.11).  
 Our observations present many possibilities and warrant future studies to 
determine how ER stress and IRE1α-XBP1 signaling may influence inflammation 
in macrophages. First, all of the studies presented here were performed in a 
macrophage cell line RAW264.7. In order to characterize the physiological 
relevance of these signaling events and to determine whether they can be 
recapitulated in vivo, we must turn to animal models or primary cell culture 
models including bone marrow-derived or peritoneal macrophages. Next, an 
extensive characterization of the interplay and cross-communication between 
TLR2/4- and ER stress-dependent IRE1α-XBP1 activation is required. 
Outstanding questions that remain include what are the signals induced by LPS-
TLR2/4 that contribute to IRE1α-XBP1 activation and how does TLR2/4 
communicate with UPR. Presumably, LPS activation of the IRE1α-XBP1 pathway 
is not directly related to protein misfolding as the downstream outputs are very 
different from that of canonical UPR signaling (Fig. A6).  
 In addition, to understand how ATF3 as a transcriptional repressor and 
XBP1 as an activator of inflammation can influence inflammatory gene 
expression, we need to investigate and compare the trancriptomes regulated by 
both to determine whether these two b-ZIP transcription factors can jointly 
modulate a unique subset of inflammatory mediators in macrophages. Lastly, the 
observation that a similar percentage of genes induced under either condition 
contained XBP1 binding motifs in their proximal promoters was very intriguing 
in light of their difference in XBP1 dependency. Only by addressing these critical 
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questions can we gain a more comprehensive understanding of the complex 
relationship between ER stress, IRE1α-XBP1 signaling and inflammation. 
 Previous reports linking canonical UPR activation and inflammation have 
attributed the cross-talk to be mediated through NF-κB or AP-1. Phosphorylation 
and degradation of IκB by IκB kinase (IKK) promoted NF-κB activation by 
allowing this transcription factor to enter the nucleus and transcriptionally 
induce classical pro-inflammatory gene expression (Bonizzi and Karin, 2004). 
AP-1 is also a transcription factor that can heterodimerize with members of the 
JUN, FOS and ATF families to specify the types of genes regulated (Eferl and 
Wagner, 2003). AP-1 targets that have been reported include TNF, IL-8 and other 
cytokines (Angel et al., 2001). Activated IRE1α interacting with TRAF2 can 
activate IκB kinase (IKK), which as described above results in nuclear 
translocation and activation of NF-κB and its pro-inflammatory targets (Hu et al., 
2006; Urano et al., 2000). Furthermore, IRE1α signaling can intersect with AP-1 
through the IRE1α-TRAF2-JNK complex. JNK engagement leads to 
phosphorylation AP-1 (Garg et al., 2012). Despite these advances, the 
physiological implications and underlying mechanisms of these findings are 
unknown. Given that some of the pro-inflammatory target genes identified from 
our microarray can also be regulated by NF-κB, additional studies delineating 
the interplay between these pathways are essential. Particularly interesting 
questions are whether IRE1α activation by canonical ER stress can initiate two 
parallel pathways (i.e. TRAF2-JNK interaction and XBP1s-ATF3) to mediate an 
inflammatory response, what are the transcriptional targets of each pathway and 
	  164	  	  
how much overlap, if any, do they share, and whether ATF3 can jointly and 
differentially mediate inflammatory gene expression in response to diverse 
stimuli with various transcription factors such as XBP1 vs. AP-1.   
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APPENDIX B 
IRE1α  UNDERGOES ER STRESS-DEPENDENT PHOSPHORYLATION  
AT A UNIQUE “SSPS” MOTIF 
 
 
B.1 ABSTRACT 
 Disruptions in ER homeostasis lead to activation of the unfolded protein 
response (UPR) and have been linked to a number of human diseases collectively 
called conformational disorders. To maintain equilibrium in the ER lumen, ER-
to-nucleus signaling pathways have evolved that engage both transcriptional 
and translational responses. A key mammalian sensor of ER homeostasis is 
IRE1α. Although the general sequence of events in IRE1α activation has been 
resolved, the precise mechanistic details remain unknown. Here, we identify a 
novel post-translational motif on the IRE1α protein that may be required for its 
phosphorylation and activation. Tandem mass spectrometry identified a “SSPS” 
domain located on the linker cytosolic region of IRE1α that was heavily 
phosphorylated under ER stress. The “SSPS” site is conserved among mammals, 
suggesting a functional role for this motif in IRE1α trans-autophosphorylation. 
Thus, we propose that IRE1α activation upon ER stress requires phosphorylation 
at a unique and conserved “SSPS” motif, which may be an initiating event in the 
phosphorylation cascade.  
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B.2 INTRODUCTION 
 Protein misfolding in the ER activates the unfolded protein response 
(UPR). The most well-conserved signaling branch of UPR is the IRE1α-XBP1 
pathway (Calfon et al., 2002). Upon sensing alterations in ER homeostasis either 
through direct binding of misfolded proteins or indirect dissociation of the ER 
chaperone GRP78/BiP, IRE1α activation occurs through dimerization, trans-
autophosphorylation, oligomerization, and activation of its cytosolic RNase 
domain (Ron and Walter, 2007; Walter and Ron, 2011). However, the exact 
mechanistic details underlying mammalian IRE1α activation remain unclear. 
Several reports have provided some mechanistic insight into IRE1α activation 
and signaling by demonstrating that IRE1α regulation can occur in a cell or 
tissue-specific manner by its interaction with various co-factors, both activating 
and inhibitory (Hetz and Glimcher, 2009; Woehlbier and Hetz, 2011). 
Identification of these co-factors has provided valuable insight into how IRE1α 
may communicate and engage in cross-talk with other signaling pathways such 
as apoptosis and autophagy (Woehlbier and Hetz, 2011). In addition to co-
factors, another avenue of regulation commonly occurs through post-
translational modifications. Supporting this notion, IRE1α trans-
autophosphorylation is well-accepted to be a key activating step (Ron and 
Walter, 2007; Walter and Ron, 2011). Furthermore, yeast studies on IRE1p have 
identified two neighboring serine residues, Ser840 and Ser841, located in the 
activation loop of the kinase domain to be critical for the trans-
autophosphorylation activity of yeast IRE1p (Sicheri and Silverman, 2011). 
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However, no comprehensive characterization of mammalian IRE1α post-
translational modification and specifically phosphorylation sites has been 
performed.   
 To gain a comprehensive and mechanistic understanding of IRE1α 
signaling, activating and regulation, we turned to tandem mass spectrometric 
(MS/MS) analyses of mammalian IRE1α protein. In addition to uncovering and 
characterizing novel IRE1α-interacting factors such as NMIIB as described in 
Chapter 3, we also aimed to examine the post-translational status of IRE1α 
protein and whether and how this changed in response to ER stress. To this end, 
we performed mass spectrometry analysis in collaboration with Dr. Xuemei Han 
from the Yates Lab at Scripps Research Institute to identify phosphorylation sites 
as well as determine the individual and joint contribution of these site(s) to 
overall IRE1α trans-autophosphorylation and activation.  
 
B.3 MATERIALS AND METHODS 
Cell lines and drug treatment 
IRE1α-/- and wild-type control MEFs (gifts from Dr. L. Glimcher, Weill Cornell) 
were maintained in DMEM supplemented with 10% FBS (Hyclone) and 1% 
penicillin/streptomycin (Cellgro). Tg was acquired from EMD Calbiochem.  
 
Plasmids and transfection 
pMSCV-IRE1α-HA encoding WT human IRE1α was generously provided by Dr. 
C. Hetz (University of Chile).  
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IRE1α  immunopurification and mass spectrometry 
IRE1α-/- MEFs stably expressing human pMSCV-IRE1α-HA were treated with 
300 nM Tg for 2 hr. Cells were harvested in lysis buffer (150 mM NaCl, 1% Triton 
X-100, 1 mM EDTA, and 50 mM Tris HCl pH 7.5) supplemented with protease 
inhibitor cocktail (Sigma) and allowed to lyse on ice for 20 min. Cells were 
sonicated 10 s with Branson Digital 250 Cell Disruptor at 10% amplitude 
followed by centrifugation. Supernatant was immunprecipiated overnight at 4°C 
with HA-agarose beads followed by washes the next day and immunoprecipitate 
was loaded on a 6% polyacrylamide SDS-PAGE gel. Gel was incubated with 
Coomassie Brilliant Blue (0.5 g Coomassie Brilliant Blue R-250 in 450 ml 
methanol, 450 ml MQ water, and 100 ml acetic acid) with gentle rocking for 30 
min at room temperature followed by 2 washes with MQ water 5 min each. Gel 
was destained in destaining solution (45% methanol, 45% MQ water, and 10% 
acetic acid) that was changed every 30 min until bands could be clearly 
visualized. Protein bands were excised from Coomassie-stained gels and 
destained, and subjected to an in-gel trypsin digestion. Peptide mixtures were 
analyzed by online nanoflow liquid chromatrography tandem mass 
spectrometry (LC-MS/MS) on an Agilent 1200 quaternary HPLC system 
(Agilent, Palo Alto, CA) connected to an LTQ-Orbitrap mass spectrometer 
(Thermo Fisher Scientific) through an in-house built nanoelectrospray ion source.  
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B.4 RESULTS AND DISCUSSION 
IRE1α  is phosphorylated at a unique “SSPS” motif upon ER stress 
 Human IRE1α is a 977 amino acid type 1 ER transmembrane protein with 
multiple functional domains (Fig. B.1). The N-terminal domain resides in the ER 
lumen and contains an MHC-like region believed to be involved in direct 
binding of misfolded proteins. This is followed by a transmembrane region that 
tethers the IRE1α protein to the ER membrane. C-terminal of the transmembrane 
domain lies a short linker, kinase, and RNase regions. The kinase domain 
promotes trans-autophosphorylation of adjacent IRE1α proteins, a critical event 
in IRE1α activation upon ER stress. As yeast IRE1 protein has been reported to be 
extensively phosphorylated, the same has been speculated for mammalian 
IRE1α. However, outstanding questions such as the exact residue(s) and the 
individual contribution of each phosphorylation site to overall IRE1α activation 
and signaling remain unknown.  
 In an attempt to resolve IRE1α post-translational modification sites, we 
performed a mass spectrometry analysis of IRE1α in collaboration with Dr. 
Xuemei Han in the laboratory of Dr. John Yates at The Scripps Research Institute 
and obtained over 81% overall coverage of the human IRE1α protein (Fig. B.1). 
Surprisingly, our mass spectrometry only identified a few sites of 
phosphorylation, including a unique “SSPS” motif located in the linker region 
(Fig. B.2). Upon treatment with thapsigargin (Tg), a potent ER stress inducer, 
IRE1α phosphorylation occurred simultaneously at two and even all three of the 
Ser residues on the SSPS motif, suggesting that extensive phosphorylation at this 
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motif is ER stress-dependent (Fig. B.2). Alignment using the DNA Strider 
software demonstrated that this motif was highly conserved within mammalian 
IRE1, including the gut-specific IRE1β protein (Fig. B.3).  
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Figure B.1.  Schematic of human IRE1α  protein and its functional domains.  
Human IRE1α protein is depicted to scale with numbers 1-977 denoting the 
respective amino acids. Mass spectrometric analysis with the Yates Lab identified 
a unique “SSPS” motif at amino acids 548 to 551 in the linker region undergoing 
di- or tri-phosphorylation upon ER stress. Lines beneath indicate peptides 
recovered from mass spectrometry with 81.2% overall coverage.  
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Figure B.2.  Peptides recovered from mass spectrometry depicting ER stress-
induced IRE1α  phosphorylation sites.  
IRE1α-/- MEFs stably expressing HA-tagged human IRE1α were untreated or 
treated with 300 nM Tg (ER stress agent) for 2 hr, immunoprecipitated with HA-
agarose beads and lysates were run on a gel. Coomassie Blue staining revealed 
the IRE1α band at approximately 110 kDa, which was excised and submitted to 
our collaborator Dr. Xuemei Han in the Yates lab for MS/MS analysis of 
phosphorylation sites. Peptides recovered demonstrate mono-, di- and tri-
phosphorylation at the SSPS (amino acids 548-551) motif as well as additional 
unique serine (Ser527, Ser 562) and threonine (Thr561) phosphorylation sites.  
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Figure B.3.  SSPS is a conserved motif in mammalian IRE1α .  
Sequence alignment of IRE1 protein from amino acids 521 to 565 in human, 
mouse and rat using the DNA Strider software. Gray shaded boxes indicated 
conserved amino acid. Arrows and numbers indicate the serine or threonine 
residue identified by MS/MS as an ER stress-dependent phosphorylation site.  
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B.5 FUTURE DIRECTIONS 
 Further studies are warranted to follow up on this exciting but 
preliminary observation. First and foremost, Quick-change mutagenesis assays 
will be performed to determine the functional significance of phosphorylation at 
this motif. As the MS/MS analysis demonstrated that tri-phosphorylation at 
SSPS can occur upon ER stress and in an attempt to study the most exaggerated 
mutant, we will first mutate all three Ser residues (SSPS) to either Ala (AAPA) to 
generate a loss-of-function mutant or to Asp (DDPD) to generate a gain-of-
function/phospho-mimetic mutant, transfect the plasmids into IRE1α-/- MEFs 
and perform Phos-tag based Western blot analyses of IRE1α phosphorylation. 
Additional markers of IRE1α activation and signaling will also be examined. 
These include molecular and biochemical studies of canonical UPR and ER stress 
markers such as IRE1α foci formation, Xbp1 mRNA splicing, XBP1s protein 
production, Q-PCR analysis of UPR target genes including chaperones and 
degradation components, and IRE1α-mediated mRNA decay. We predict that 
the AAPA triple loss-of-function mutant will display defective IRE1α 
phosphorylation and that the DDPD phospho-mimetic mutant will exhibit an 
increase in basal IRE1α phosphorylation. However, if basal phosphorylation 
does not occur in the DDPD mutant, then additional ER stress signals are 
required for IRE1α activation.  
 Next, we will also determine the effect of the SSPS motif of IRE1α on its 
biological and physiological parameters including cell fate determination 
(survival, proliferation, apoptosis) and ER stress-dependent ER expansion. 
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Furthermore, generation of single and combinatorial double mutants is required 
to precisely characterize the requirement and importance of each serine residue 
to IRE1α signaling. In addition to identification of peptides with tri-
phosphorylation of SSPS, peptides containing mono- or di-phosphorylation were 
also present (Fig. B.2). Therefore, studies using single and double 
phosphorylation mutants will be essential in delineating the individual as well as 
collective contribution of each residue to IRE1α regulation. To truly understand 
the physiological significance of this motif, a knock-in mouse model using the 
AAPA motif can be generated and used for metabolic and ER stress studies. 
Overall, these studies will provide a comprehensive and thorough examination 
of the physiological importance of the SSPS motif on IRE1α phosphorylation and 
signaling.  
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APPENDIX C∗ 
PUTATIVE IRE1α-INTERACTING PROTEINS IDENTIFIED BY  
MASS SPECTROMETRY 
 
C.1 INTRODUCTION 
 As previously discussed in Chapter 3, a proteomic screen on IRE1α was 
performed in collaboration with Xuemei Han in the Yates Lab (Scripps Research 
Institute) to identify potentially new IRE1α-interacting partners that may play a 
functional role in its activation, regulation and signaling. The mechanistic, 
functional and physiological role of one of the interactors, non-muscle myosin 
IIB (NMIIB), was characterized in response to ER stress (Chapter 3). However, 
other putative interacting partners were also extracted from the study. Listed in 
Table C.1 are five additional factors that are putative binding partners of IRE1α 
identified by tandem mass spectrometry (MS/MS).  
  
C.2 RESULTS AND DISCUSSION 
 Briefly, IRE1α-/- MEFs stably expressing human pMSCV-IRE1α-HA were 
non-treated or treated with 300 nM Tg for 2 hr. Cells were harvested, lysed and 
immunoprecipitated with HA-agarose beads. Lysates were processed by 
Western blot and gel was stained with Coomassie Brilliant Blue. The IRE1α-HA 
bands from both non-treated and ER stress conditions were excised and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
∗ This appendix is associated with Chapter 3 on uncovering novel IRE1α-interacting 
factors by using tandem mass spectrometry.  
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submitted for tandem mass spectrometry (see Chapter 3 for a detailed protocol). 
MS/MS identified peptides that were then mapped to proteins, representing 
potential IRE1α-interacting factors that may regulate its activation and signaling.  
These factors, along with their putative functions as characterized on UniProt, 
are listed in decreasing order of number of peptides recovered (Table C.1).  
 Interestingly, although most of these proteins are not very well 
characterized, their putative functions span several different biological processes 
including mRNA splicing, nucleosome remodeling, helicase activity, and 
nonsense-mediated decay. As our goal is to identify regulators of IRE1α, we 
further examined the number of peptides recovered from non-treated cells 
compared to cells exposed to ER stress (Table C.2). Surprisingly, the majority of 
the potential interacting factors segregated and were either enriched in control 
(CON) or ER stress (Tg) conditions. For example, the top hit, SF3B3 was highly 
enriched for control non-stress conditions whereas the next hit, FARP1, was 
enriched for ER stress conditions. These results indicated that our screen may 
have identified both negative and positive regulators of IRE1α. Recent insight 
into the IRE1α interactome (see Chapter 1) show that negative regulators bind to 
IRE1α to maintain it in an inactive conformation and dampen its signaling 
whereas activators bind to IRE1α under ER stress to promote and enhance its 
signaling. Hence, further analysis of these putative regulators are required to 
understand their functional and physiological roles in ER stress and UPR 
signaling. 
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Table C.1. Putative IRE1α-interacting factors.  
Candidate binding partners of IRE1α and their putative functions are listed. 
Please refer to text for discussion regarding how these factors may potentially 
regulate IRE1α activation and signaling.  
 
 
UniProt 
ID Identification Putative function 
Q15393 SF3B3 (Splicing factor 3B subunit 3) mRNA splicing/processing 
Q9Y4F1 FARP1 (FERM, RhoGEF and pleckstrin domain-containing protein 1) 
Rho-guanine nucleotide 
exchange factor 
Q9P2R3 ANKFY1 (Ankyrin repeat and FYVE domain-containing protein 1) Metal ion binding 
O60264 
SMARCA5 (SWI/SNF-related matrix-
associated actin-dependent regulator 
of chromatin subfamily A member 5) 
Helicase with ATP-
dependent nucleosome-
remodeling activity 
Q92900 UPF1 (Regulator of nonsense transcripts 1) 
RNA-dependent helicase and 
ATPase required for 
nonsense-mediated decay 
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Table C.2. MS/MS peptide recovery for potential IRE1α-binding partners.  
MS/MS data for these factors were analyzed for the number of peptides 
recovered under basal non-stress conditions (CON) or when treated with a drug 
to induce ER stress (Tg).  
 
 
 
 
Identification # CON peptides # Tg peptides 
SF3B3 8 1 
FARP1 0 8 
ANKFY1 3 2 
SMARCA5 1 3 
UPF1 0 2 
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 In light of the role of IRE1α in splicing Xbp1 and other mRNAs and even 
potentially microRNAs under ER stress, SF3B3 and its association with the 
spliceosome machinery is an intriguing discovery. Even more surprising is that 
the interaction between IRE1α and SF3B3 appears to be enriched under basal 
conditions, suggesting that SF3B3 may be functioning to suppress IRE1α 
activation or maintaining IRE1α in an inactive monomeric conformation. An 
alternative possibility could be that SF3B3 is acting as an adaptor or scaffolding 
protein to facilitate the recruitment of other IRE1α-binding factors. FARP1 is a 
putative Rho-guanine nucleotide exchange factor (GEF) that activates small 
GTPases, which integrate into various cellular signaling pathways. It is 
interesting to note that one of the primary downstream targets of PERK 
activation, phosphorylation of eIF2α, regulates the GEF eIF2B. eIF2α 
phosphorylation prevents eIF2B GEF activity, resulting in attenuated protein 
synthesis. Understanding how FARP1 may integrate into IRE1α signaling may 
identify new cellular pathways that are responsive to ER stress and communicate 
with UPR. SMARCA5 is a nucleosome-remodeling factor with helicase and 
ATPase activity, and enriched for complexing with IRE1α upon ER stress. 
Nucleosome-remodeling factors typically act in concert with transcription factors 
to remodel the chromatin in preparation for transcription. XBP1s is one of the 
primary downstream targets of IRE1α signaling and an essential UPR 
transcription factor. The interaction between IRE1α and SMARCA5 may shed 
light on a new role for IRE1α in direct modulation of the chromatin landscape in 
response to ER stress to induce UPR genes. In addition to promoting Xbp1 
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splicing and generating XBP1s, IRE1α may participate in transcriptional 
regulation through the action of SMARCA5. Lastly, UPF1 is part of a multimeric 
protein complex involved in mRNA surveillance and non-sense mediated decay 
(NMD) that targets mRNAs containing premature stop codons for degradation. 
This role is reminiscent of IRE1α-mediated mRNA decay (RIDD) that functions 
to alleviate an elevated burden on the ER during ER stress by cleaving target 
mRNAs. Even though only two peptides were recovered that mapped to UPF1, 
both were specific to Tg-induced ER stress. Hence, this may suggest a potential 
role for UPF1 in RIDD. As the mechanistic details of RIDD remain elusive, 
elucidating how UPF1 incorporates into IRE1α signaling and function could 
provide key insight into RIDD. Notably, ATF4, a downstream transcription 
factor of PERK pathway, has been reported to be a target of NMD, further 
reinforcing the notion that cross-talk could occur between UPR and NMD 
regarding ER capacity and status, and to coordinate incoming ER load. In 
conclusion, this proteomic screen on IRE1α-interacting factors has yielded 
several exciting and promising candidates whose functions span from mRNA 
processing and surveillance to chromatin remodeling. Future investigations into 
how these factors modulate and integrate into IRE1α signaling will greatly 
enhance our understanding of IRE1α function.  
 
C.3 FUTURE DIRECTIONS 
The preliminary data presented here on putative IRE1α-interacting 
partners, though exciting and encouraging, requires further validations. First, 
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biochemical verification of a bona fide interaction between IRE1α and these 
factors are required. Along these lines, it would be interesting to note whether 
the interaction is indeed dependent on ER stress and if so, whether the 
interaction diminishes or increases with escalating ER stress. Of note, these 
experiments can also help us to assess the accuracy and sensitivity of our 
MS/MS experiment. The next step after validating the interaction would be to 
determine whether these factors exert a functional influence on IRE1α signaling, 
either positive or negative, by employing both gain- and loss-of-function 
approaches (see Chapter 3). Given the high concentration of factors in the cellular 
milieu, many proteins can appear to “interact” but lack functional significance. 
Finally, the in vivo physiological significance of these factors will be assessed by 
using mouse models. All together, investigating and establishing the functional 
and biological role of these factors in IRE1α signaling and UPR will be essential 
in obtaining a comprehensive and mechanistic view of mammalian IRE1α 
activation, regulation and signaling, and may identify novel targets for 
therapeutic development in the treatment of conformational diseases.  
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